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ABSTRACT
I. The Development of a General Strategy Towards Dimeric Hexahydropyrroloindole
Alkaloids. A Concise Total Synthesis of (+)-Chimonanthine, (+)-Folicanthine and (-)-
Calycanthine
An efficient and convergent strategy for the synthesis of dimeric hexahydropyrroloindole
alkaloids is described. The simultaneous formation of the vicinal quaternary stereocenters using
a reductive dimerization reaction provides gram-scale access to an optically active key
intermediate employed in the synthesis of (+)-chimonanthine, (+)-folicanthine, and (-)-
calycanthine.
II. The Development of a General Strategy Towards Dimeric Hexahydropyrroloindole
Alkaloids. A Concise Total Synthesis of (+)-WIN 64821, (-)-Ditryptophenaline and (-)-1'-
(2-Phenylethylene)-ditryptophenaline
The concise enantioselective total synthesis of (+)-WIN 64821 and (-)-ditryptophenaline
in six and seven steps, respectively, from commercially available amino acid derivatives is
described. The gram-scale synthesis of key intermediates and simultaneous introduction of the
vicinal quaternary stereocenters provides a highly effective and preparative synthesis of these
natural alkaloids. Additionally, the synthesis and structural confirmation of the natural alkaloid
(-)-1 '-(2-phenylethylene)-ditryptophenaline is described.
III. N-Heterocyclic Carbene-Alcohol Hydrogen Bonds. Studies and Application in the
Amidation of Unactivated Esters
A single-step and catalytic amidation of unactivated esters with amino alcohols is
described. Treatment of equimolar quantities of amino alcohols and unactivated esters with N,N-
bismestiylimidazolylidene (5 mol%) affords the desired amides in high yield under mild reaction
conditions. The compatibility of the present methodology with a wide range of functional
groups, heterocycles, and optically active substrates in addition to both aromatic and aliphatic
esters is noteworthy. Preliminary data regarding an unprecedented hydrogen-bonded
carbene-alcohol complex is reported. Further investigation of this hydrogen bond revealed steric
and electronic influences on the nature of this bond, cumulating in discovery of a practical metal
free method for the stabilization and storage of these nitrogen heterocyclic carbenes. Also
described is a method for the synthesis of optically active imidazo-[1,5-a]-pyridinium salts as
precursors to optically active nitrogen heterocyclic carbenes.
Thesis Supervisor: Professor Mohammad Movassaghi
Title: Assistant Professor of Chemistry
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The Development of a General Strategy Towards Dimeric
Hexahydropyrroloindole Alkaloids. A Concise Total Synthesis of (+)-
Chimonanthine, (+)-Folicanthine and (-)-Calycanthine
Introduction and Background
The rich history of dimeric hexahydropyrroloindole alkaloids can be traced back to the
late 1880's in the southern United States. Hundreds of sheep and cattle died as the result of
grazing on the shrub Calycanthus glaucus.' In 1888, Eccles isolated the active component from
these shrubs, the alkaloid (+)-calycanthine (1).2 The correct determination of the structure of
calycanthine would wait almost seventy years until R. B. Woodward addressed this problem
using a variety of methods including chemical degradation.3 Contemporaneously the structure of
(+)-calycanthine (1) was secured by X-ray diffraction analysis, consistent with Woodward's
proposed structure.4
A striking structural feature of calycanthine is the presence of vicinal quaternary
stereocenters adjacent to two aminals (C3a-C3a', sp3-sp3). This structural motif can be seen in
many other natural products such as (+)-chimonanthine (2)5, (+)-folicanthine (3)5, and dozens of
other dimeric hexahydropyrroloindole derived alkaloids. A related and large subset of the
bisindole super family of alkaloids contain a diketopiperzaine fused to the
hexahydropyrroloindole substructure as seen by the representative derivatives such as (+)-WIN
64821 (4),6 (+)-chaetocin (5),7 and (+)-11,11 l'-dideoxyverticillin A (6).8 Another closely related
group of alkaloids contain two or more hexahydropyrroloindole substructures with an additional
interesting C3a-C7' (sp3_sp 2) connectivity as seen in (-)-idiospermuline (7)9 and (-)-psycholeine
(8) (Figure 1).10
Me R











i = OH, (+)-Chaetocin A (5) 3a "" rl(+)-11,11 '-Dideoxyverticillin A (6) N "N
•A g •An (-)-Psycholeine (8)(-)-Idiospermuline (7)




In the early 1950's, a hypothesis regarding the biosynthesis of calycanthaceous alkaloids
was developed independently by Woodward3 and Robinson (Scheme 1)." A series of structure
elucidation studies revealed that (+)-calycanthine (1) and (-)-chimonanthine (2) were isomers
arising from the rearrangement of their respective N,N-aminal substructures (Scheme 1).
Alkaloids 1 and 2 represent only two of five aminal-arrangement products possible for the
hypothetical intermediate 13. Indeed, several alkaloids containing the other possible
arrangements have been isolated. 12 Intermediate 12 is believed to come from a dimerization of
tryptamine (9) through the intermediacy of the corresponding oxidation product, benzylic radical
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Scheme 1. Woodward's and Robertson's hypothesis for the biosynthesis of the calycanthaceous alkaloids.
In 1969, Kirby provided experimental evidence for the incorporation of isotopically
labeled precursors into (-)-chimonanthine (2, Scheme 2).13 The results of these feeding
experiments using doubly labeled tryptamine 14 and racemic tryptophan 15 are consistent with
the oxidative dimerization hypothesis outlined in Scheme 1 for the biosynthesis of
calycanthaceous alkaloids.
TrT t mhn R H (1)
1
RNH2  Chimonanthus
S 3H fragrans (praecox)
H
14, R=H 14r
15, R =CO 2H 16
Scheme 2. Feeding experiments using isotopically labeled tryptophan and tryptamine.
Previous Synthetic Studies
Several synthetic studies in the 1960's were focused on the total synthesis of
chimonanthine (2). These early routes benefited from the biosynthetic hypothesis described by
Woodward and Robinson and focused on the oxidative homodimerization of two suitable indole
or oxindole precursors. In 1962, Hendrickson reported the total synthesis of racemic and meso
chimonanthine (2) by the homodimerization of an oxindole derivative 17 (Scheme 3).14 The
vicinal quaternary centers were formed by treating oxindole 17 with excess sodium hydride
followed by the slow addition of iodine in benzene to afford a separable mixture of the two
diastereomeric dimers (±)-18 and meso-18 in 21% combined yield. Exhaustive reduction of each
diastereomer with excess lithium aluminum hydride afforded (±)- and meso-chimonanthine (2) in














(±)-2, 3 % meso-2, 6 %
Scheme 3. Henderickson's synthesis of the chimonanthines. Conditions: a) NaH, I2, THF, PhH. b) LiAlH 4, THF.
Shortly after the Hendrickson synthesis of chimonanthine, Hino reported a synthesis of
folicanthine15 (3) in racemic form through a stepwise introduction of the vicinal quaternary
centers (Scheme 4). Bisoxindole 19 was alkylated two times with chloroacetonitrile in the
presence of sodium iodide to afford the corresponding bisnitrile that was reduced to the
corresponding bisamine 20 with platinum(IV) oxide and dihydrogen. The diamine 20 was
converted to a bisphenylimine derivative, N-alkylated with methyl iodide to afford the
corresponding bisiminium diiodide, and subsequently hydrolyzed to afford the N-methyl amine
21. Reduction of the bisoxindole 21 with lithium aluminum hydride gave folicanthine (3) in
racemic form (Scheme 4, yield not reported). The stereochemistry of this synthetic folicanthine
was assigned as racemic as "the infrared spectrum in carbon tetrachloride solution
superimposable with that of natural folicanthine". 15c
a,b
(+)-3 21
Scheme 4. Hino's synthesis of (±)-folicanthine (3). Conditions: a) CICH2CN, K2CO 3, Nal. b) PtO2, H2, AcOH,
30 % two steps. c) imine formation; Mel, 100 "C; HCl, H20, yield and specific conditions not given. d) LiAlH 4,
1,4-dioxane, yield not given.
In 1964, Scott, McCapra, and Hall reported an elegant and highly concise total synthesis
of chimonanthine taking full advantage of the oxidative dimerization strategy mentioned above
and simply starting with N-methyl tryptamine (22).16 Treatment of compound 22 with methyl
magnesium iodide in diethyl ether provided the corresponding Grignard salt that was rapidly
oxidized upon treatment with ferric chloride. The oxidation of the Grignard salt resulted in the
oxidative coupling and C-C bond formation to afford 19% yield of (±+)-chimonanthine (2) along
with 7% yield of meso-chimonanthine (2, Scheme 5). This single-step ferric chloride promoted
oxidative dimerization of tryptamine derivatives to the desired chimonanthines provided a rapid
entry to these dimeric alkaloids and further highlighted the challenges associated with
stereochemical control in synthesis of the vicinal quaternary stereogenic centers.
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Scheme 5. Scott, McCapra and Hall's elegant synthesis of chimonanthines.
In a related approach, Takayama reported a synthesis of chimonanthines utilizing
hypervalent iodine reagents (Scheme 6). 17 Dimerization of N-methoxycarbonyl tryptamine (25)
with phenyliodine bis(trifluoroacetate) (PIFA) in 2,2,2-trifluoroethanol (TFE) afforded a mixture
of the racemic carbamate 26 and meso-carbamate 26. Reduction of these methyl carbamates
with Red-Al afforded chimonanthine (2) in racemic form along with meso-chimonanthine (2) in
13% and 30% yields, respectively (Scheme 6). In a similar manner, Verotta reported the use of
thallium(III) trifluoroacetate as the oxidant in this type of dimerization reaction.'8 The use of a
trypamine substrate adorned with a chiral auxiliary enabled them to access optically active
derivatives after chromatographic separation of diastereomers.
HNHCO 2Me H N
RN R=CO 2Me, (±)-26 ba R=Me, (±)-2, 13% 2b
R=CO 2Me, meso-26HN NR R=Me, meso-2, 30% b
25 HN HH
Scheme 6. Takayama's synthesis of the chimonanthines. Conditions: a) PIFA, TFE. b) Red-Al, PhMe.
In 1994, Rodrigo described a related approach for the synthesis of racemic folicanthine
(3) by oxidative dimerization of an oxindole-derived enolate (Scheme 7).'9 Treatment of the
anion of oxindole 27 with carbon tetraiodide afforded the racemic dimer 28 in 49-57% yield
along with 8% yield of meso-28. Folicanthine (3) was prepared in 14% yield and in racemic











(+)-3, 14% (±)-28, 49-57%
Scheme 7. Rodrigo's synthesis of (t)-folicanthine. Conditions: a) NaH, CI4.
Prior Enantioselective Synthesis
Overman reported the first enantioselective total synthesis of chimonanthine in 1999.2 "
This elegant synthesis relied on two intramolecular Heck reactions to secure the vicinal
quaternary stereocenters (Scheme 8). In this synthesis the enediamide 31 was prepared in six
steps from the tartaric acid derived diiodide 29 and the dimethyl butanedioate (30). The key
transformation proceeds via two intramolecular Heck cyclization reactions to sequentially secure
the two quaternary stereocenters and afford the bisoxindole 32 in 90% yield as a single
diastereomer. This beautifully designed transformation provided access to optically active and
advanced intermediates that were converted to chimonanthine through additional steps. As the
result of these studies Overman was also able to revise the absolute stereochemistry of this
natural product. Subsequently, the Overman group reported a second approach20b to these
molecules by utilizing an alkylation reaction as the key step. This approach relied on two
alkylation reactions of bisoxindole 34 with bistrifluormethanesulfonate 33 to sequentially
introduce the vicinal quaternary stereocenters. The careful choice of the counter ion was found
to be critical in controlling the stereochemistry of the product of this double alkylation reaction.
The bisoxindole 36 could be converted to (+)-chimonanthine (2) utilizing transformations related
to their earlier report.
Me Me
BnO OBn OM Me Me
SO0 M H N M
29 a 0eN'
+ MBn M,- Bn A, ...
I %N4 -IeIBnN
Me0 2C C0 2Me 0NBn .,NMe
30 31 / 32 H
Me Me Me Me
. - 'm I
OMITfO OTf b OLi MI
+ 33 , OTf 'NB n
OH HO NBn BnN -
BNnBnN OBnN NBn O
35 36 (+)-2
34
Scheme 8. Overman's enantioselective total syntheses of (-) and (+)-chimonanthine (2). Conditions: a) 10 mol %
Pd(PPh3 )2C12, Et3N, DMA, 100 oC, 90%. b) 2.1 equiv LiHMDS, THF, DMPU, -78 oC, 55%.
Results and Discussion
Early Synthetic Studies of Chimonanthine
The rapid assembly of the chimonanthine core structure utilizing and oxidative
dimerization strategy was clearly an exciting approach as illustrated more than four decades ago
in the Scott, McCapra, and Hall's single-step synthesis of chimonanthines. These reports
inspired our early approach toward the development of general and enantioselective syntheses of
these alkaloids. We hoped to address the challenges associated with enantioselective and
diastereoselective total synthesis of these alkaloids through the use of rationally designed
tethered substrates to bring together two tryptamine or tryptophan units. As the first set of
targets for our studies we chose the calycanthaceous alkaloids given the presence of their
substructure in many alkaloids in this large family of natural products.
Three scenarios were envisioned for our planed stereoselective synthesis: 1) the use of
optically active tethers with trypamine derivatives; 2) the use of achiral tethers with tryptophan
derivatives; and 3) identification of appropriate optically active tethers with tryptophan
I
#
derivatives to maximize substrate directed stereoselective introduction of the vicinal quaternary
stereocenters. The primary amine and the indolyl nitrogen of tryptophan and trypamine along
with the carbonyl of tryptophan were expected to serve as suitable attachment points for tethers
(Figure 2). We reasoned that if a suitable carbamate based linker (L2) was employed, it could be
removed after dimerization by a reduction step, converting the carbamate carbonyl into the
required methyl group found in the chimonanthines. The distance of the tether to the reactive
indole C3 position did pose a concern for control of stereochemistry. Linking two tryptophan
units together was considered beneficial owing to the resident chiral center. While a carbamate
linker (L2) could be used in conjunction with a tryptophan substrate, an ester (L3) linker could
offer an alternative point for the linker, particularly since the carbonyl groups would be removed
later. Lastly, we considered attachment of the tether to the indolyl nitrogen (L1). This would be
advantageous in that the tether would be closer to the reactive indole C3 center; however, at the
time the effect of nitrogen substituents on the hypervalent iodine promoted dimerization step was
uncertain.
0
3 N-L2 N-L 2
R \ R
N N
i, 36 L, 37
Figure 2. Substrates and points of attachment for tethers.
We first examined tryptamine units linked together through alkyl carbamates using the
primary amino group (i.e., 36, R and L,= H, L2= carbamate linker). We prepared carbamate
linked tryptamine dimers with simple alkyl linkers such as 1,4-"butyl, 1,4-(E)-2-butenyl, and
1,10-"decyl. Unfortunately, these tethered dimeric tryptamines were all insoluble under the
optimum conditions for hypervalent iodine mediated dimerization (PIFA, base, TFE, -40 'C),
resulting in little conversion to the desired dimerization products and mostly recovered starting
material. We reasoned that placement of additional heteroatoms in the linker would provide a
more practical tethering scheme. 21 The tethered tryptamine derivative 38 was one of the first
substrates to exhibit suitable solubility for the planned oxidative carbon-carbon bond formation.
Interestingly, exposure of substrate 38 to the optimum oxidation reaction conditions followed by
hydrolysis led to the unexpected C3a-C2' adduct 41 and not the desired C3a-C3a' adduct
(Scheme 9). The structure of compound 41 was determined through the analysis of a series of
2D-NMR spectroscopic data. Based on a range of circumstantial evidence available to us in the
context of these and related studies, the formation of compound 41 was best explained by a
plausible initial formation of the desired C3a-C3a' adduct 39 which was likely unable to undergo
aminal formation due to the presence of the linker, thereby allowing a competitive C3a' to C2'
migration to give product 40. Increasing the tether length by adding additional methylenes
between the amide and the ester group (from one methylene to three or five) did not prevent this






Scheme 9. Representative C-C bond formation with a tethered tryptamine substrate 38. Conditions: a) PIFA, 2-Cl-
pyridine, TFE, 16%, along with 36% recovered 38. b) KOH,, 31%.
We next envisioned the use of tethered tryptophan subunits to afford the desired C3a-
C3a' products by positioning the tether on the ester functional group so as to not tie back the
amino ethyl fragment. This also provides a more nucleophilic carbamate as compared to an
amide function group for trapping of the initial indolenine adduct (i.e., 39). Furthermore, we
were interested to see the extent of diastereoselection in the oxidative bond formation imposed
by the Ca-stereocenter of a tethered tryptophan substrate. With these parameters in mind we
prepared substrates such as 42 from readily available N-Boc L-tryptophan (Scheme 10).
Exposure of the tethered tryptophan derivative 42 to the optimum reaction conditions using PIFA
as the oxidant afforded a complex mixture of products. From this mixture the major product
could be isolated in only 16% yield. Hydrolysis of the major product with potassium hydroxide
-0
afforded a biscarboxylic acid that upon a series of NMR spectroscopic analyses, was found to be
consistent with the dimeric hexahydropyrroloindole derivative 43 containing the R,S
configuration at the vicinal quaternary stereocenters (Scheme 10).
H
BocN R
HOC CO2 HHO2C S .,NBoc
H
42 BocHN NH 43
Scheme 10. Representative C3a-C3a' bond formation with a tethered tryptophan substrate 42. Conditions: a) PIFA,
2-Cl-pyridine, TFE, 16%. b) KOH,, 93%.
With the successful use of the tethered carbamate 42 to access the desired C3a-C3a'
product seen in dimer 43, we turned our attention to tethered systems that could be engineered to
favor the desired R,R or S,S relative stereochemistry at the vicinal quaternary carbons. We next
explored tryptamine derived substrates tethered through the indolyl nitrogen with the pendant
carbamates free to intercept a plausible C-C coupled indolenine intermediate prior to the
undesired C3 to C2 rearrangement mentioned above. The closer proximity of the tether to the
indole C3 position was envisioned to impart greater stereochemical control in the dimerization
reaction. Two sets of substrates were prepared as represented by structures 44 and 45 in Figure
3. Substrate 44 was prepared by N-alkylation of the indolyl nitrogen with 1-iodo-3-
'butyldimethylsilyloxypropane followed by TBAF desilylation and linking of the resulting
primary alcohol with dichlorodiisopropylsilane. Substrate 45 was prepared in a similar fashion
with the exception of using a L-tartaric acid derivative as the electrophile.
NHCO2Me NHCO2Me
44 N 45
O Si'Pr 2  MeaM .
•  ~SiiPr 2
Figure 3. Representative indolyl tethered tryptamine derived substrates.
Oxidation of tether dimeric trypamine derivative 44 under optimum reaction conditions
with PIFA and subsequent treatment with TBAF afforded a 3:1 mixture of the C3a-C3a' meso-
46 and (±)-46 in only 7% combined yield (Scheme 11). The stereochemistry of the products was
rigorously confirmed by NMR experiments in addition to independent synthesis. Synthesis of
dimers (±)-26 and meso-26 using the Takayama protocol (vide supra)'7 and N-alkylation with
excess 3-'butyldimethylsilyloxypropanal and sodium triacetoxyborohydride followed by
desilylation of the alcohol with TBAF afforded authentic samples of diols (±)-46 and meso-46.
NHCO2Me HO.-.--\H N
a,b MeO2CN
C N i NCO2Me
44 ) SiiPr2  ,OH
7% (3:1, meso-46:(±)-46)
Scheme 11. C3a-C3a' bond formation with the tethered tryptamine substrate 44. Conditions: a) PIFA, 2-
Cl-pyridine, TFE. b) TBAF, THF, 7% (2 steps).
The low yield of the corresponding product when using substrate 45 (11% yield, of
oxidative C-C coupled product) was further complicated due to the failure of various attempts to
remove the tartrate based linking group owing to the sensitivity of the dimer to acidic and strong
oxidative conditions. The lowered efficiency observed with substrates 44 and 45 in these
intramolecular C-C bond forming reactions was due to the presence of the indolyl alkyl
substituents. This was illustrated further using the N-allyl and N-benzyl derived tryptamine
derivatives 47 and 48 (Scheme 12). The intermolecular oxidative coupling of these substrates
was less effective compared to related systems with no indolyl alkyl groups as described by
Takayama (Scheme 6). Upon treatment with PIFA under optimum conditions, the N-allyl and N-
benzyl substrates 47 and 48 afforded the corresponding C-C coupled dimer in only 4% and 3%
yield, respectively, as a mixture of diastereomers. In the case of hexacycle 49, treatment with
ruthenium bisisoprene dimer complex 22 in water afforded the hexacycle 51 as a mixture of
diastereomers (86:14, meso-51, (±)-51), with stereochemistries confirmed through NMR and by
direct comparison with authentic samples prepared through an independent synthesis via
previously reported procedures. 17 Interestingly, a series of experiments highlighted the sensitivity
of the hexacyclic structures 49 and 50 to oxidative and acidic reaction conditions. A set of
control experiments on (+)-26 and meso-26 confirmed the high sensitivity of these compounds
under the standard PIFA oxidation conditions. For example, exposure of dimer (±)-26 or meso-








47, R = allyl 49, R = allyl, 4%
48, R = benzyl b 50, R = benzyl, 3%
51, R = H (86:14, meso-51:(±)-51)
Scheme 12. C3a-C3a' bond formation with the N-allyl and N-benzyl tryptamine derived substrates 47 and 48.
Conditions: a) PIFA, 2-Cl-pyridine, TFE. b) 6 mol% [RuC12(Cl0 H18)]2, H20, 90 'C, 4.5 h, 16%.
Reductive Dimerization Approach
These observations taken collectively in addition to other findings in the context of our
early studies all pointed to significant challenges associated with stereochemical control using
the above strategy for development of a practical and concise total synthesis of these alkaloids.
To decouple the issues of reactivity and stereoselectivity, we sought ways to impart the required
stereochemical information to the substrate prior to the dimerization and carbon-carbon bond
formation. Importantly, we envisioned the exchange of the single electron oxidation pathways,
explored above, to access the C3a centered radical for a single electron reduction of the
corresponding alkyl halide. 3 Indeed, an important precedent for this hypothesis was observed by
Danishefsky, who, en route to amauromine and the ardeemin natural products, observed
dimerization products in the course of radical prenylation of a similar selenide substrate (Figure
4).24 In this regard, we were inspired by the work of Crich who had successfully utilized cyclic
isomers of tryptophan to construct hexahydropyrroloindole alkaloids (Figure 4).75
Radical Me Radical




Danishefsky's side product (+)-Debromoflustramine B
Figure 4. Prior precedent for our reductive homocoupling approach.
Scheme 13 illustrates our retrosynthetic analysis for (+)-chimonanthine [(+)-2] based on a











Scheme 13. A reductive homodimerization approach to (+)-chimonanthine (2).
Tricycle 54 (Scheme 14) was envisioned to serve as an outstanding precursor for the
intermediate 52 (Scheme 13). The strategic positioning of the sulfonyl group on the aniline
nitrogen would enable the positioning of the desired halides at the C3a position.
Hexahydropyrroloindole derivative 54 was conveniently prepared in two steps from
commercially available N-methoxycarbonyl tryptophan methyl ester on >20g scale as a single
diastereomer with >99% ee (Scheme 14). The decarboxylation of 54 was achieved using the
corresponding acid chloride in conjunction with the Chatgilialoglu2 reagent, affording the
tricycle 55 in 84% yield and >99% ee as determined by chiral HPLC analysis.' Free radical
bromination of 55 under a variety of reaction conditions was problematic, affording the desired
product in variable yields and with extensive loss in optical activity. Through a series of control
experiments, we recognized the particular sensitivity of the tricycle 55 toward Brnnsted acids,
and the competitive electrophilic bromination of tryptamine derivative 57 giving rise to the
bromide 56 (Scheme 14). Various basic additives did not thwart this undesired pathway.
Although this undesired electrophilic bromination reaction was an obstacle in our early studies,
the lessons learned from these experiments later proved highly valuable for development of
efficient strategies for the synthesis of related alkaloids.
(+)-2
(+)-2
2Me H R Br,
HCO 2Me 1) H3P0 4  NC0 2MeRadical NCO 2Me
2) PhS02CI • Bromination N
Pvridine S02Ph SO2Ph
54, R = C02Me- a,b 56
N-methoxycarbonyl 55, R = H /Electrophilic
L-tryptophan methyl ester EectBromination/ rmnto
Scheme 14. Synthesis of our initial precursor for the hexahydropyrrolyl radical 52 and the observed competitive
electrophilic bromination reaction. Conditions: a) KOH,. b) oxalyl chloride, DMF (cat.); (Me3Si)3SiH, AIBN,
PhMe, 110 'C, 84% (2 steps), >99% ee.
Given the greater stability of hexahydropyrroloindole derivative 5425 as compared to 55,
we decided to postpone the decarboxylation reaction until after the critical dimerization reaction
(Scheme 15). Bromination of 55 with 1,3-dibromo-5,5-dimethylhydantoin in the presence of
AIBN afforded the desired benzylic bromide 58 in good yield and with complete retention of
optical activity (Scheme 15). We next focused on the key dimerization reaction. A variety of
reductive conditions were explored for the generation of the C3a radical center including the use
of Mg, Li, SmI2, a wide range of reducing copper complexes, FeCI3-Mg systems, and "Bu 6Sn2
along with heat or photochemical activation. Our first successful dimerization of bromide 58
was achieved using 0.5 equiv of Mn2(CO)1 0 in dichloromethane under visible light irradiation for
16 h, affording the desired dimer 61 as a single diastereomer in 18% yield and >99% ee (Scheme
15). Using an equimolar quantity of Mn2(CO)Io, the yield of the desired product 61 rose to 33%,
but no further improvement was observed after an extensive survey of reaction conditions. We
reasoned that given the second order dependence of the dimerization rate with respect to the
benzylic radical concentration (i.e., 60, Scheme 15), the reaction time using Mn2(CO)o0 (16 h)
was too long and non-ideal. We identified a cobalt(I) complex, Co(PPh3)3C127 as a potential
















(+)-2 (+)-63 I (+)-62 bU2 'n (+)-61 bU2' n
Scheme 15. Total synthesis of (+)-chimonanthine (2). Conditions: a) 1,3-dibromo-5,5-dimethylhydantoin, AIBN,
CCl4 , 80 oC, 1 h, 77%. b) CoCI(PPh3)3, acetone, 23 'C, 15 min, 60%. c) KOHaq-MeOH, 23 'C, 30 min, 90%. d)
Oxalyl chloride, DMF, CH2C12, 23 °C, 1.5 h; (Me 3Si)3SiH, AIBN, toluene, 80 °C, 3.5 h, 64%. e) Na(Hg), Na2HPO4,
MeOH, 23 'C, 3.5 h, 99%. f) Sodium bis-(2-methoxyethoxy) aluminium hydride, toluene, 110 'C, 1.5 h, 82%.
Significantly, treatment of the bromide 58 with 1.2 equiv Co(PPh3)3C1 in benzene
afforded the product in 34% yield in only 15 min. The dimerization was found to be most
sensitive to the choice of reaction solvent. We recognized acetone as the best solvent choice
giving the product in 60% yield as a single diastereomer and >99% ee on a 3g scale (Table 1).
Table 1. The effect of solvent on the key dimerization reaction.







After saponification, dimer 61 was subject to double decarboxylation using the
Chatgilialoglu procedure we had used earlier on the tricycle (vide supra) to afford the hexacycle
62 in 64% yield. Removal of the benzenesulfonyl groups with sodium amalgam to give product
63 followed by reduction of the methoxycarbonyl groups with Red-Al afforded (+)-





N-methylation of (+)-2 yielded the first synthetic sample of (+)-folicanthine (3) in
quantitative yield. Congruent with Overman's revision20a of the absolute stereochemistry of the
chimonanthine alkaloids, the absolute stereochemistry of our synthetic (+)-folicanthine (3) was
antipodal to the originally assigned structure (Scheme 16). Dissolution of (+)-2 in acetic acid-d 4
and deuterium oxide followed by heating provided isomeric (-)-calycanthine (1, Scheme
16 ).14b,16b We monitored this transformation by 'H NMR spectroscopy and observed a ratio
(-85:15) in favor of (-)-calycanthine (1) in 24 h. Isolation of (-)-1 and subjection to the
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Scheme 16. Total synthesis of (+)-folicanthine (3) and (-)-calycanthine (1). Conditions: a) formalin, NaBH(OAc) 3,
MeCN, 23 'C, 30 min. b) acetic acid-d 4, D20, 95 'C, 24 h, 54% (-)-1, 5% (+)-2.
Conclusion
The concise and efficient total synthesis of (+)-chimonanthine, (+)-folicanthine, and (-)-
calycanthine is described. The convergent assembly of these alkaloids utilizes a reductive Co(I)-
promoted dimerization of readily available endo-bromide (+)-58. The gram-scale synthesis of
enantiomerically enriched hexacycle (+)-61 provides ready access to optically active alkaloids 1-
3. This chemistry simultaneously secures the vicinal quaternary stereocenters directed by the
C8a-stereochemistry and offers the shortest enantioselective synthesis of these alkaloids from
commercially available materials.
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Experimental Section
General Procedures. All reactions were performed in oven-dried or flame-dried round-
bottomed flasks. The flasks were fitted with rubber septa and reactions were conducted under a
positive pressure of argon. Stainless steel syringes or cannulae were used to transfer air- and
moisture-sensitive liquids. Where necessary (so noted), solutions were deoxygenated by
dinitrogen purging for a minimum of 10 min. Flash column chromatography was performed as
described by Still et al. using silica gel (60-A pore size, 32-63 /m, standard grade, Sorbent
Technologies).' Analytical thin-layer chromatography was performed using glass plates pre-
coated with 0.25 mm 230-400 mesh silica gel impregnated with a fluorescent indicator (254
nm). Thin layer chromatography plates were visualized by exposure to ultraviolet light and
iodine vapors or an aqueous solution of ceric ammonium molybdate (CAM). Organic solutions
were concentrated on Biichi R-200 rotary evaporators at ~20 Torr (house vacuum) at 25-35 *C.
Materials. Commercial reagents and solvents were used as received with the following
exceptions: dichloromethane, acetonitrile and toluene were purchased from J.T. Baker
(CycletainerTM ) and were purified by the method of Grubbs et al. under positive argon pressure.2
Acetone was distilled from anhydrous calcium sulfate. Methanol (>99.9 % HPLC grade, 50.020
% water) was purchased from Aldrich chemical company and used as received. CH2C12 saturated
with NH3 was prepared by agitation of a 2:1 (v/v) biphasic mixture of CH2CI2 and 28-30%
aqueous NH4OH, separation of the organic layer and drying over Na 2SO 4 . AIBN was
recrystallized from diethyl ether. Na2HPO4 was dried by flame-drying under reduced pressure
for 5 min.
Instrumentation. Proton nuclear magnetic resonance (1H NMR) spectra were recorded with
Varian inverse probe 500 INOVA and Varian 500 INOVA spectrometers and are recorded in
parts per million from internal tetramethylsilane on the 8 scale and are referenced from the
residual protium in the NMR solvent (CHCI3: 6 7.27, DMSO-d6: 8 2.50). Data is reported as
follows: chemical shift [multiplicity (s = singlet, d = doublet, t = triplet, m = multiplet), coupling
constant(s) in Hertz, integration, assignment]. Carbon-13 nuclear magnetic resonance (13C NMR)
spectra were recorded with a Varian 500 INOVA spectrometer and are recorded in parts per
million from internal tetramethylsilane on the 8 scale and are referenced from the carbon
resonances of the solvent (CDCl3 : 8 77.23, DMSO-d6: 8 39.51). Data is reported as follows:
chemical shift [assignment]. Infrared data (IR) were obtained with a Perkin-Elmer 2000 FTIR,
and are reported as follows: [frequency of absorption (cm-'), intensity of absorption (s = strong, m
= medium, w = weak, br = broad)]. Optical rotations were measured on a Jasco-1010 polarimeter.
Enantiomeric excess was determined by chiral HPLC analysis performed on an Agilent
Technologies 1100 series HPLC system with a Daicel Chirapak AD-H column. We are grateful
to Dr. Li Li for obtaining the mass spectrometric data at the Department of Chemistry's
Instrumentation Facility, Massachusetts Institute of Technology. The structure of (+)-
chimonanthine was obtained with the assistance of Dr. Peter Mueller at the X-ray crystallography
laboratory of the Department of Chemistry, Massachusetts Institute of Technology.
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A fine suspension of carbamate S1 (25.2 g, 95.4 mmol, 1 equiv) in aqueous phosphoric
acid (85%) was vigorously stirred. After 5h, a homogenous light tan solution formed. The thick
solution was added drop-wise to a vigorously stirred mixture of dichloromethane (600 mL) and
an aqueous solution of sodium carbonate (11% wt/wt, 600 ml). The pH of the aqueous layer was
monitored throughout the addition, and once it reached pH = 7, another portion of solid sodium
carbonate (66 g) was added slowly. The addition was continued in this manner until completion
(total Na 2CO3 added = 198 g). The layers were separated and the aqueous layer was extracted
with CH2CI2 (4 x 200 mL). The combined organic layers were dried over anhydrous sodium
sulfate, were filtered, and were concentrated under reduced pressure to afford a white foam (24.3
g, 96%). The hexahydropyrroloindole (1.7 g, 6.4 mmol, 1 equiv) was dissolved in pyridine (8.60
mL) and benzenesulfonyl chloride (1.65 mL, 12.8 mmol, 2.00 equiv) was added and the mixture
vigorously stirred. After 2 h, pyridine was removed under reduced pressure and the residue was
suspended in ethyl acetate (50 mL). The organic suspension was sequentially washed with
aqueous hydrochloric acid solution (IN, 2 x 25 mL), saturated aqueous sodium bicarbonate
solution (50 mL), and brine (100 mL). The organic layer was dried over anhydrous sodium
sulfate, was filtered, and was concentrated under reduced pressure to afford a dark red residue.
The residue was purified by flash column chromatography (eluent: 50% EtOAc in hexanes) to
afford hexahydropyrroloindole (+)-54 as a white solid (1.7 g, 64%; 61% from Si). This
compound was determined to be of >99% ee by chiral HPLC analysis (Chirapak AD-H, 90 %
hexanes / 10% isopropanol, 3.0 mL/min, 254 nm, tR (minor, not observed) = 11.9 min, tR (major)
= 23.0 min). All spectral data were in agreement with the literature.3
'H NMR (500 MHz, CDC13, 50 oC):
'
3C NMR (125.8 MHz, CDCl3 , 50 oC):
8 7.76 (d, J = 8.0 Hz, 2H, SO 2Ar-o-H), 7.51 (t,
J = 7.5 Hz, 1H, SO 2Ar-p-H), 7.46 (d, J = 8.0
Hz, 1H, C7H), 7.40 (t, J = 7.3 Hz, 2H, SO2Ar-
m-H), 7.23 (app-t, J = 8.0 Hz, 1H, C6H), 7.03-
7.07 (m, 2H, C4H, C5H), 6.29 (d, J = 6.0 Hz,
1H, CsaH), 4.60 (d, J = 9.0 Hz, 1H, CzH), 3.67
(t, J = 6.8 Hz, 1H, C3aH), 3.60 (s, 3H,
NCO2CH 3), 3.16 (s, 3H, CO2CH3 ), 2.59 (d, J
= 13.0 Hz, 1H, C3Hedo), 2.46 (ddd, J =13.0,
9.0, 7.5 Hz, 1H, C3Hexo).
171.5 (C=O), 154.9 (NC=O), 142.9 (Cva),
140.3 (SO2Ar-i-C), 133.1 (C4a), 132.9 (SO 2Ar-
p-C), 129.08 (SOzAr-m-C), 129.07 (C,), 126.9
(SO 2Ar-o-C), 125.3 (C5), 124.5 (C4), 118.5
C.-O. Chan, C. J. Cooksey, D. Crich, J. Chem. Soc. Perkin Trans. 1 1992, 777.
FTIR (thin film) cm-':
(CO), 80.3 (C8a), 59.2 (C2), 52.9 (NCOCH3),
52.1 (COCH 3), 45.9 (C3 ), 33.9 (C3).
3065 (m), 2953 (s) 1753 (s), 1712 (s), 1384
(s), 1359 (s).
calc'd for C20H21N20 6S [M+H]+: 417.1115
found: 417.1105
HRMS (ESI):
M.p. (ethyl acetate-hexanes): 160.5-161.5 oC
+88 o (c = 1.00, CH 2C12)
H CO 2Me Br
'CON M O .,N  AIBN (10 mol%)
N'CO 2Me + Me rN 0C4, 80,1hMe' Br CC14, 80
S02Ph





Dibromohydantoin (2.90 g, 10.0 mmol, 1.00 equiv) followed by AIBN (164 mg, 1.00
mmol, 0.100 equiv) were added to a suspension of the tricycle (+)-54 (4.16 g, 10.0 mmol, 1
equiv) in CCl4 (250 mL) at room temperature. The mixture was heated to 80 oC for 1 h at which
point the solution became dark orange-red and a white solid precipitated. The reaction mixture
was cooled to room temperature, the volatiles were removed under reduced pressure, and the
residue was purified by flash column chromatography (eluent: 0 --- 40% ethyl acetate in
hexanes) to afford the tricyclic bromide (+)-58 as a white foam (3.80 g, 77%). This compound
was determined to be of >99% ee by chiral HPLC analysis (Chirapak AD-H, 10% isopropanol in
hexanes, 3.0 mL/min, 254 nm, tR (minor, not observed) = 8.2 min, tR (major) = 14.8 min)).
1H NMR (500 MHz, CDC13, 50 oC):
13C NMR (125.8 MHz, CDC13, 50 oC):
FTIR (thin film):
HRMS-ESI (m/z):
TLC (40% EtOAc in hexanes), Rf.
7.87 (d, J = 7.5 Hz, 2H, SO2Ph-o-H), 7.55 (d,
J = 8.0 Hz, 1H, C4H), 7.52 (app tt, J = 7.5, 1.0
Hz, 1H, SO 2Ph-p-H), 7.42 (t, J = 8.0 Hz, 2H,
SO 2Ph-m-H), 7.34 (app td, J = 7.5, 1.0 Hz,
1H, C6H), 7.26 (d, J = 8.0 Hz, 1H, C7H), 7.14,
(td, J = 7.5 Hz, 1.0 Hz, 1H, C5H), 6.36 (s, 1H,
C 8aH), 4.62 (d, J = 9.0 Hz, 1H, C2H), 3.70 (s,
3H, NCO2CH 3), 3.27 (d, J = 13.0 Hz, 1H,
C3H), 3.17 (s, 3H, CO2CH 3), 3.04 (dd, J =
13.0, 9.0 Hz, 1H, C3H).
170.2 (C=O), 154.3 (NC=O), 142.1 (CXa),
140.1 (SO 2Ph-i-C), 133.5 (C4a), 133.4 (SO2Ph-
p-C), 131.3 (SO 2Ph-m-C), 129.2 (C6), 127.7
(SO2Ph-o-C), 125.9 (C5), 124.8 (C4 ), 118.4
(CO), 87.4 (Csa), 60.2 (C3a), 59.9 (C 2), 53.2
(NCO 2CH3), 52.4 (CO2CH 3), 44.9 (C3).
2954 (s), 1755 (s), 1716 (s), 1601 (m), 1447
(s).
calc'd for C20H19BrN2NaO 6S[M+Na]+:517.0039
found: 517.0016.
+107 (c = 1.00, CHCl3).
0.33 (UV, I2).











60 % (+)-61 SO2Ph
Dimeric hexahydropyrroloindole (+)-61:
A solid sample of freshly prepared tristriphenylphosphine cobalt chloride (CoCI(PPh3)35,
6.40 g, 72.7 mmol, 1.20 equiv) was added rapidly to a degassed (dinitrogen purge, 10 min)
solution of tricyclic bromide (+)-58 (3.00 g, 6.06 mmol, 1 equiv) in acetone (61.0 mL) under an
argon atmosphere. The solution immediately turned blue and a precipitate resulted. After 15
min, the reaction mixture was diluted with deionized water (200 mL) and extracted with ethyl
acetate (3 x 150 mL). The combined organic extracts were washed with brine (100 mL), were
dried over anhydrous sodium sulfate, were filtered, and were concentrated under reduced
pressure. The resulting yellow oil was purified by flash column chromatography (10% acetone
in CH 2C12) to yield the dimeric hexahydropyrroloindole (+)-61 (1.50 g, 60%) as white foam. The
hexacycle (+)-61 was found to be of >99% ee by chiral HPLC analysis (Chirapak AD-H, 20%
isopropanol in hexanes, 3.0 mL/min, 254 nm, tR (minor, not observed) = 8.3 min, tR (major) =
13.5 min).
1H NMR (500 MHz, DMSO-d 6, 100 oC):




TLC (65% EtOAc in hexanes), Rfi
8.00 (d, J = 7.0 Hz, 4H, SO 2Ph-o-H), 7.70 (t, J
= 7.3 Hz, 2H, SO2Ph-p-H), 7.63 (t, J = 7.8 Hz,
4H, SO zPh-m-H), 7.27 (d, J = 7.5 Hz, 2H,
C4H), 7.16 (t, J = 7.8 Hz, 2H, C6H), 7.08 (br
d, J = 7.5 Hz, 2H, C7H), 6.92 (t, J = 7.5 Hz,
2H, C5H), 6.43 (s, 2H, CsaH), 4.67 (d, J = 9.0
Hz, 2H, C2 H), 3.31 (br s, 6H, NCO2CH 3), 3.12
(s, 6H, CO 2CH 3), 2.72 (dd, J = 12.8, 9.3 Hz,
2H, C3H), 2.47 (d, J = 13.0 Hz, 2H, C3H).
169.6 (C=O), 153.0 (NC=O), 142.0 (CXa),
141.2 (SOzPh-i-C), 132.4 (C4a), 129.1 (SO2Ph-
p-C), 129.0 (SO2Ph-m-C), 128.7 (SO2 Ph-o-C),
125.0 (C6), 124.3 (C5), 122.7 (C4), 114.0 (C7),
81.0 (C8a), 60.8 (C30), 58.5 (C2), 51.8
(NCO 2CH 3), 51.1 (CO 2CH 3), 36.8 (C3).
2954 (m), 1750 (s), 1721 (s), 1602 (m), 1447(s).
calc'd for C40H39N40 12S2 [M+H]+: 831.2000
found: 831.2025.
+51 (c = 1.00, CHCI3).
0.23 (UV, 12).














1. (COCI)2, CH2CI2 MeO 2C, NFý
DMF, 23 OC, 1.5h
2. (Me3Si)3SiH, PhMe N 02M
AIBN, 80 OC, 3.5h, CO2Me
64 % (+)-62 SO 2Ph
Hexacycle (+)-62:
An aqueous solution of potassium hydroxide (5 N, 10 mL) was added to a solution of
dimer (+)-61 (334 mg, 0.402 mmol, 1 equiv) in methanol (10 ml) at 23 'C. After 30 min, the
resulting clear solution was cooled to 0 oC and adjusted to pH ~ 2 by the drop-wise addition of
aqueous hydrochloric acid solution (~12N). The reaction mixture was extracted with chloroform
(10 x 20 mL) and the combined organic extracts were dried over anhydrous sodium sulfate, were
filtered, and were concentrated under reduced pressure to afford the hexacyclic dicarboxylic acid
as a white solid (291.3 mg, 90 %). The dicarboxyclic acid (263 mg, 0.328 mmol, 1 equiv) was
concentrated from benzene (2 x 2.5 mL) under reduced pressure. Oxalyl chloride (114 [IL, 1.31
mmol, 4.00 equiv) was added to a solution of dicarboxylic acid S2 in CH2C12 (2.75 mL) at 23 'C.
Dimethylformamide (DMF, 3.8 [L, 0.049 mmol, 0.15 equiv) was added, resulting in vigorous
gas evolution. After 1.5 h, the volatiles were removed under reduced pressure and the residue
was concentrated from benzene (2 x 3 mL) to remove the remaining oxalyl chloride.
Tristrimethylsilylsilane ((Me3Si) 3SiH, 305 [tL, 0.985 mmol, 3.00 equiv) followed by AIBN (11
mg, 0.066 mmol, 0.20 equiv) were added to a solution of the crude dicarboxylic acid chloride in
toluene (6.60 mL) and the mixture was heated to 80 oC. After 30 min, an additional portion of
tristrimethylsilylsilane (305 [tL, 0.985 mmol, 3.00 equiv) and AIBN (11 mg, 0.066 mmol, 0.20
equiv) were added. After 1.5 h, an additional portion of AIBN (11 mg, 0.066 mmol, 0.20 equiv)
was added. After 1.5 h, the reaction mixture was cooled to 23 'C and concentrated under
reduced pressure. The resulting residue was purified by flash column chromatography (60%
ethyl acetate in hexanes) to afford the hexacycle (+)-62 as a white solid (149.0 mg, 64%).
1H NMR (500 MHz, DMSO-d 6, 100 oC):
13C NMR (125.8 MHz, DMSO-d 6, 100 'C):
7.91 (app d, J= 7.5 Hz, 4H, SO2Ph-o-H), 7.71
(app t, J = 7.5 Hz, 2H, SO 2Ph-p-H), 7.63 (app
t, J = 7.5 Hz, 4H, SO2Ph-m-H), 7.38 (d, J =
8.5 Hz, 2H, C4H), 7.19 (app t, J = 8.5 Hz, 2H,
C6H), 7.03 (br d, J = 7.5 Hz, 2H, CH), 6.87
(t, J = 7.5 Hz, 2H, CAH), 6.28 (s, 2H, CsaH),
3.74 (dd, J = 11.5, 8.0 Hz, 2H, C2H), 3.56 (s,
6H, NCOzCH 3), 2.57 (td,J = 11.8, 5.5 Hz, 2H,
C2H), 1.97 (td, J = 12.0, 8.0 Hz, 2H, C3H),
1.85 (dd, J= 12.5, 5.5 Hz, 2H, C3H).
153.1 (C=O), 141.7 (C7 a), 139.7 (SO 2Ph-i-C),
132.9 (C4a), 130.2 (SO2Ph-p-C), 128.9
(SO2Ph-m-C), 128.6 (SO2Ph-o-C), 125.6 (C6),
123.8 (C5), 123.0 (C4), 113.0 (C7), 80.7 (C8 a),
62.0 (C3a), 51.9 (CH 3), 43.9 (C2), 35.1 (C3).
FTIR (thin film):
HRMS-ESI (m/z):
2955 (m), 1713 (s), 1599 (w), 1476 (m), 1447
(s).
calc'd for C36H34N 4NaOsS2 [M+Na]+:
737.1716
found: 737.1720.
+161 (c = 1.00, CH2C12).
TLC (50% EtOAc in hexanes), Rf: 0.53 (UV, I2).
SO2Ph
H N 5% Na(Hg)
MeO 2C" N Na2HPO 4, MeOH
- 23 OC, 3.5h
N H CO 2Me 99 %
(+)-62 SO 2Ph
Hexacycle (+)-63:
Anhydrous sodium phosphate dibasic (Na 2HPO4, 170 mg, 1.20 mmol, 8.00 equiv)
followed by freshly prepared 5% Na(Hg)6 (590 mg, 1.28 mmol, 8.50 equiv) were added to a
solution of hexacycle (+)-62 (107 mg, 0.150 mmol, 1 equiv) in methanol (2.0 mL). The resulting
suspension was stirred and an additional sample of Na(Hg) (400 mg) was added approximately
every hour until the completion of the reaction as judged by TLC analysis (total time 3.5 h). The
reaction mixture was diluted with water (30 mL) and the aqueous layer was separated from the
mercury. The aqueous layer was extracted with dichloromethane (3 x 30 mL) and the combined
organic extracts were dried over anhydrous sodium sulfate, were filtered, and were concentrated
under reduced pressure to afford a white gel. The residue was purified by flash chromatography
(20% ethyl acetate in CH2C12) to afford the product (+)-63 (64.6 mg, 99%) as white foam.' This
hexacycle (+)-63 was determined to be >99% ee by chiral HPLC analysis (Chirapak AD-H, 10%
isopropanol in hexanes, 3.0 mL/min, 254 nm, tR (minor, not observed) = 7.6 min, tR (major) =
11.7 min).
'H NMR (500 MHz, DMSO-d6, 100 °C):




TLC (20% EtOAc in CH 2C12), Rf.
7.23 (d, J = 7.5 Hz, 2H, C4H), 7.02 (td, J =
7.8, 1.2 Hz, 2H, C6H), 6.64 (td, J = 7.5, 1.0
Hz, 2H, C5H), 6.59 (d, J = 7.5 Hz, 2H, C7H),
6.11 (s, 2H, NH), 4.91 (s, 2H, CsaH), 3.54-
3.58 (m, 8H, C2H, NCO2CH 3), 2.75 (td, J =
10.8, 6.0 Hz, 2H, C2H), 2.52 (td, J = 12.0, 8.0






(C=O), 150.4 (C 7 a), 128.1 (C 6), 128.0
124.0 (C4), 116.9 (C5), 108.2 (C 7), 77.4
60.9 (C3a), 51.3 (CH3), 44.2 (C 2), 31.8
3365 (br m), 2954 (m), 1695 (s), 1607 (m),
1451 (s).
calc'd for C24H26N4NaO4 [M+Na]+: 457.1846
found: 457.1830.
+474 (c = 1.00, CH2CI2).
0.38 (UV, CAM).
6 The reagent was prepared according to R. N. McDonald, C. E. Reineke, Org. Synth., Coll. Vol. VI1988,461.
7 For the synthesis of 16 in racemic form, see: a) M. Nakagawa, H. Sugumi, S. Kodato, H. Hino, Tetrahedron, 1981, 22,5323.









Hexacycle (+)-63 (64 mg, 0.147 mmol, I equiv) was concentrated from anhydrous
benzene (2.5 ml) and the residue was dissolved in anhydrous toluene (14.7 mL) and placed under
an argon atmosphere. A solution of Red-Al (65% wt, 450 [tL, 1.47 mmol, 10.0 equiv) in toluene
was added via syringe and the reaction mixture was heated to reflux. After 1.5 h, the mixture
was cooled to 23 oC and excess reducing agent was quenched by the slow addition of methanol
(5:95) in dichloromethane saturated with ammonia. The resulting mixture was concentrated
under reduced pressure and the residue was purified by flash column chromatography (5%
methanol in dichloromethane saturated with ammonia) to afford (+)-chimonanthine (2) as a
white solid (41.7 mg, 82 %). X-ray quality crystals were grown by slow evaporation of a
benzene solution of (+)-2. All spectral data were in agreement with the literature.8c
'H NMR (500 MHz, CDCl3 , 50 oC):
13C NMR (125.8 MHz, CDC13, 50 oC):
FTIR (thin film):
HRMS-ESI (m/z):
7.19 (d, J = 7.5 Hz, 2H, C4H), 6.98 (t, J = 7.3
Hz, 2H, C6H), 6.66 (t, J = 7.3 Hz, 2H, C5H),
6.53 (d, J = 7.5 Hz, 2H, C7H), 4.40 (br-s, 2H,
CsaH), 4.23 (s, 2H, NH), 2.51-2.57 (m, 6H,
C2H, C2H, C3H), 2.33 (s, 6H, CH3), 2.05 (app
dd, J = 10.5, 5.0 Hz, 2H, C3H).
151.2 (C7a), 133.8 (C4 ), 128.2 (C,), 124.6
(C4), 118.8 (C5), 109.4 (C7), 85.5 (Csa), 63.8
(C3a), 52.9 (C2), 37.4 (CH3), 36.1 (C3).
3406 (m), 2934 (m), 1603 (m), 1484
1361 (s).
calc'd for C22H27N4 [M+H]+: 347.2230
found: 347.2222.
(m),
+254 (c = 1.00, EtOH).8[a]D22:
M.p. (C6H6): 176-178 oC.
TLC (5% CH 3OH in CH 2CI2 saturated with NH3), Rf. 0.26 (UV, CAM).
8 a) [a]D"2 : +280 (MeOH, concentration not reported), T. Tokuyama, J. W. Daly, Tetrahedron, 1983, 39, 41. b) [a],: +224
(conditions not reported), N. H. Lajis, Z. Mahmud, R. F. Toia, Planta Med. 1993, 59,383. c) [a]D20 : +264.5 (c = 1, EtOH), L.
Verotta, T. Pilati, M. Tat6, E. Elisabetsky, T. A. Amador, D. S. Nunes, J. Nat. Prod. 1998, 61,392. d) [a]D': +274 (c = 0.5,
EtOH), L. E. Overman, J. F. Larrow, B. A. Stearns, J. M. Vance, Angew. Chem. Int. Ed. 2000, 39, 213. Data related to (-)-
chimonanthine: e) [a]D: -329 (EtOH, conditions not reported), H. F. Hodson, B. Robinson, G. F. Smith, Proc. Chem. Soc. 1961,
465. f) [a]D': -328 (c = 1.0, EtOH), R. K. Duke, R. D. Allan, G. A. R. Johnston, K. N. Mewett, A. D. Mitrovic, C. C. Duke, T.
W. Hambley, J. Nat. Prod. 1995, 58, 1200. g) [a]D,': -310 (c = 0.5, EtOH), L. E. Overman, D. V. Paone, B. A. Steams, J. Am.
Chem. Soc. 1999,121,7702.
Comparison of our data for (+)-chimonanthine (2) with literature:
Verotta's report8 c  This report
Assignment (+)-chimonanthine (2) (+)-chimonanthine (2)
('H NMR, 200 MHz, CDC13) ('H NMR, 500 MHz, CDCI3, 50 oC)
C2 2.50 (m) 2.57, (m)
C3 2.50 (m), 2.07 (dt, J= 12.0, 6.4 Hz) 2.57 (m), 2.05 (app dd, J= 10.5,5.0 Hz)
C3a
C4a
C4 7.20, (d, J = 7.4 Hz) 7.19, (d, J = 7.5 Hz)
C5 6.67 (t, J = 7.3 Hz) 6.66 (t, J = 7.3 Hz)
C6 7.00 (t, J = 7.6 Hz) 6.98 (t, J = 7.3 Hz)
C7 6.55, (d, J = 7.7 Hz) 6.53, (d, J = 7.5 Hz)
C7a
N8 4.23 (s)
C8a 4.35 (br s) 4.40 (br s)
N1-CH3 2.31 (s) 2.33 (s)
Tokuyama's report8a This report
(+)-chimonanthine (2) (+)-chimonanthine (2)
('3C NMR, 25.05 MHz, CDC13) (13C NMR, 125.8 MHz, CDC13, 50 oC)
150.6 (s) 151.1 (C7a)
133.1 (s) 133.8 (C4a)
128.1 (d) 128.2 (C6)
124.4 (d) 124.6 (C4)
118.7 (d) 118.8 (C5)
109.4 (d) 109.4 (C7)
85.2 (d) 85.5 (C8a)
63.2 (s) 63.8 (C3a)
52.7 (t) 52.9 (C2)
37.2 (q) 37.4 (Me)
36.5 (t) 36.1 (C3)
CH20, NaBH(OAc)3








Formalin (37%, 5.5 ýtL, 0.0734 mmol, 5.2 equiv) followed by solid sodium
triacetoxyborohydride (15.6 mg, 0.0734 mmol, 5.2 equiv) were added to a solution of (+)-
chimonanthine (2, 5.0 mg, 0.0141 mmol, 1 equiv) in acetonitrile (700 RL) at 23 OC and placed
under an argon atmosphere. After 30 min, a solution of methanol (5:95) in dichloromethane
saturated with ammonia was added slowly. After 5 min, the resulting slurry was concentrated
under reduced pressure and the residue was purified by flash column chromatography (1%
methanol in dichloromethane saturated with ammonia) to afford (+)-folicanthine (3)9 as a white
solid (5.3 mg, 100%). All spectral data were in agreement with the literature.
'H NMR (500 MHz, CDCI3, 50 oC):
'





6.98 (t, J = 7.5 Hz, 2H, C6H), 6.94 (d, J = 6.5
Hz, 2H, C4H), 6.51 (t, J = 7.0 Hz, 2H, C5H),
6.27 (d, J = 7.5 Hz, 2H, CAH), 4.37 (s, 2H,
CsaH), 3.00 (s, 6H, N8CH3), 2.62-2.64 (m, 2H,
CzH), 2.41-2.50 (m, 10H, C2H, C3H, NCH3),
1.95-1.99 (m, 2H, C3H).
153.2 (C7a), 133.2 (C4a), 128.3 (C6), 124.0
(C4 ), 116.9 (C5), 106.1 (C,), 92.3 (Csa), 63.0
(C3a), 52.9 (C2), 38.3 (NsCH 3), 35.6 (C3 ), 35.5
(NICH 3).
3047 (w), 2931 (m), 1603 (s), 1493 (s), 1155
(m).
calc'd for C24H31N4 [M+H]+: 375.2549
found: 375.2547.
+207 (c = 0.75, MeOH).1'
184-189 oC.
TLC (5% MeOH in CH2Cl 2 saturated with NH3), Rf. 0.40 (UV, CAM).
9For a synthesis of folicanthine in racemic form, see: C.-1. Fang, S. Home, N. Taylor, R. Rodrigo, J. Am. Chem. Soc. 1994, 116,
9480.
10 Data for (-)-folicanthine is available: a) [a], 21 S: -364.4 (c = 2.043, MeOH), K. Eiter, O. Svierak, Monatsh. Chem. 1952, 83,
1453. b) [a]D: -364 (EtOH, concentration not reported), see ref. 8e. c) [a],: -364 (EtOH, concentration not reported), J. E.
Saxton, W. G. Bardsley, G. F. Smith, Proc. Chem. Soc. 1962, 148.
Me,
Comparison of our data for (+)-folicanthine (3) with literature for (±)-3:
Rodrigo's report9  This report
Assignment (±)-folicanthine (3) (+)-folicanthine (3)
('H NMR, 250 MHz, CDCl3) ('H NMR, 500 MHz, CDC13, 50 oC)
C2 2.58-2.67 (m), 2.30-2.49 (m) 2.62-2.64, (m), 2.41-2.50 (m)
C3 2.30- 2.49 (m), 1.92-1.98 (m) 2.41-2.50 (m), 1.95-1.99 (m)
C3a
C4a
C4 6.89-6.99 (m) 6.94 (d, J= 6.5 Hz)
C5 6.49 (t, J = 7.3 Hz) 6.51 (t, J = 7.0 Hz)
C6 6.89-6.99 (m) 6.98 (t, J = 7.5 Hz)
C7 6.25, (d, J = 7.8 Hz) 6.27, (d, J = 7.5 Hz)
C7a
N8-CH 3  3.00 (s) 3.00 (s)
C8a 4.38 (s) 4.37 (s)
NI-CH3  2.40 (s) 2.41-2.50 (m)
Rodrigo's report9  This report
Assignment (+)-folicanthine (3) (+)-folicanthine (3)
















(+)-Chimonanthlne (2) (-)-Calycanthine (1)
(-)-Calycanthine (1):
A solution of (+)-chimonanthine (2, 10.0 mg, 0.0289 mmol, 1 equiv) in a mixture of
acetic acid-d4 (0.43 M) in deuterium oxide (700 [tL) was placed in a J-Young tube and the
contents were sealed under an atmosphere of argon and heated to 95 oC. Equilibrium was
reached within 24 h, affording a ~85:15 ratio in favor of (-)-calycanthine (1). After 48 h, the
reaction mixture was cooled to 23 'C and partitioned between dichloromethane (10 mL) and
saturated aqueous sodium bicarbonate (10 mL). The layers were separated, and the aqueous
layer was extracted with dichloromethane (4 x 10 mL). The combined organic extracts were
dried over anhydrous sodium sulfate, were filtered, and were concentrated under reduced
pressure to afford a brown residue. The residue was purified by flash column chromatography
(1% methanol in dichloromethane saturated with ammonia) to afford (-)-calycanthine (1, 5.4 mg,
54%) as a white solid along with recovered (+)-chimonanthine (2, 0.5 mg, 5%).
1H NMR (500 MHz, CDCI3, 20 oC):




7.01 (d, J = 7.5 Hz, 2H, C4H), 6.82 (app t, J =
7.5 Hz, 2H, C6H), 6.55 (t, J = 7.5 Hz, 2H,
C5H), 6.27 (d, J = 8.0 Hz, 2H, C7H), 4.58 (br
s, 2H, NH), 4.32 (s, 2H, CsaH), 3.13 (td, J =
13.3, 5.3 Hz, 2H, C3H), 2.62 (dd, J= 11.3, 5.3
Hz, 2H, C2H), 2.42 (s, 6H, CH 3), 2.27 (dt, J =
12.5, 3.6 Hz, 2H, C2H), 1.29 (dd, J = 13.3, 3.8
Hz, 2H, C3H).
145.6 (C7a), 126.7 (C6), 125.2 (C4a), 124.6
(C4), 116.5 (C5), 112.2 (C7), 71.2 (Csa), 46.7
(C2), 42.8 (CH3), 36.1 (C3a), 31.9 (C3).
3418 (m), 2929 (m), 1678 (w), 1605 (m), 1487
(s).
calc'd for C22H27N4 [M+H]+: 347.2230
found: 347.2217.
-612 (c = 0.18, EtOH)."
M.p. (EtOH): 230-232 oC.
TLC (5% CH3OH in CH 2CI2 saturated with NH3), Rf. 0.53 (UV, CAM).
11 For data on (-)-calycanthine, see: a) [a]D25: -570 (MeOH, concentration not reported), see ref. 8a. b) [a]D: -633 (MeOH,
concentration not reported), see ref. 8b. c) [a]D20: -463 (c = 1, EtOH), see ref. 8c. For data on (+)-calycanthine, see: d) [arD'8 :
+684.3 (EtOH, concentration not reported), E. Spdith, W. Stroh, Chem. Ber. 1925, 58, 2131. e) [a],D': +675 (c = 1.0, CHC13), see
ref. 8f. f) [Ca]Dj: +664 (c = 0.7, EtOH), see ref. 8g.
Comparison of our data for (-)-calycanthine (1) with literature:
Verotta's reportsc This report
Assignment (-)-calycanthine (1) (-)-calycanthine (1)
('H NMR, 200 MHz, CDC13) ('H NMR, 500 MHz, CDC13,20 oC)
2.63 (ddd, J= 12.0, 5.6, 1.4 Hz), 2.62 (dd, J = 11.3,5.3 Hz),C2 2.26 (ddd, J= 12.0.4.1, 1.4 Hz) 2.27 (dt, J = 12.5,3.6 Hz)
3.15 (dt, J= 13.2, 5.5 Hz), 3.13 (app-td, J= 13.3,5.3 Hz),
1.30 (ddd,J = 13.2,4.1, 1.4 Hz) 1.29 (dd,J = 13.3, 3.8 Hz)
C3a
C4a
C4 6.28, (dd, J= 8.0, 1.0 Hz) 7.01, (d, J= 7.5 Hz) 12
C5 6.55 (td, J= 7.5, 1.0 Hz) 6.55 (t, J= 7.5 Hz)
C6 6.83 (dt, J = 7.5, 1.0 Hz) 6.82 (app t, J = 7.5 Hz)
C7 7.02, (dd, J= 8.0, 1.0 Hz) 6.27, (d, J = 8.0 Hz)12
C7a
N8 1.63 (br s) 4.58 (br s)
C8a 4.33 (s) 4.32 (s)
N1-CH 3 2.42 (s) 2.42 (s)
Tokuyama's reportsa This report
(-)-calycanthine (1) (-)-calycanthine (1)
(C3C NMR, 25.05 MHz, CDC13) (13C NMR, 125.8 MHz, CDC13, 20 oC)
145.3 (s) 145.6 (C7a)
126.5 (d) 126.7 (C6)
125.0 (s) 125.2 (C4a)
124.4 (d) 124.6 (C4)
116.4 (d) 116.5 (C5)
112.0 (d) 112.2 (C7)
71.0 (d) 71.2 (C8a)
46.6 (t) 46.7 (C2)
42.6 (q) 42.8 (Me)
36.0 (s) 36.1 (C3a)
31.7 (t) 31.9 (C3)
12Our assignment of C4 and C7 methines is supported by HMBC data.
Crystal Structure of (+)-Chimonanthine (2).
















a = 15.692(2) A
b = 16.844(2) A






0.073 mm - 1
744
Crystal size




Completeness to theta = 29.580
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2sigma(I)]
R indices (all data)
Absolute structure parameter
Largest diff. peak and hole








Full-matrix least-squares on F2
3024/2/243
1.052
R1 = 0.0361, wR2 = 0.0970
R1 = 0.0407, wR2 = 0.1010
No anomalous signal




Table 2. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (A2 x 103) for (+)-
chimonanthine. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor.









































































































































































































































































































Symmetry transformations used to generate equivalent
atoms:
Table 4. Anisotropic displacement parameters (, 2 x 103) for (+)-chimonanthine. The anisotropic
displacement factor exponent takes the form: -2p 2 [ h2 a*2 U 1 + + 2 h k a* b* U1 2]























































































































































































Table 5. Hydrogen coordinates ( x 104) and isotropic displacement parameters (A2 x 103)
for (+)-chimonanthine.









































































































Table 6. Hydrogen bonds for (+)-chimonanthine [A and O].
D-H...A d(D-H) d(H...A) d(D...A) <(DHA)
N(8)-H(8)...N(1')#1 0.918(15) 2.091(15) 3.0072(19) 174.8(19)
Symmetry transformations used to generate equivalent atoms:
#1 -x+1,-y+1,z
Chapter II
The Development of a General Strategy Towards Dimeric
Hexahydropyrroloindole Alkaloids. A Concise Total Synthesis of (+)-WIN
64821, (-)-Ditryptophenaline and (-)- l'-(2-Phenylethylene)-ditryptophenaline
Introduction and Background
The development of a cobalt(I)-mediated reductive carbon-carbon bond forming reaction
allowed for the rapid construction of the vicinal quaternary stereocenters of the calycanthaceous
alkaloids (see Chapter I). Attention was next focused on more complex natural products, the
dimeric diketopiperazine alkaloids (Figure 1). This new project was done in collaboration with
Dr. James A. Ashenhurst, a post-doctoral researcher in the group.
Ph
(+)-WIN 64821 (1) (-)-Ditryptophenaline (2)
(-)-N1-(2-phenyl-ethylene)- R = OH, (+)-Chaetocin (4)
ditryptophenaline (3) R = H, (+)-11,11 '-Dideoxyverticillin A (5)
Figure 1. Representative dimeric diketopiperazine alkaloids.
The structurally fascinating and biologically active secondary metabolites (+)-WIN
64821 (1) and (-)-ditryptophenaline (2), isolated from Asperigillusflavus cultures, are members
of the dimeric diketopiperazine alkaloid family (Figure 1).' Many of these alkaloids, including
the closely related (-)-N'-(2-phenylethylene)-ditryptophenaline (3),2 contain vicinal quaternary
stereocenters 3 that connect two hexahydropyrroloindole substructures (Figure 1).4 Bioactivity-
guided studies led to the identification of (+)-1 as a potent competitive substance P antagonist
with submicromolar potency for the human neurokinin 1 and the cholecystokinin B receptors, 2
whereas alkaloids (-)-2 and (-)-3 were found to be weaker inhibitors for the former receptor.'
Many closely related and potently biologically active epidithiodiketopiperazine derivatives1d are
known, including (+)-chaetocin (4) (Figure 1), the first inhibitor of a lysine-specific histone
methyltransferase,le and (+)-11,1 1'-dideoxyverticillin A (5) (Figure 1), a tyrosine kinase inhibitor
with potent antitumor activity.'f
Previous Synthetic Work
Based on the pioneering work of Hino,4" Nakagawa reported the first synthesis of (-)-2








Scheme 1. Nakagawa's synthesis of (-)-2.
In 2001, Overman reported an elegant total synthesis of (-)-ent-WIN 64821 and (-)-(2),
employing alkylation reactions for introduction of the quaternary stereocenters (see Chapter I)
(Scheme 2).6 Double alkylation of bisoxindole 8 with bistriflate 7 affords the dialkylation
product, which after further steps yields diastereomeric diols 9 and 10. Diol 9 was further
elaborated to afford (-)-ent WIN 64821 in nine additional steps. Similarly, diol 10 was
converted to (-)-ditryptophenaline (2) in ten additional steps.
Bn
HO











Scheme 2. Overman's synthesis of (-)-ent-WIN 64821 ent-(1) and (-)-ditryptophenaline (2).
)ZD
Retrosynthetic Analysis
Our retrosynthetic analysis of (+)-WIN 64821 (1) illustrates our planned approach to
these dimeric diketopiperazines alkaloids (Scheme 3). We envisioned simultaneously securing
the imposing vicinal quaternary stereocenters of (+)-1 by a reductive dimerization 7'8 of a C3-
halogenated diketopiperazine 12 (Scheme 3). While diketopiperazine 13 could be readily
accessed from L-tryptophan and L-phenylalanine, the strategic positioning of an electron
withdrawing group (E) on the indolyl nitrogen atom of 13 could allow the preparation of the
desired C3-halogenated derivative 12. Inspired by the pioneering reports by Hino,4a Crich,4" and
Danishefsky9 on the synthesis and chemistry of C3a functionalized hexahydropyrroloindoles, we
envisioned a C3-halogenated diketopiperazine 12 to serve as a versatile precursor to a fleeting







Scheme 3. Retrosynthetic analysis of (+)-WIN 64821 (1).
Results and Discussion
A short synthesis of the key diketopiperazine is shown in Scheme 4. The direct N-
sulfonylation of N-Boc-L-tryptophan (14) was achieved by treatment with LiHMDS (3 equiv)10
followed by benzenesulfonyl chloride (Scheme 2). Condensation of tryptophan derivative (-)-15
and L-phenylalanine methyl ester (16) provided the desired amide (-)-17. Dissolution of (-)-17
in dichloromethane and sequential treatment with trifluoroacetic acid followed by morpholine
resulted in the precipitation of the target diketopiperazine (-)-18 as a single diastereorner and
>99% ee. 11,12 Importantly, attempts to directly N-sulfonylate cyclo-L-tryptophan-L-phenylalanine
(13, E = H) were unsuccessful due to its sensitivity toward base promoted epimerization leading
to a mixture of diastereomers. The bromides endo-(+)-19 and exo-(-)-20, which are the key
MeO 0,,
C2H a. PhS2CI HCIH 2N 
HN .,,PhC02H b. EDCS=a. + MeO 2C,,/Pho (-)-177





B NH +NY Ph +
d. Br2, 86%
Ph -BNH
19:20. 44 :56 PhSO .N HN. Ph
S0Ph 2Ph 10g-scale 0 (-)-18
(-)-20 (+)-19 >20g-scale
Scheme 4. Synthesis of diastereomeric bromides (+)-19 and (-)-20. Conditions: a) LiHMDS, THF, PhSO 2CI, -78
°C, 71%. b) EDC*HCl, HOBt, Et3N, CH2C12, 23 °C, 94%. c) TFA, CH2Cl2, 0--23 'C, 3 h; morpholine, CH 2CI2 , 23
°C, 48 h, 80%. d) Br 2, MeCN, 0 °C, 15 min, 86%. Work done in collaboration with Dr. James Ashenhurst.
precursors for (+)-WIN 64821 (1) and (-)-ditryptophenaline (2), respectively, were prepared in
86% combined yield by exposure of N-benzenesulfonyl diketopiperazine (-)-18 to bromine in
acetonitrile after extensive optimization by Dr. Ashenhurst.'3 The diastereomeric bromides were
easily separated and were found to be amenable to storage on >10g-scale.
The total synthesis of (+)-WIN 64821 was completed in two additional steps from the
endo-bromide (+)-19 (Scheme 5). After extensive experimentation of various reaction
parameters and substrates, 14 a practical set of reaction conditions was identified for the
dimerization of diketopiperazines of the general structure 12 (Scheme 3). Under optimal
reaction conditions, treatment of (+)-19 with tris(triphenylphosphine)cobalt chloride (21 1.8
equiv) 15 in acetone ([19] = 0.1M) at 23 °C provided direct access to the N-sulfonylated dimer (-)-
22 as a single diastereomer in 43-48% yield. Importantly, this reductive dimerization
exclusively provided the required cis-5,5-fused bicycle of the hexahydropyrroloindole
substructure. 16 It should be noted that both the dimerization substrate, endo-bromide 19, and to a
lesser extent the diketopiperazines in the exo series (e.g., 20, Scheme 4), along with the
corresponding dimerization products were found to be sensitive toward base promoted
epimerization and autoxidative decomposition. Ultimately, reductive removal of the N-
benzenesulfonyl groups in (-)-22 was achieved using samarium diiodide in a mixture of
anhydrous tetrahydrofuran, N-methylpyrrolidinone, and 'butanol to give the first synthetic sample
of the natural enantiomer (+)-WIN 64821 (1, [a]21D = +230 (c = 0.15, MeOH); lit.:lb [1]D = +200
(c = 0.15, MeOH)) in 75% yield." Notably, these conditions did not lead to significant reductive
fragmentation of the C3-C3' bond, nor the epimerization of the base sensitive diketopiperazine
substructure.
Similarly, the total synthesis of (-)-ditryptophenaline (2) was completed in three steps
from the (-)-exo-bromide 20 (Scheme 5). Treatment of (-)-20 with methyl iodide and potassium
carbonate gave the corresponding N'4-Me exo-bromide (-)-23 in 93% yield. Treatment of (-)-23
with the cobalt(I)-complex 21 in acetone at 23 °C afforded the dimer (-)-24 as a single
diastereomer in 47-52% yield. Reductive removal of the benzenesulfonyl groups provided (-)-
ditryptophenaline (2, [a]21D = -292 (c = 0.97, CH2CI2); lit.:Ia [a]24D = -330 (c = 0.52, CH2CI2)) in
79% yield."l Significantly, the reaction conditions described here for the dimerization event were
directly applicable to gram-scale synthesis (e.g., (+)-19--(-)-22, 43% yield on Ig-scale, and (-)-
23---(-)-24, 47% yield on 2.5g-scale). The successful application of this key transformation to
both endo and exo series of diketopiperazine substrates (Scheme 5) offers a practical route for












1-.. ", .... L- (-)-23, R = Me (-)-Ditryptophenaline (2)
Scheme 5. Concise total synthesis of (+)-WIN 64821 (1), (-)-ditryptophenaline (2) from bromides (+)-19 and (-)-
20. Conditions: a) CoCI(PPh3)3, acetone, 23 °C, 30 min, 48%. b) SmI, NMP, 'BuOH, THF, 23 'C, 1 h , 75%. c)
Mel, K2CO3, acetone, 23 oC, 3 d, 93%. d) CoCI(PPh3)3, acetone, 23 oC, 15 min, 52%. e) SmI2, NMP, 'BuOH, THF,
23 'C, 35 min, 79%. Work done in collaboration with Dr. James Ashenhurst.
Heating a solution of (-)-ditryptophenaline (2) at 70 'C with excess phenylacetaldehyde
in acetonitrile over 8 hours provided the first synthetic sample of (-)-3 ([a] 22D = -131.5 (c = 0.36,
CHCI3) lit.:2 [la]D = -125 (c = 0.05, CHCI3))" in 29% yield, accompanied by products derived
from thermal decomposition (Scheme 6). Our synthetic (-)-3 matched all literature data for this
alkaloid, confirming the reported structure for this natural product. The thermal decomposition of
(-)-3 can be avoided using a two-step sequence at ambient temperature. Condensation of (-)-2
with dimethoxyacetal of phenylacetaldehyde at 23 °C gave the N',N"'-bis-3-styrene derivative
(-)-25 in 81% yield within 1.5 h. Partial hydrolysis of (-)-25 at 23 'C cleanly resulted in
alkaloid (-)-3 in 48% yield in 20 min with the majority of the mass balance as recovered (-)-25.
MeN.
b. 30 mol % CSA (-)-Ditryptophenaline (2) a. BnCHO, 70 TC









Scheme 6. Two routes to monostyrene derivative 3. Conditions: a) BnCHO, MeCN. 70 oC, 8h, 29%. b)
BnCH(OMe)2, 30 mol % CSA, 23 'C, 81 %. c) TFA-d, H20, C6D6, 23 OC, 48 %.
Conclusion
The enantioselective total synthesis of (+)-WIN 64821 (1), and (-)-ditryptophenaline (2)
in six and seven steps, respectively, from commercially available amino acid derivatives is
described. The simultaneous introduction of the vicinal quaternary stereocenters in these
alkaloids was achieved by a reductive homodimerization of readily available alkyl bromides. In
addition to the first synthetic sample of naturally occurring (+)-1, we provide structure
confirmation of the natural alkaloid (-)-3. The gram-scale synthesis of key intermediates and
dimerization of bromides (+)-19 and (-)-23 provides a concise and preparative route to these
I
\
alkaloids. Further development and application of this chemistry to the synthesis of other homo-
and hetero-dimeric alkaloids is ongoing and will be reported in due course.
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Experimental Section
General Procedures. All reactions were performed in oven-dried or flame-dried round-
bottomed flasks. The flasks were fitted with rubber septa and reactions were conducted under a
positive pressure of argon. Stainless steel syringes or cannulae were used to transfer air- and
moisture-sensitive liquids. Where necessary (so noted), solutions were deoxygenated by
dinitrogen purging for a minimum of 10 min. Flash column chromatography was performed as
described by Still et al. using silica gel (60-A pore size, 32-63 /m, standard grade, Sorbent
Technologies).' Analytical thin-layer chromatography was performed using glass plates pre-
coated with 0.25 mm 230-400 mesh silica gel impregnated with a fluorescent indicator (254
nm). Thin layer chromatography plates were visualized by exposure to ultraviolet light and an
aqueous solution of ceric ammonium molybdate (CAM) followed by heating (>1 min) on a hot
plate (~250 oC). Organic solutions were concentrated on Biichi R-200 rotary evaporators at ~20
Torr (house vacuum) at 25-35 'C.
Materials. Commercial reagents and solvents were used as received with the following
exceptions: dichloromethane, acetonitrile and tetrahydrofuran were purchased from J.T. Baker
(CycletainerTM ) and were purified by the method of Grubbs et al. under positive argon pressure.2
Acetone was distilled from anhydrous calcium sulfate. Methyl iodide was passed through a short
column of basic alumina prior to use. 1-methyl-2-pyrrolidinone (NMP) was distilled from
calcium hydride.
Instrumentation. Proton nuclear magnetic resonance ('H NMR) spectra were recorded with
Varian inverse probe 500 INOVA and Varian 500 INOVA spectrometers and are recorded in
parts per million from internal tetramethylsilane on the 8 scale and are referenced from the
residual protium in the NMR solvent (CHCI3: 8 7.27, DMSO: 8 2.50, CHD 2CN: 8 1.94, C6HD 5: 6
7.19). Data is reported as follows: chemical shift [multiplicity (s = singlet, d = doublet, t =
triplet, m = multiplet), coupling constant(s) in Hertz, integration, assignment]. Carbon-13
nuclear magnetic resonance (13C NMR) spectra were recorded with a Varian 500 INOVA
spectrometer and are recorded in parts per million from internal tetramethylsilane on the 8 scale
and are referenced from the carbon resonances of the solvent (CDC13: 6 77.23, DMSO-d6: 8
39.51, CD3CN: 8 118.69, C6D 6: 8 128.39). Data is reported as follows: chemical shift
[assignment]. Infrared data (IR) were obtained with a Perkin-Elmer 2000 FTIR, and are reported
as follows: [frequency of absorption (cm-1'), intensity of absorption (s = strong, m = medium, w =
weak, br = broad)]. Optical rotations were measured on a Jasco-1010 polarimeter. We are
grateful to Dr. Li Li for obtaining the mass spectrometric data at the Department of Chemistry's
Instrumentation Facility, Massachusetts Institute of Technology.
'W. C. Still, M. Kahn, A. Mitra, J. Org. Chem. 1978, 43, 2923-2925.





THF, -78 OC, 1 h
PhSO2CI
-78 OC, 2 h
5
CO 2H




N-Boc-L-tryptophan ((-)-14, 5.00 g, 16.4 mmol, 1 equiv) was azeotropically dried by
concentration from benzene (20 mL) and the residue dissolved in tetrahydrofuran (34 mL) and
cooled to -78 'C. A solution of lithium hexamethyldisilazide (8.25 g, 49.3 mmol, 3.00 equiv) in
tetrahydrofuran (30 mL) was added via cannula over 5 min. The reaction mixture was allowed
to stir for 1 h before benzenesulfonyl chloride (2.53 mL, 19.7 mmol, 1.20 equiv) was added in
one portion. The solution became red and the mixture was stirred for an additional 2 h at -78 'C.
Excess base was quenched at this temperature by addition of a solution of acetic acid in ethyl
acetate (1:1 v/v, 5 mL) and the resulting mixture was warmed to room temperature. The mixture
was diluted with aqueous hydrochloric acid (1 N, 100 mL) and extracted with ethyl acetate (3 x
100 mL). The organic layers were combined and dried over anhydrous sodium sulfate, were
filtered, and were concentrated in vacuo to afford a yellow-orange residue. The residue was
purified by flash column chromatography on silica gel (eluent: 5% acetic acid, 45% hexanes,
50% dichloromethane). Fractions containing the product (-)-15 were pooled, concentrated down
to approximately 10% of the volume, then diluted with toluene (300 mL) and concentrated. This
process was repeated two more times to afford the product as a white solid (5.2 g, 71%). Product
(-)-15 was determined to be of >99% ee by chiral HPLC analysis .of the methyl ester
(TMSCHN2, PhH, MeOH (3.5:1). Chirapak AD-H, 90% hexanes / 10% isopropanol, 2.0
mL/min, 254 nm, tR (minor, not observed) = 12.5 min, tR (major) = 19.2 min).3
'H NMR (500 MHz, DMSO, 20 oC):
13C NMR (125.8 MHz, DMSO, 20 oC):
FTIR (thin film) cm-':
12.72 (s, 1H, CO2H), 7.86-7.90 (m, 3H,
SO 2Ph-o-H, CsH), 7.66 (t, J = 7.3 Hz, 1H,
SO 2Ph-p-H), 7.53-7.60 (m, 4H, SO 2Ph-m-H,
C2H, C5H), 7.33 (app t, J = 8.1, 7.3 Hz, 1H,
C7H), 7.26 (t, J = 7.5 Hz, 1H, C6H), 7.19 (d, J
= 8.2 Hz, 1H, NH) 4.17 (m, 1H, C,,H), 3.10
(dd, J= 14.8,4.3 Hz, 1H, CloH), 2.93 (dd, J=
14.8, 10.3 Hz, 1H, CoH), 1.31 (s, 9H,
C(CH3)3).
173.4 (CI2), 155.4 (Ccbaate), 137.0 (SO 2Ph-i-
C), 134.5, (SO 2Ph-p-C), 134.3 (C9), 130.6
(C4), 129.8 (SO 2Ph-m-C), 126.6 (SO 2Ph-o-C),
124.8 (C7), 124.5 (C3), 123.4 (C6), 119.8 (Cs),
119.1 (C2), 113.2 (C8), 78.2 (CMe3), 53.3
(C,,), 28.2 (C(CH3)3), 26.2 (C,0).
3309 (br-m), 2979 (m), 1716 (s), 1663 (m),
1175 (s).
3 On 10-gram scale this same procedure provided the desired product (-)-15 in 70% yield. Additionally, on 10-gram
scale the product was isolated by direct crystallization of the crude reaction mixture from ethyl acetate hexanes
(first-crop = 55% yield (Dr. James Ashenhurst)).
HRMS (ESI) (mlz):
[(]D 22:
calc'd for C22HN 2NaO6S [M+Na]+: 467.1247
found: 467.1253
-23.3 (c = 1.00, DMF)
TLC (5% acetic acid, 5% CH3OH, 40% hexanes, 50% CH2CI2), Rf. 0.57 (UV, CAM)
CO2H HCI -H2N
PhO 2SN NHBoc MeO 2C(-)-15
EDC.HCI, HOBt
Et3N, CH2CI2





PhSO 2N 2 NHBoc
(-)-(S)-Methyl 2-((S)-2-('butoxycarbonylamino)-3-(1-(phenylsulfonyl)-1H-indol-3-yl)propanamido)-
3-phenvlpropanoate (17):
N-Sulfonylated tryptophan (-)-15 (6.50 g, 14.6 mmol, 1 equiv), L-phenylalanine methyl
ester hydrochloride ((+)-16, 4.60 g, 21.4 mmol, 1.46 equiv), and 1-hydroxybenzotriazole hydrate
(2.89 g, 21.4 mmol, 1.46 equiv) were suspended in dichloromethane (146 mL). Triethylamine
(8.93 mL, 64.0 mmol, 4.38 equiv) was added and the suspension was stirred until a golden
homogenous solution formed (5 min). To this solution was added EDCoHCI (4.29 g, 22.4 mmol,
1.53 equiv) and the resulting mixture was stirred for 8 h before another portion of EDC*HCI
(1.70 g, 8.87 mmol, 0.60 equiv) and triethylamine (4.00 mL, 28.7 mmol, 1.96 equiv) were added.
The reaction mixture was allowed to stir for an additional 15 h. The mixture was washed
sequentially with an aqueous solution of hydrochloric acid (1 N, 100 mL) and saturated aqueous
sodium bicarbonate solution (100 mL). The organic layer was dried over anhydrous sodium
sulfate, was filtered, and was concentrated in vacuo to afford a yellow foam. The crude product
was purified by flash column chromatography on silica gel (eluent: 30% ethyl acetate in
hexanes) to yield the product (-)-17 as a white foam (8.3 g, 94%). On 20-gram scale the
purification of (-)-17 is not necessary; see procedure of (-)-18.
1H NMR (500 MHz, CDC13 , 20 oC):
13 C NMR (125.8 MHz, CDC13, 20 oC):
6 7.98 (d, J = 8.5 Hz, 1H, CAH), 7.86 (app dt,
J = 7.5, 1.6 Hz, 2H, SO2Ph-o-H), 7.56 (d, J =
7.5 Hz, 1H, C5H), 7.52 (tt, J = 7.5, 1.6 Hz, 1H,
SOzPh-p-H), 7.44 (s, 1H, C2H), 7.43 (t, J =
8.0 Hz, 2H, SO 2Ph-m-H), 7.33 (app td, J =
7.0, 1.0 Hz, 1H, C7H), 7.25 (app td, J = 7.5,
0.8 Hz, 1H, C6H), 7.19-7.22 (m, 3H, C2 0H,
C2 1H, C22H), 6.92 (m, 2H, C19H, C23H), 6.23(br d, J = 6.0 Hz, 1H, N 14H), 5.00 (br d, J =
5.5 Hz, 1Hz, No1 H), 4.74 (dd, J = 13.5, 6.0
Hz, 1H, C15H), 4.40 (br d, J = 6.0 Hz, 1H,
C1lH), 3.68 (s, 3H, OCH 3), 3.10-3.18 (m, 2H,
C12H), 3.02 (dd, J = 14.0, 6.0 Hz, 1H, C17H),
2.98 (dd, J = 14.0, 6.0 Hz, 1H, C17H), 1.43
(br-s, 9H, C(CH 3)3).
6 171.4 (C16), 170.7 (C13), 155.4 (Ccarbamate),
138.1 (SO2Ph-i-C), 135.6 (C18), 135.2 (C9),
133.9 (SO 2Ph-p-C), 130.8 (C4), 129.3 (SO2Ph-
m-C), 129.2 (C19, C23), 128.6 (C20 , C22), 127.2
(C21), 126.8 (SO2Ph-o-C), 125.0 (C7), 124.6
(C2), 123.4 (C6), 119.8 (C5), 117.8 (C 3), 113.7(Cs), 80.4 (CMe3), 54.3 (C11), 53.4 (C1 5), 52.5
37.9 (C 7,), 28.3 (C(CH 3)3), 27.9
FTIR (thin film) cm-':
HRMS (ESI) (m/z):
3307 (br-s), 2979 (m), 1745 (s), 1658 (s),
1523 (br-s).
calc'd for C3 2H35N3NaO 7S [M+Na]÷: 628.2088
found: 628.2064
[a]D22:
TLC (40% EtOAc in hexanes), Rf.







a. TFA, CH2C1223 0C, 2 h
b. morpholine, CH2C12




10 16 117 0(-)-18 0
56%
(-)-(3S,6S)-3-Benzyl-6-((1-(phenylsulfonyl)-1H-indol-3-yl)methyl)piperazine-2,5-dione (18):4
Trifluoroacetic acid (6.0 mL) was added to a solution of dipeptide (-)-17 (3.00 g, 4.95
mmol, 1 equiv) and 1,3-dimethoxybenzene (1.30 mL, 9.90 mmol, 2.00 equiv) in
dichloromethane (15.0 mL) at 0 oC. After 2 h, the volatiles were removed and the residue was
redissolved in dichloromethane (24 mL). Morpholine (6 mL) was added and the resulting
mixture was vigorously stirred for 48 h as the diketopiperazine (-)-18 precipitated as a white
solid. The product was collected by filtration and washed sequentially with dichloromethane
(10.0 mL). The filter cake was dissolved in warm dimethylformamide (~55 'C, 100 mL) and
triturated by slow addition of deionized water (500 mL). The white gel was collected via
filtration and dried under reduced pressure (~20 Torr) at 70 oC to afford the diketopiperazine (-)-
18 as a white solid (1.32 g, 56%). Diketopiperazine (-)-18 was determined to be >99% ee by
chiral HPLC analysis (Chirapak AD-H, 85% hexanes / 15% isopropanol, 3.0 ml/min, 254 nm, tR
(major) = 8.3 min, tR = (minor, not observed) = 19.3 min).
On 20-gram scale the same procedure provided the desired product (-)-18 in 82% over all
yield starting from the carboxylic acid (-)-14 without the purification of the amide (-)-17.
'H NMR (500 MHz, DMSO-d 6, 20 oC):
13C NMR (125.8 MHz, DMSO-d 6, 20 oC):
8 8.14 (br d, J = 2.0 Hz, 1H, N14H), 8.02 (br d,
J = 2.0 Hz, 1H, N,0H), 7.94 (app dd, J = 7.8,
1.5 Hz, 2H, SO 2Ph-o-H), 7.87 (d, J = 8.5 Hz,
1H, CsH), 7.65 (tt, J = 7.5, 1.3 Hz, 1H,
SO 2Ph-p-H), 7.55 (m, 2H, SO2-m-H), 7.47 (d,
J = 7.5 Hz, 1H, C5H), 7.41 (s, 1H, C2H), 7.34
(td, J = 7.0, 1.0 Hz, 1H, C7H), 7.25 (td, J =
7.5, 1.0 Hz, 1H, C6H), 7.18-7.22 (m, 3H,
C20H, C21H, C22H), 6.86 (app dd, J = 8.0, 2.5
Hz, 2H, C,9H, C23H), 3.99-4.03 (m, 2H, C,,H,
C15H), 2.61 (dd, J = 14.5, 5.0 Hz, 1H, C12H),
2.55 (dd, J = 13.3, 4.8 Hz, 1H, C,7H), 2.31
(dd, J= 13.5, 5.3 Hz, 1H, C17H), 2.29 (dd, J=
14.0 Hz, 6.5 Hz, 1H, C12H).
8 166.4 (C16), 166.3 (C13), 137.1 (SO2Ph-i-C),
136.1 (C18), 134.5 (SO 2Ph-p-C), 134.2 (C9),
130.6 (C4), 129.84, 129.82, 128.1 (C 20, C22),
126.7 (SO 2Ph-o-C), 126.6 (C21), 125.1 (C2),
124.7 (C7), 123.3 (C6), 120.2 (C5), 117.6 (C3),
4 Experiment later optimized in collaboration with Dr. James Ashenhurst to afford (-)-18 in 80 % yield.
FTIR (nujol) cm-l:
HRMS (ESI) (m/lz):
113.0 (C8), 55.4 (C15), 54.0 (C11), 39.55 (C17),
29.3 (C12).
2954 (s), 1675 (s), 1665 (s), 1460 (s), 1376
(s), 1270 (m), 1117 (m), 975 (m).
calc'd for C26H23N 3NaO4S [M+Na]÷: 496.1301
found: 496.1296
[a]D22:
TLC (5% CH3OH in CH2C12), Rf.
-145.7 (c = 1.00, DMF)
0.33 (UV, CAM)













2 10 16 19N H 17 
44 56 Sa 2Ph (-)-20
86 %
(+)-endo-Bromide 19 and (-)-exo-Bromide 20:6
A solution of bromine in acetonitrile (1.0 M, 1.00 mL, 1.00 mmol, 4.00 equiv) was added
to a vigorously stirred suspension of the diketopiperazine (-)-18 (118 mg, 0.249 mmol, 1 equiv)
in acetonitrile (2.50 mL) at 0 oC. The resulting homogeneous red solution and was stirred for 15
min before excess bromide was quenched by the addition of a saturated aqueous solution of
sodium thiosulfate (25 ml). The mixture was extracted with dichloromethane (3 x 25 mL) and
the organic layers were dried over anhydrous sodium sulfate, were filtered, and were
concentrated in vacuo to afford an orange residue. The residue was purified by flash column
chromatography on silica gel (eluent: 5% isopropanol, 45% benzene, 50% hexanes) to provide




1H NMR (500 MHz, CDCI3, 20 oC):
13C NMR (125 MHz, CDC13, 20 oC):
FTIR (thin film):
7.99 (d, J = 7.4 Hz, 2H, SO 2-o-H), 7.61 (d, J =
8.1 Hz, 1H, CAH), 7.55 (t, J = 7.4 Hz, 1H,
SO2Ph-p-H), 7.44 (app t, J = 8.0, 7.6 Hz, 2H,
SOzPh-m-H), 7.29-7.36 (m, 4H, CsH, C7H,
C20H, C22H), 7.25-7.27 (app t, 1H, C21H), 7.19(d, J = 7.1 Hz, 2H, C19H, C23H), 7.14 (app t, J
= 7.6, 7.1 Hz, 1H, C6H), 6.54 (s, 1H, C2H),
5.65 (s, 1H, N14H), 4.37 (app t, J = 7.8, 7.5
Hz, 1H, CIIH), 4.25 (dd, J = 10.6, 3.6 Hz, 1H,
C15H), 3.66 (dd, J = 14.7, 3.6, 1H, C17H), 3.25(dd, J = 14.4, 6.6, 1H, C12H), 3.00 (dd, J =
14.4, 8.8, 1H, C12H), 2.85 (dd, J = 14.7, 10.6,
1H, C17H).
167.9 (C13), 167.1 (C16), 138.9 (C9), 137.9
(SOzPh-i-C), 135.7 (C18), 133.9 (SO2Ph-p-C),
133.6 (C4), 131.1 (CO), 129.5 (C20, C22), 129.2
(C19, C23 ), 129.1 (SO2Ph-m-C), 128.5 (SO2Ph-
o-C), 127.8 (C21), 126.0 (C6), 125.1 (C5),
117.1 (C8), 87.2 (C2), 61.1 (C3), 58.5 (C11),
57.1 (C15), 40.6 (C12), 36.2 (C17).
3222 (br-w), 1695 (s), 1366 (s), 1169 (s), 1089
(s).
6 On 12-gram scale this same procedure provided the desired products (-)-exo-bromide 20 and (+)-endo-bromide
19 in 46% and 42% yield, respectively (88% total yield, 48:52-endo:exo (Dr. James Ashenhurst)).





+47.7 (c = 1.02, MeOH)
119-123 °C (dec)
TLC (10% 'PrOH, 40% PhMe, 50% hexanes), Rf 0.14 (UV, CAM)
(-)-exo-Bromide 20:
1H NMR (500 MHz, CDC13, 20 oC):





7.88 (d, J = 7.5.Hz, 2H, SO2 Ph-o-H), 7.69 (d,
J = 8.2 Hz, 1H, CH), 7.56 (t, J = 7.5 Hz, 1H,
SO 2Ph-p-H), 7.44 (app t, J = 8.0, 7.7 Hz, 2H,
SO 2Ph-m-H), 7.36-7.39 (m, 3H, C20H, C22 H,
C7H), 7.31 (app t, 2H, C21H, CSH), 7.19-7.22
(m, 3H, C19H, C23H, C6H), 6.54 (s, 1H, CzH),
5.65 (s, 1H, N 14H), 4.37 (dd, J = 9.5, 3.1 Hz,
1H, C15H), 3.78 (dd, J = 11.6, 5.0 Hz, 1H,
C11H), 3.61 (dd, J = 14.3, 3.5 Hz, 1H, C,7H),
3.08 (dd, J = 12.7, 5.3 Hz, 1H, C12H), 2.95
(dd, J = 14.3, 9.6 Hz, 1H, C17H), 2.43 (app t, J
= 12.2, 1H, C12H).
166.0 (C13), 163.7 (C16), 141.3 (C9), 137.8
(SOzPh-i-C), 135.4 (C18 ), 134.0 (SO 2Ph-p-C),
132.8 (C4), 131.4 (C7), 129.7 (C20, C22), 129.6
(C19, C23), 129.3 (SO2Ph-m-C), 128.2 (SO2Ph-
o-C), 128.0 (C21), 126.7 (C6), 124.9 (C5),
118.0 (C8), 85.7 (C2), 58.6 (C 1 ), 58.1 (C3),
56.5 (C15), 47.0 (C12), 37.9 (C17).
3227 (br-w), 3064 (w), 1684 (s), 1369 (s),
1171 (s).
calc'd for C27H23BrN 3O4S [M+H]+: 552.0514
found: 552.0602
-198 (c = 1.00, CH 2CI2)
122-123 'C (dec.)
TLC (10% 'PrOH, 40% PhMe, 50 % hexanes), Rf. 0.28 (UV, CAM)
K2C0 3, CH31
Acetone
23 OC, 3 d
soPh (-)-20 'SOPh' (-)-23S2Ph 93 %
(-)-N-Methyl exo-bromide 23:
Potassium carbonate (1.86 g, 13.4 mmol, 25.0 equiv) followed by methyl iodide (10.76
mL) were sequentially added to a vigorously stirred solution of the exo-bromide (-)-20 (297 mg,
0.538 mmol, 1 equiv) in acetone (13.45 mL) at 23 oC. The reaction flask containing the resulting
suspension was covered in aluminum foil and stirred for 3 d at 23 'C. The volatiles were
removed and the resulting white solid residue was partitioned between ethyl acetate (100 mL)
and deionized water (100 mL). The layers were separated and the aqueous layer was extracted
with ethyl acetate (3 x 30 mL). The combined organic layers were dried over anhydrous sodium
sulfate, were filtered, and were concentrated in vacuo to provide crude (-)-23 as a white solid
residue. The residue was purified by flash column chromatography on silica gel (eluent: 2%
methanol in dichloromethane) to give the product (-)-23 as a white solid foam (282 mg, 93%).
On 3-gram scale this same procedure provided the desired product (-)-23 in 88% yield.
'H NMR (500 MHz, CDCl3 , 20 oC):
13C NMR (125.8 Hz, CDCl3 , 20 oC):
FTIR (thin film) cm-':
HRMS (ESI) (m/z):
[a]D22:
TLC (5% CH30H in CH2Cl2), Rf.
8 7.90 (app ddd, J = 8.5, 2.0, 1.0 Hz, 2H,
SO2Ph-o-H), 7.62 (d, J = 8.0 Hz, 1H, CAH),
7.57 (tt, J = 7.5, 1.3 Hz, 1H, SO2Ph-p-H), 7.47
(app t, J = 7.8 Hz, 2H, SO 2Ph-m-H), 7.35 (app
t, J = 7.3 Hz, 2H, C20H, C22H), 7.28-7.32 (m,
2H, C7H, C21H), 7.16 (app dd, J = 7.5, 1.5 Hz,
1H, CsH), 7.10-7.13 (m, 3H, C6H, C19H,
C23H), 6.41 (s, 1H, C2H), 4.42 (t, J = 3.8 Hz,
1H, C15H), 3.52 (dd, J = 13.8, 2.8 Hz, 1H,
C,,H), 3.49 (dd, J = 12.5, 4.5 Hz, 1H, C,,H),
3.17 (dd, J= 13.8, 4.3 Hz, 1H, C,7H), 3.12 (s,
3H, C24H), 2.48 (dd, J = 12.0, 4.5 Hz, 1H,
Cl2H), 0.57 (t, J = 12.5 Hz, C,12H).
6 163.42 (CAmide), 163.38 (CAmide), 141.5 (C9),
137.7 (SO 2Ph-i-C), 134.5 (C,8), 133.9 (SO 2Ph-
p-C), 132.1 (C4), 131.2 (C7), 130.2 (C19, C23),
129.7 (C20, C22), 129.3 (SO 2Ph-m-C), 127.9
(C2 1), 127.7 (SOzPh-o-C), 126.2 (C6), 125.4
(C5), 116.5 (C8), 85.4 (C2), 63.6 (CIs), 58.7
(C3), 58.1 (C1,), 47.7 (C12), 36.4 (C1,7), 33.1
(C24).
3063(w), 1681(s), 1664(s), 1447(m), 1172(m).
calc'd for C27H24BrN3NaO 4S[M+Na]+:588.0563
found: 588.0546







S N ' 0
H N 12 13 NHH~~53~1;NH -
(-)-22 j ' *N '(+2N22 10 rN H 17 198O 2P0S02Ph
(-)-endo-Dimer 22:7
Freshly prepared tristriphenylphosphine cobalt chlorides (CoCI(PPh3)3, 610 mg, 0.693
mmol, 1.80 equiv) was added rapidly as a solid to a degassed (dinitrogen purge, 10 min) solution
of bromide (+)-19 (319 mg, 0.577 mmol, 1 equiv) in acetone (5.80 mL) at 23 °C under an argon
atmosphere. The solution immediately turned blue. After 15 min, the reaction mixture was
diluted with deionized water (75 mL) and extracted with ethyl acetate (3 x 50 mL). The
combined organic extracts were washed with brine (50 mL), were dried over anhydrous sodium
sulfate, were filtered, and were concentrated under reduced pressure. The resulting yellow foam
was purified by flash column chromatography on silica gel (eluent: 10% acetone, 90%
dichloromethane) to afford the (-)-endo-dimer 22 (120 mg, 44%) as a white solid.
On a gram scale this same procedure provided the desired product (-)-22 in 43% yield.
1H NMR (500 MHz, CDCl3 , 20 °C):
'
3C NMR (125 MHz, CDCl3, 20 oC):
FTIR (thin film):
HRMS-ESI (mlz):
8.15 (d, J = 7.5 Hz, 4H, SO 2Ph-o-H), 7.65 (t, J
= 7.3 Hz, 2H, SO2Ph-p-H), 7.59 (app t, J =
7.85, 7.21, 4H, SO2Ph-m-H), 7.35 (t, J = 7.8
Hz, 4H, CsH, C7H), 7.22-7.30 (m, 8H, C20H,
C21H, C22H, C6H), 7.13 (d, J = 8.0 Hz, 2H,
CsH), 7.08 (d, J = 6.7 Hz, 4H, C,19H, C23H),
6.50 (s, 2H, C2H), 5.36 (s, 2H, N14H), 4.67 (t,
J = 8.8 Hz, 2H, C,15H), 4.20 (dd, J = 10.5, 3.6
Hz, 2H, C,,H), 3.39 (dd, J = 14.5, 3.6 Hz, 2H,
C,7H), 2.74 (dd, J = 15.0, 9.7 Hz, 2H, C12H),
2.52 (dd, J = 15.0, 8.3 Hz, 2H, C12H), 2.49
(dd, J= 14.5, 10.6 Hz, 2H, C17H).
168.9 (C13), 168.5 (C16), 142.2 (C9), 141.6
(SO 2Ph-i-C), 135.6 (Cs), 135.3 (C4), 133.3
(SO 2Ph-p-C), 129.9 (C7) , 129.5 (C20 , C22),
129.1 (SO2Ph-m-C), 129.1 (C,19, C23), 127.8
(C21), 127.4 (C5), 127.3 (SO 2Ph-o-C), 125.3
(C6), 117.6 (C8), 82.0 (C2), 59.6 (CO), 57.7(C,1), 57.0 (C15), 36.2 (C17), 33.0 (Cl 2).
3337 (br-w), 1695 (s), 1388 (m), 1341 (m),
1161 (m).
calc'd for Cs2H45N6OsS2 [M+H]+: 945.2735
found: 945.2709
7 Experiment later optimized in collaboration with Dr. James Ashenhurst to afford (-)-15 in 48 % yield.
8 a) M. Aresta, M. Rossi, A. Sacco. Inorg. Chim. Acta 1969, 3,227. b) Baysdon, S. L.; Liebeskind, L. S. Organometallics 1982,
1,771.
% u (+)- IVS02Ph
M.p. (CH2CI2):
TLC (20% acetone in CH 2CI2), Rf.









MeN 12 13 24
N (-)-24 10 18
SO 2Ph
(-)-exo-Dimer 24:
Freshly prepared tristriphenylphosphine cobalt chloride (CoCI(PPh3)3, 790 mg, 0.890
mmol, 1.80 equiv) was added rapidly as a solid to a degassed (dinitrogen purge, 10 min) solution
of bromide (-)-23 (282 mg, 0.498 mmol, 1 equiv) in acetone (5.0 mL) at 23 °C under an argon
atmosphere. The solution immediately turned blue. After 15 min, the reaction mixture was
diluted with deionized water (100 mL) and extracted with ethyl acetate (3 x 30 mL). The
combined organic extracts were washed with brine (2 x 20 mL), were dried over anhydrous
sodium sulfate, were filtered, and were concentrated under reduced pressure. The resulting
yellow oil was purified by flash column chromatography on silica gel (eluent: 20% acetone, 30%
hexanes, 50% dichloromethane) to afford the (-)-exo-dimer 24 (125 mg, 52%) as a white solid.
On a 2.5-gram scale this same procedure provided the desired product (-)-24 in 47%
yield.
1H NMR (500 MHz, CDCl3 , 20 °C):
13C NMR (125.8 Hz, CDC13, 20 °C):
FTIR (thin film) cm -':
HRMS (ESI) (m/z):
8 7.97 (app d, J = 7.5 Hz, 4H, SO2Ph-o-H),
7.58 (app t, J = 7.5 Hz, 2H, SO 2Ph-p-H), 7.47
(t, J = 7.8 Hz, 4H, SO 2Ph-m-H), 7.40 (d, J =
7.5 Hz, 2H, CsH), 7.25 (t, J = 7.8 Hz, 4H,
C20H, C23H), 7.21 (d, J = 8.5 Hz, 2H, C8H),
7.17 (d, J = 7.0 Hz, 4H, C19H, C23H), 7.09 (t, J
= 7.0 Hz, 2H, C21H), 7.06 (d, J = 7.3 Hz, 2H,
C7H), 6.93 (t, J = 7.3 Hz, 2H, C6H), 6.63 (s,
2H, C2H), 3.97 (dd, J = 4.5, 3.5 Hz, 2H,
C15H), 3.74 (dd, J = 11.8, 4.8 Hz, 2H, C11H),
3.31 (d, J = 4.5 Hz, 4H, C17H), 2.98 (s, 6H,
C24H), 2.59 (dd, J = 12.0, 5.0 Hz, 2H, C12H),
1.36 (t, J = 12.0 Hz, 2H, C12H).
8 164.3 (C13), 162.6 (C16), 142.6 (C9 ), 141.3
(SO2Ph-i-C), 136.5 (C18), 133.2 (SO2Ph-p-C),
130.2 (C7), 129.7 (C19, C23), 129.2 (SO2Ph-m-
C), 129.1 (C20 , C22), 128.2 (C4), 127.3 (C21),
126.8 (SO2Ph-o-C), 124.6 (C5), 124.3 (C6),
113.4 (C8), 78.9 (C2), 63.0 (C15), 59.8 (C3),
57.7 (C11), 39.4 (C1 2), 36.8 (C17), 33.0 (C24).
3063 (w), 2940 (w), 1670 (s), 1447 (m), 1170
(m).
calc'd for C54H4,N 6NaOS 2 [M+Na]':
995.2867
found: 995.2870
-214.1 (c = 1.00, CH2C12)
168-172 'C (dec.)M.p. (CH 2C12):
TLC (20% acetone, 40% hexanes, 40% CH 2CI2), Rf 0.32 (UV, CAM)
Sml 2, NMP, tBuOH




A fresh solution of samarium diiodide in tetrahydrofuran (0.1 M, 3.20 mL, 0.320 mmol,
6.04 equiv) was added dropwise over one hour to a degassed (dinitrogen purge, 10 min) solution
of dimer (-)-22 (50 mg, 53 jimol, 1 equiv), 1-methyl-2-pyrrolidinone (3.15 ml), and 'butanol
(3.15 mL) at 0 oC. After 20 min a white precipitate formed. After complete addition, the dark
black reaction mixture was poured into a saturated aqueous sodium carbonate solution (100 mL)
and extracted with ethyl acetate (2 x 30 mL). The combined organic layers were washed with
water (3 x 50 mL), were dried over anhydrous sodium sulfate, and were concentrated in vacuo.
The residue was purified by flash column chromatography on silica gel (eluent: 30% acetone in
dichloromethane) to afford (+)-WIN 64821 (1) as a white solid (26.3 mg, 75%). All spectral
data were in agreement with those reported in the literature.'
1H NMR (500 MHz, CD 3CN, 20 oC):
13C NMR (125.8 MHz, CD3CN, 20 oC):




TLC (30% Acetone in CH 2C12), Rf.
6 7.34 (d, J = 7.5 Hz, 2H, C5H), 7.10-7.17 (m,
12H, C19H, C20H, C21H, C22H, C23H, C7H),
6.73 (t, J = 7.5, 2H, C6H), 6.68 (d, J = 7.8 Hz,
2H, C8H), 5.87 (s, 2H, N 4H), .5.85 (s, 2H,
N1H), 4.86 (s, 2H, C2H), 4.16 (t, J = 5.1 Hz,
2H, C15H), 4.06 (t, J = 8.4 Hz, 2H, C11H). 3.09
(dd, J = 14.7, 4.9 Hz, 2H, C17H), 2.96-3.01
(m, 4H, C17H, C12H), 2.51 (dd, J = 14.0, 7.9,
2H, C12H).
6 170.1 (C13), 169.3 (C16), 150.4 (C 9), 137.7
(C18), 131.8 (C4), 130.7 (C19, C23), 130.5 (C7),
129.7 (C20, C22), 128.0 (C21), 126.4 (C 5), 120.6
(C6), 110.8 (C8), 80.9 (C2), 61.3 (C3), 58.1(C, ), 57.3 (C 5s), 37.1 (C12), 36.4 (C17).
3382 (br-w), 1674 (s), 1410 (m), 910 (m), 733
(m).
calc'd for C4oH 37N60 4 [M+H]÷: 665.2871
found: 665.2859
+230 (c = 0.15, MeOH) 9
181-183 'C (dec)
0.33 (UV, CAM).
9 a) [a]D = +200.0 (c = 0.15, MeOH), Barrow, C. J.; Cai, P.; Snyder, J. K.; Sedlock, D. M.; Sun, H. H.; Cooper, R. J. Org. Chem.
1993, 58, 6016. b) [a]D = -200.0 (c = 0.19, MeOH), Overman, L. E.; Paone, D. V. J. Am. Chem. Soc. 2001,123, 9465.
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Comparison of our data for (+)-WIN-64821 (1) with literature:
Assignment Barrow's Report9 a Overman's Report9b This Work
(+)-WIN 64821 (1) (-)-WIN 64821 (1) (+)-WIN 64821 (1)
'H NMR, 360 MHz, CD3CN 'H NMR, 500 MHz, CD 3CN 'H NMR, 500 MHz, CD3CN, 20
oC
N1 5.84 (s) 5.86 (s) 5.85 (s)
C2 4.85 (br-s) 4.86 (br-s) 4.86 (s)
C3
C4
C5 7.34 (d, J= 8.0 Hz) 7.33 (d, J = 7.6 Hz) 7.34 (d, J= 7.5 Hz)
C6 6.73 (td, J = 8.0, 1.2 Hz) 6.72 (t, J = 7.5 Hz) 6.73 (t, J = 7.5 Hz)
C7 7.10 (td, J = 8.0, 1.2 Hz) 7.10 (t, J = 8.3 Hz) 7.10-7.17 (m)
C8 6.67 (d, J= 8.0 Hz) 6.67 (d, J= 7.8 Hz) 6.68 (d, J= 7.8 Hz)
C9
C11l 4.05 (t, J= 8.5 Hz) 4.05 (br t, J= 8.5 Hz) 4.06 (t, J = 8.4 Hz)
2.98 (dd, J = 14.0, 8.0 Hz) 2.95-3.00 (m) 2.96-3.01 (m)C12 2.50 (dd, J = 14.0, 7.5 Hz) 2.50 (dd, J= 14.0, 7.9 Hz) 2.51 (dd, J = 14.0, 7.9 Hz)
C13
C14 5.88 (br-s) 5.94 (s) 5.87 (s)
C15 4.15 (bt, J = 5.5 Hz) 4.14 (br t, J= 5.2 Hz) 4.16 (t, J = 5.1 Hz)
C16
3.09 (dd, J = 14.5, 5.0 Hz) 3.09 (dd, J= 14.7, 4.9 Hz) 3.09 (dd, J = 14.7, 4.9 Hz)C17 2.98 (dd, J= 14.5, 6.0 Hz) 2.97 (dd, J= 14.7, 6.3 Hz) 2.96-3.01 (m)
C18
C19, C23 7.13 (s) 7.12-7.15 (m) 7.10-7.17 (m)
C20, C22 7.13 (s) 7.12-7.15 (m) 7.10-7.17 (m)
C21 7.13 (s) 7.12-7.15 (m) 7.10-7.17 (m)
Assignment Barrow's Report9a Overman's Report9b This Work
(+)-WIN 64821 (1) (-)-WIN 64821 (1) (+)-WIN 64821 (1)
3`C NMR, CDCN 13C NMR, 125 MHz, CDCN10  '3C NMR, 125.8 MHz, CD3CN, 20 OC
C2 80.82 81.06 80.9
C3 61.14 61.54 61.3
C4 131.90 131.74 131.8
C5 126.53 126.41 126.4
C6 120.86 120.57 120.6
C7 130.60 130.44 130.5
C8 110.82 110.82 110.8
C9 150.56 150.26 150.4
C11 57.93 58.35 58.1
C12 36.88 37.44 37.1
C13 170.36 169.92 170.1
C15 57.17 57.58 57.3
C16 169.55 169.09 169.3
C17 36.17 36.75 36.4
C18 137.88 137.67 137.7
C19,C23 130.82 130.65 130.7
C20, C22 129.84 129.68 129.7
C21 128.11 127.97 128.0
to Professor L. E. Overman, personal communication 2007, and see: Overman, L. E.; Paone, D. V. J. Am. Chem. Soc. 2001, 123,
9465.
Sml2, NMP, tBuOH




A fresh solution of samarium diiodide in tetrahydrofuran (0.1 M, 10.8 mL, 1.08 mmol,
6.58 equiv) was added dropwise over 35 min to a degassed (dinitrogen purge, 10 min) solution of
dimer (-)-24 (160 mg, 164 [Lmol, 1 equiv), 1-methyl-2-pyrrolidinone (9.85 ml), and 'butanol
(9.85 mL) at 0 'C. During the addition the reaction mixture turned bright yellow and then
became clear with a white precipitate. After complete addition, the dark black reaction mixture
was poured into a saturated aqueous sodium carbonate solution (300 mL) and extracted with
ethyl acetate (2 x 150 mL). The combined organic layers were washed with water (300 mL),
were dried over anhydrous sodium sulfate, and were concentrated in vacuo. The residue was
purified by flash column chromatography on silica gel (eluent: 100% ethyl acetate) to afford (-)-
ditryptophenaline (2) as a white solid (90.2 mg, 79%). All spectral data were in agreement with
those reported in the literature. 5b.
1H NMR (500 MHz, CDCl3 , 20 oC):
13C NMR (125.8 MHz, CDC13, 20 oC):
FTIR (thin film) cm-':
HRMS (ESI) (m/lz):
8 7.57 (app t, J = 7.5 Hz, 4H, C2oH, C22H),
7.51 (app t, J = 7.0 Hz, 2H, C21H), 7.14 (app
d, J = 7.5 Hz, 4H, C19H, C23H), 7.07 (td, J =
8.0, 1.0 Hz, 2H, C7H), 6.97 (d, J = 7.5 Hz, 2H,
CsH), 6.70 (td, J = 7.5, 1.0 Hz, 2H, C6H), 6.55
(d, J = 7.5 Hz, 2H, C7H), 4.81 (s, 2H, C2H),
4.69 (s, 2H, NIH), 4.26 (m, 2H, Cs1 H), 3.66
(ddd, J = 12.0, 5.0, 1.5 Hz, 2H, C11H), 3.53
(dd, J = 14.5, 3.0 Hz, 2H, C17H), 3.25 (dd, J =
14.5, 4.5 Hz, 2H, C17H), 3.03 (s, 6H, C24H),
2.02 (dd, J = 12.5, 5.0 Hz, 2H, C12H), 1.57 (t,
J = 12.0 Hz, 2H, C12H).
8 165.6 (C13), 164.1 (C1 6), 150.3 (C 9), 134.6
(C1 8), 129.8 (C7), 129.6 (C20 , C 2 2), 129.5 (C19,
C23), 128.1 (C21), 126.6 (C4), 126.0 (C5), 119.1
(C6), 109.8 (C8), 78.8 (C2), 63.3 (C15), 59.1
(C3), 58.8 (C11), 36.4 (C17), 36.1 (C12), 32.8
(C24).
3344 (br-m), 2924 (m), 1658 (s), 1454 (s),
1318 (m).
calc'd for C4 2H41N 60 4 [M+H]÷: 693.3184
found: 693.3192




TLC (ethyl acetate), Rf.
-292 (c = 0.97, CH2CI 2) 12
200-204 oC (dec)
0.37 (UV, CAM)
12 a) [a]D23.5 = -330 (c = 0.52, CH2C12), Springer, J. P.; Btichi, G.; Kobbe, B.; Demain, A. L.; Clardy, J. Tetrahedron Lett. 1977,
18, 2403. b) [a]D," = -318.1 (c = 0.46, CH 2CI), Nakagawa, M.; Sugumi, H.; Kodato, S.; Hino, T. Tetrahedron Lett. 1981, 22,
5323. c) [a]D = -317 (c = 0.11, CH2CI2), Overman, L. E.; Paone, D. V. J. Am. Chem. Soc. 2001,123,9465.
Comparison of our data for (-)-ditryptophenaline (2) with literature:
Assignment Maes's Report' Overman's Report9b  This Work13
(-)-ditryptophenaline (2) (-)-ditryptophenaline (2) (-)-ditryptophenaline (2)
'H NMR, 500 MHz, CDC13  'H NMR, 500 MHz, CDC13  'H NMR, 500 MHz, CDCI1, 20 oC
N1 4.70 (s) 4.65 (br s) 4.69 (s)
C2 4.80 (s) 4.79 (s) 4.81 (s)
C3
C4
C5 6.94 (d, J= 7.5 Hz) 6.94 (d, J= 7.5 Hz) 6.97 (d, J = 7.5 Hz)
C6 6.66 (br-t, J = 7.4 Hz) 6.66 (ddd, J = 7.5,7.5, 0.7 Hz) 6.70 (td, J = 7.5, 1.0 Hz)
C7 7.03 (dt, J = 7.6, 0.9 Hz) 7.03 (ddd, J = 7.7, 7.7, 1.1 Hz) 7.07 (td, J = 8.0, 1.0 Hz)
C8 6.51 (d, J= 7.8 Hz) 6.51 (d, J= 7.8 Hz) 6.55 (d, J= 7.5 Hz
C9
Cli 3.63 (ddd,J = 12.0, 4.9, 1.2 Hz) 3.63 (ddd,J = 12.0,4.9, 1.3 Hz) 3.66 (ddd, J= 12.0, 5.0, 1.5 Hz)
1.99 (dd, J = 4.9, 12.4 Hz) 1.99 (dd, J= 12.4, 4.9 Hz) 2.02 (dd, J= 12.5, 5.0 Hz)C12 1.55 (t, J = 12.2 Hz) 1.55 (t, J = 12.2 Hz) 1.57 (t, J = 12.0 Hz)
C13
C15 4.22 (m) see reference 4.26 (m, 2H)
C16
3.49 (dd, J = 14.3, 3.1 Hz) 3.49 (dd, J= 14.3, 3.2 Hz) 3.53 (dd, J = 14.5, 3.0 Hz)C17 3.21 (dd, J = 4.4, 14.3 Hz) 3.22 (dd, J = 14.3,4.4 Hz) 3.25 (dd, J = 14.5,4.5 Hz)
C18
C19, C23 7.10 (d, J = 7.0 Hz) 7.10 (d, J= 7.0 Hz) 7.14 (app d, J = 7.5 Hz)
C20, C22 7.51 (t, J = 7.3 Hz) 7.52 (t, J = 7.0 Hz) 7.57 (app t, J= 7.5 Hz)
C21 7.46 (tt, J= 7.3 Hz) 7.46 (t, J = 7.3 Hz) 7.51 (app t, J= 7.0 Hz)
C24 2.99 (s) 2.99 (s) 3.03 (s)
13 Data for this report were obtained with the solvent referenced at 7.27 ppm. See the Instrumentation section on page S1.
Comparison of our data for (-)-ditryptophenaline (2) with literature continued:
Assignment Maes's Report 1  Overman's Reporteb  This Work14
(-)-ditryptophenaline (2) (-)-ditryptophenaline (2) (-)-ditryptophenaline (2)
13C NMR, 125.8 MHz, CDC13  13C NMR, 125 MHz, CDC13  13C NMR, 125.8 MHz, CDC13, 20
OC
C2 78.55 78.55 78.8
C3 58.89 58.86 59.1
C4 126.36 126.38 126.6
C5 125.59 125.63 126.0
C6 118.78 118.84 119.1
C7 129.52 129.53 129.8
C8 109.49 109.53 109.8
C9 150.09 150.06 150.3
Cl1 58.44 58.45 58.8
C12 35.95 35.92 36.1
C13 165.30 165.31 165.6
C15 63.00 63.03 63.3
C16 163.86 163.85 164.1
C17 36.10 36.09 36.4
C18 134.42 134.41 134.6
C19, C23 129.19 129.21 129.5
C20, C22 129.23 129.26 129.6
C21 127.81 127.81 128.1
C24 32.44 32.42 32.8
14 Data for this report were obtained with the solvent referenced at 77.23 ppm. See the Instrumentation section on page S1.
19' 17'
PhCH2CHO
CH 3CN, 70 -C, 8 h
29 %
(-)-Ditryptophenaline (2) (-)-1 '-(2-Phenylethylene)-ditryptophenaline (3)
(-)-1'-(2-Phenvlethylene)-ditrvptophenaline (3):
To a suspension of (-)-ditryptophenaline (2, 40.0 mg, 57.7 [tmol, 1 equiv) in acetonitrile
(2.80 mL) was added phenylacetaldehyde (72 ýtL, 0.58 mmol, 10 equiv) and the resulting
mixture was heated to 70 oC for 8 h. The mixture was allowed to cool to room temperature and
the crude reaction mixture was purified directly by flash column chromatography on silica gel
(eluent: 10% Et3N, 45% hexanes, 45% dichloromethane) to afford the natural product (-)-1'-(2-
phenylethylene)-ditryptophenaline (3) as a white powder (13.5 mg, 29%). All spectral data were
in agreement with those reported in the literature. 15 16
'H NMR (500 MHz, CDCl3 , 20 oC): 8 7.54 (J = 7.5 Hz, 2H, C20,H, C22,H), 7.43 (d,
J = 7.0 Hz, 2H, C28,H, C32 .H), 7.39 (t, J = 7.5
Hz, 1H, C21,H), 7.36 (t, J = 7.3 Hz, 2H, C29,H,
C31'H), 7.36 (d, J = 14.5 Hz, 1H, C25,H), 7.30
(t, J = 7.8 Hz, 2H, C20H, C22H), 7.20 (dd, J =
8.0, 1.0 Hz, 2H, C19,H, C23H), 7.15-7.18 (m,
3H, C2 1H, C7,H, C30,H), 7.10 (d, J = 7.5 Hz,
2H, C19H, C23H), 7.06 (t, J = 7.5 Hz, 1H,
C7H), 7.06 (d, J = 7.5 Hz, 1H, CsH), 6.95 (d,
J = 7.5 Hz, 1H, C5H), 6.95 (d, J = 7.5 Hz, 1H,
C8,H), 6.80 (td, J = 7.5, 0.5 Hz, 1H, C6,H),
6.68 (td, J = 7.5, 1.0 Hz, 1H, C6H), 6.56 (d, J
= 14.5 Hz, 1H, C26,H), 6.52 (d, J= 8.0 Hz, 1H,
CsH), 5.52 (s, 1H, C2,H), 4.89 (s, 1H, CzH),
4.75 (br s, 1H, NH), 4.40 (app t, J = 3.5 Hz,
1H, C,5.H), 4.24 (m, 1H, C15H), 3.75 (dd, J =
11.5, 4.0 Hz, 1H, C,1H), 3.72 (dd, J = 11.5,
4.5 Hz, 1H, C1,,H), 3.58 (dd, J= 14.3, 3.8 Hz,
1H, CI,TH), 3.53 (dd, J = 14.5, 3.5 Hz, 1H,
C,7H), 3.25 (app td, J = 14.3, 4.5 Hz, 2H,
15Barrow, C. J.; Sedlock, D. M. J. Nat. Prod. 1994, 57, 1239. CDC13 referenced to 7.25 ppm for 'H NMR analysis and 77.0 ppm
for '3C NMR analysis. [c]D = -125 (c = 0.05, CHCl 3).16 We also prepared (-)-l'-(2-phenylethylene)-ditryptophenaline (3) by hydrolysis of the corresponding (-)-
bisstyrenylditrytophenaline (25). In situ 'H NMR monitoring confirmed the formation of 3 within 20 min upon treatment of a
solution of 25 in C6D6 (0.2M) at 23 oC with water (0.5 equiv) in the presence of trifluoroacetic acid-dl (0.87 equiv). Addition of
triethylamine to quench the acid additive followed by chromatography of the reaction mixture on silica gel (eluent: 50% ethyl
acetate, 40% hexanes, 10% triethylamine) provided the recovered (-)-bisstyrenylditrytophenaline (25,42%), (-)-1'-(2-
phenylethylene)-ditryptophenaline (3,48%), along with (-)-ditryptophenaline (2, <10%).
'
3C NMR (125.8 MHz, CDC13, 20 OC):
FTIR (thin film) cm-':
HRMS (ESI) (m/z):
[a], 2 2 :
C17H, C17,H), 3.04 (s, 3H, C24.H), 3.00 (s, 3H,
C2 4H), 2.23 (dd, J = 12.5, 5.0 Hz, 1H, C12H),
2.13 (dd, J = 12.0 5.0 Hz, 1H, C12,H), 1.53 (t,
J = 12.0 Hz, 1H, C12H), 1.49 (t, J = 12.0 Hz,
1H, C12,H).
6 165.5 (C13), 165.0 (C 13'), 164.4 (C1 6), 163.7
(C16,), 150.2 (C9), 146.7 (C9,), 138.2 (C2 7,),
135.1 (C18s), 134.7 (C18), 130.06, 130.04,
129.8 (C19., C23), 129.7 (C20', C22'), 129.3 (C19,C23), 129.1 (C20, C22), 128.9 (C29', C31 '), 128.3
(C4'), 128.1 (C21), 127.88, 127.86, 126.13
(C4 ), 126.1 (C5,), 125.8 (C5), 125.6 (C30,),
125.2 (C28', C32'), 120.5 (C6.), 119.1 (C6),
109.9 (C8), 109.8 (C8.), 109.1 (C26,), 81.1
(C2,), 78.7 (C2), 63.5 (C1 5.), 63.2 (C15), 59.2
(C3), 58.65 (C3,), 58.62 (Cl,.), 58.5 (C 1), 37.9
(C12.), 36.8 (C17,), 36.40 (CI,), 36.37 (C12),
33.2 (C24,), 32.7 (C24).
3355 (br-w), 1659 (s), 1594 (m), 1484 (m),
1453 (m).
calc'd for CsoH 47N60 4 [M+H]+: 795.3653
found: 795.3655
-131.5 (c = 0.36, CHCI 3)15
M.p. (CH2CI2): 193-197 'C (dec)
TLC (10% Et3N, 45% hexanes, 45% CH2C12), Rf. 0.33 (UV, CAM)
Comparison of our data for (-)-1'-(2-Phenylethylene)-ditryptophenaline (3) with literature:
Assignment Barrow's Report"s  This Work17
(-)-1 '-(2-phenylethylene)- (-)-1 '-(2-phenylethylene)-
ditryptophenaline (3) ditryptophenaline (3)
1H NMR, 500 MHz, CDC13  'H NMR, 500 MHz, CDCI3 , 20 "C
N1 4.78 (s) 4.75 (br s)
C2 4.91 (s) 4.89 (s)
C3
C4
C5 6.94 (d, J= 7.5 Hz) 6.95 (d, J= 7.5 Hz)
C6 6.66 (t, J= 7.4 Hz) 6.68 (td, J = 7.5, 1.0 Hz)
C7 7.03 (t, J = 7.6 Hz) 7.06 (t, J = 7.5 Hz)
C8 6.50 (d, J= 7.7 Hz) 6.52 (d, J= 8.0 Hz)
C9
Cll 3.73 (m) 3.75 (dd, J = 11.5,4.0 Hz)
2.23 (dd, J= 12.3, 5.0 Hz) 2.23 (dd, J= 12.5,5.0 Hz)
1.54 (t, J= 12.0 Hz) 1.53 (t, J= 12.0 Hz)
C13
C15 4.22 (t, J= 3.4 Hz) 4.24 (m)
C16
3.53 (dd, J= 15.0, 3.1 Hz) 3.53 (dd, J= 14.5, 3.5 Hz)
3.24 (m) 3.25 (app td, J= 14.3, 4.5 Hz)
C18
C19, C23 7.08 (d, J= 7.4 Hz) 7.10 (d, J= 7.5 Hz)
C20, C22 7.28 (t, J = 7.5 Hz) 7.30 (t, J = 7.8 Hz)
C21 7.15 (t, J = 7.5 Hz) 7.15-7.18 (m)
C24 2.98 (s) 3.00 (s)
17 Data for this report were obtained with the solvent referenced at 7.27 ppm. See the Instrumentation section on page Si.
Comparison of our data for (-)-l'-(2-Phenylethylene)-ditryptophenaline (3) with literature
continued:
Assignment Barrow's Report'5  This Work"'
(-)-1 '-(2-phenylethylene)- (-)-1 '-(2-phenylethylene)-
ditryptophenaline (3) ditryptophenaline (3)
'H NMR, 500 MHz, CDCI, 'H NMR, 500 MHz, CDCl• , 20 °C
C2' 5.46 (s) 5.52 (s)
C3'
C4'
C5' 7.04 (d, J= 7.5 Hz) 7.06 (d, J= 7.5 Hz)
C6' 6.78 (t, J= 7.5 Hz) 6.80 (td, J = 7.5, 0.5 Hz)
C7' 7.13 (t, J= 7.6 Hz) 7.15-7.18 (m)
C8' 6.92 (d, J= 7.7 Hz) 6.95 (d, J= 7.5 Hz)
C9'
C11' 3.72 (m) 3.72 (dd, J= 11.5,4.5 Hz)
2.13 (dd, J= 12.1,4.6 Hz) 2.13 (dd,J = 12.0, 5.0 Hz)C12' 1.48 (t, J= 12.1 Hz) 1.49 (t, J = 12.0 Hz)
C13'
C15' 4.37 (t, J = 3.5 Hz) 4.40 (app t, J= 3.5 Hz)
C16'
3.54 (dd, J= 15.1,3.2 Hz) 3.58 (dd, J= 14.3, 3.8 Hz)C17' 3.24 (m) 3.25 (app td, J= 14.3,4.5 Hz)
C18'
C19', C23' 7.18 (d, J= 7.5 Hz) 7.20 (dd, J = 8.0, 1.0 Hz)
C20', C22' 7.51 (t, J= 7.6 Hz) 7.54 (t, J= 7.5 Hz)
C21' 7.36 (t, J= 7.6 Hz) 7.39 (t, J = 7.5 Hz)
C24' 3.02 (s) 3.04 (s)
C25' 7.32 (d, J= 14.6 Hz) 7.36 (d, J= 14.5 Hz)
C26' 6.56 (d, J= 14.6 Hz) 6.56 (d, J= 14.5 Hz)
C27'
C28', C32' 7.40 (d, J= 7.5 Hz) 7.43 (d, J= 7.0 Hz)
C29', C31' 7.33 (t, J= 7.5 Hz) 7.36 (t,J = 7.3 Hz)
C30' 7.28 (m) 7.15-7.18 (m)
Comparison of our data
continued:
for (-)-l'-(2-Phenylethylene)-ditryptophenaline (3) with literature
Assignment Barrow's Reports1  This Work's
(-)- 1'-(2-phenylethylene)- (-)-1' -(2-phenylethylene)-
ditryptophenaline (3) ditryptophenaline (3)
'
















C19, C23 129.12 129.3
C20, C22 128.91 129.1
C21 127.81 128.1
C24 32.28 32.7
18 Data for this report were obtained with the solvent referenced at 77.23 ppm. See the Instrumentation section on page S1.
Comparison of our data for (-)-1'-(2-Phenylethylene)-ditryptophenaline (3) with literature
continued:
Assignment Barrow's Report"s  This Work1"
(-)-1 '-(2-phenylethylene)- (-)-1 '-(2-phenylethylene)-
ditryptophenaline (3) ditryptophenaline (3)
















C19', C23' 129.53 129.8
C20', C22' 129.45 129.7
C21' 127.62 127.88 or 127.86
C24' 32.91 33.2
C25' 127.62 127.88 or 127.86
C26' 108.94 109.1
C27' 138.04 138.2
C28', C32' 125.02 125.2
C29', C31' 128.62 128.9
C30' 125.39 125.6
30 mol % CSA
BnCH(OMe) 2
23 OC, 1.5 h
H U 81 %(-)-Ditryptophenaline (2)
(-)-Bisstvrenvlditrvptophenaline (25):
To a solution of (-)-ditryptophenaline (2, 95.4 mg, 0.138 mmol, 1 equiv) in neat
phenylacetaldehyde dimethyl acetal (2.76 mL) was added (+)-10-camphorsulfonic acid (9.0 mg,
42 ýtmol, 0.30 equiv). The mixture was allowed to stir for 1.5 h and then purified directly by
flash column chromatography on silica gel (eluent: 10% triethylamine in hexanes --- 10%
triethylamine, 40% ethyl acetate, 50% hexanes) to afford the desired product as a white powder
(100.3 mg, 81%).
1H NMR (500 MHz, C6D6 , 20 °C):
13C NMR (125.8 MHz, C6D6, 20 oC):
FTIR (thin film) cm ':
HRMS (ESI) (m/z):
8 7.64 (d, J = 7.5 Hz, 4H, C28H, C32H), 7.60
(d, J= 14.5 Hz, 2H, C25H), 7.31 (t, J = 7.8 Hz,
4H, C2 9H, C31H), 7.28 (t, J = 7.8 Hz, 4H,
C20H, C2 2H), 7.12-7.17 (m, 8H, C19H, C2 1H,
C23H, C30H), 6.95 (d, J = 14.5 Hz, 2H, C26H),
6.79 (app td, J = 7.8, 1.5 Hz, 2H, CH), 6.52
(d, J = 8.0 Hz, 2H, CsH), 6.45-6.48 (m, 4H,
C5H, C6H), 5.97 (s, 2H, C2H), 3.48 (dd, J =
14.5, 3.0 Hz, 2H, C17H), 3.44 (dd, J = 12.5,
5.0 Hz, 2H, CIaH), 3.42 (m, 2H, C 15H), 2.74
(dd, J = 14.5, 4.5 Hz, 2H, C17H), 2.60 (s, 6H,
C2 4H), 2.48 (dd, J = 12.0, 5.0 Hz, 2H, C12H),
1.50 (t, J = 12.0 Hz, 2H, C12H).
8 164.5 (C 13), 163.6 (C16), 146.8 (C 9), 139.5
(C27), 136.7 (C18), 130.14 (C19, C23), 130.07
(C21), 130.01 (C7), 129.7 (C25), 129.5 (C20,
C22), 129.4 (C29, C31), 129.2 (C4), 126.1 (C30),
125.8 (C28, C32), 124.9 (C5), 121.0 (C6), 109.8
(C8), 109.4 (C26), 81.8 (C2), 62.9 (C15), 59.5
(C3), 58.2 (C11), 38.5 (C12), 36.6 (C 17), 32.2
(C24).
3028 (w), 1667 (s), 1594 (m), 1484 (m), 1144
(w).
calc'd for C58H53N60 4 [M+H]+: 897.4123
found: 897.4128
-199.6 (c = 0.58, CH2C12)
M.p. (C6D6): 161-164 oC (dec)
TLC (10% triethylamine, 40% ethyl acetate, 50% hexanes), Rf. 0.38 (UV, CAM)
Chapter III
N-Heterocyclic Carbene-Alcohol Hydrogen Bonds. Studies and Application
in the Amidation of Unactivated Esters
Introduction and Background
Synthesis of amides is important in many areas of chemistry, including peptide, polymer,
and complex molecule synthesis.1 Condensation products of optically active amino alcohols and
carboxylic acids are of particular significance due to their impact in stereoselective synthesis.2
Dehydration (and oxidation) of N-hydroxyalkyl amides affords valuable heterocycles that are
present in many biologically active natural products.3 Mild methods for the synthesis of amides
rely on activation of carboxylic acid derivatives using stoichiometric quantities of condensation
or activating reagents.1 Direct coupling of amines and alcohols with unactivated carboxylic acid
derivatives is of current interest.4
The discovery of stable nitrogen-heterocyclic carbenes (NHCs)S has had a large impact
on the development of new methodologies for organic synthesis.6 NHCs have served both as
ligands in organometallic catalyst systems7 and as organic catalysts. 8 Furthermore, fascinating
reports regarding the use of NHCs as nucleophilic catalysts' for the polymerization of lactones
and transesterification reactions have appeared."1
Results and Discussion
Catalytic Amidation
As part of a program directed at the discovery of new and efficient methods for target-
oriented synthesis, we sought the development of a single-step and catalytic amidation of
unactivated esters. In preliminary studies focused on carbene-catalyzed amidation of esters, we
discovered that amino alcohols were particularly reactive (Scheme 1). A combination of superb
o o
Mes-N N-Mes ) OH
R OR' Me Me R N nOH
1 3 (5 mol %) 4 R2
+ - +
REN OH THF, 23 °C HOR'
H n 2 5
Scheme 1. Carbene-catalyzed amidation of esters with amino alcohols.
reactivity, ready availability, and ease of storage of N,N-bismesitylimidazolylidene 5b (3, IMes)
led to its selection as the catalyst for our amidation studies. Under optimal conditions
(tetrahydrofuran, 1.0 M initial concentration of substrates, 23 °C), treatment of an equimolar
amount of an amino alcohol and an unactivated ester with IMes (3, 5 mol %) affords the
corresponding amide in high yield (Table 1). Under standard conditions, the coupling of methyl
Table 1. Substrate scope for the amidation of esters by 3.







lb, R = H
ic, R = COMe
ld, R = CN
le, R = CF3if, R= F
ig, R = OMe
O
H3C OR
ih, R = Me
11, R = Bn
1l, R = 'pr
1 k, R = tBu
O
R OMe
12 la, R = CH2Ph




























4ba, R = H
4ca, R = COMe
4da, R = CN
4ea, R = CF 3
4fa, R = F
4ga, R = OMe
O





4ab, R = CH 2Ph





































a Reaction times 1.5-24 h; isolated yield after purification. b In situ generation
of IMes (6.5 mol % IMes*HCl, 5.0 mol % 'BuOK). cAnhydrous LiCl (5 mol %)
used as an additive.
Table 1. Continued.
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a Reaction times 1.5-24 h; isolated yield after purification. d >94% de, >98% ee.
phenyl acetate (la) and ethanolamine (2a) was complete in 8 h while the corresponding reaction
with methyl benzoate (ib) gave the desired amide in 75% yield after 24 h (Table 1, entries 1 and
2 respectively)."
Both aromatic and aliphatic esters with a wide range of functional groups may be
employed in this amidation reaction. The amidation reaction is sensitive to both electronic and
steric factors (Table 1, entries 2-7 and 8-11, respectively). 12 The presence of heterocycles is
tolerated both on the ester and the amino alcohol components (Table 1, entries 16-19 and 22-23,
respectively). The IMes (3)-catalyzed condensation of optically active N-Boc-l-rnethyl-L-
tryptophan methyl ester (Ir) and L-phenylalaninol (2c) provided the corresponding amide 4rc in
good yield (Table 1, entry 23).13 This catalytic amidation does not require use of excess coupling
components, heat, vacuum, molecular sieves or activated esters for completion."1 The high
88d
t
reactivity of amino alcohols can be used to an advantage in their selective coupling with
unactivated esters in the presence of amines (Scheme 2).
O H2N -OH O
Ph-OM e + 2a 3 (5 mol %), P O H
THF, 23 OC H
la H2N Ph 4aa
6 99%
Scheme 2. Selective reaction of amino alcohols in the presence of amines.
Significantly, this amidation reaction proceeds with equal efficiency when a solution of
catalyst, IMes (3), is prepared by the addition of potassium tbutoxide (5 mol %) to a suspension
of N,N-bisimidazolium chloride (6.5 mol %) in tetrahydrofuran (Table 1, entry 1).1c' d This
method is particularly effective for use of NHCs that are more difficult to isolate. 14 Despite the
clear practical advantage of using in situ-generated carbene samples, we have relied on
recrystallized samples of IMes (3) in these preliminary studies to allow thorough mechanistic
investigation.
These carbene catalysts have been previously proposed to act as nucleophilic catalysts in
transesterification reactions (through activated C2-acylimidazolium intermediates). 1oa-f' 15
However, our observations regarding the surprising stability of carbene-alcohol complexes
prompt consideration of an additional mode of catalysis for NHCs. Mixing an equimolar amount
of IMes (3) and anhydrous methanol (7b) in C6D6 (0.05 M, 20 °C) leads to immediate formation
of N,N-bismesitylimidazolylidene-methanol complex 8b (Table 2, entry 2).16 The hydroxyl
Table 2. Alcohol-carbene complexes 8a-da
Mes Mes
H N C6D6  H 4 NII 2: + H-O >- :-- H-O
H N R 20 0C H N R
3 Mes 7a-d 0.05M Mes 8a-d
Entry R 6 Ha (ppm)a 6 Hb (ppm)a A (ppm)
1 a, tBu 0.67 2.81 2.14
2 b, Me 0.05 4.37 4.32
3 c, CH2CH 2NH2  -0.70 5.24 ~4.5
4 d, Bn 0.89 -6.0 ~5.1
a 'H NMR (500 MHz) data were separately recorded for the alcohols
and the IMes-alcohol complexes in C6D6 (0.05 M) at 20 oC.
proton of complex 8b displays a significant downfield shift in the 'H NMR spectrum (Table 2,
entry 2). 17 Significantly, the C2 resonance of complex 8b at 209.7 ppm is upfield by 9.7 ppm
compared to the C2 resonance of carbene 3.'8 We have also prepared the hexadeuterated variant
of this complex, IMes-d 2-methanol-d 4 (8b-d6),14 that displays a C4 resonance (6 121.1, triplet,
JicD = 27.0 Hz) and a C2 resonance (6 203.9, singlet) in C6D6, most consistent with an
imidazolylidene-d 2 fragment rather than an imidazolium-d 3 substructure.19 The hydroxyl proton
of other alcohols including 'butanol, ethanolamine, and benzyl alcohol, display a similar
downfield shift upon complex formation with IMes (3) (Table 2). Samples containing unequal
ratios of IMes to alcohol(s) exhibit averaged resonances suggesting dynamic systems with
exchange rates faster than the NMR time scale. Benzylamine does not show a significant
interaction with IMes (3), while mixing benzyl mercaptan with 3 leads to rapid precipitation of
imidazolium thiolate salts under the conditions described in Table 2. These observations are
consistent with the expected basicity of imidazolylidenes (pKa (DMSO) I'BuHCl = 22.7). 2°,
The IMes-methanol complex 8b represents the first X-ray structure of a carbene-alcohol
hydrogen-bonded complex (Figure 1).21 The distance between the carbene C2 and the oxygen (C-
View B 0i)
Figure 1. Thermal ellipsoid representation of complex 8b.
-H-O) is only 2.832(2) A. The oxygen atom resides only 0.04 A above the plane defined by the
imidazolylidene ring, thus allowing a nearly linear (1740) hydrogen bond interaction.
Significantly, the N-C-N bond angle of 102.5' found in complex 8b is much closer to the same
bond angle of 101.40 present in the parent IMes (3) 5b as compared to the bond angle of 108.60
found in the corresponding bismesitylimidazolium chloride.20a This carbene-alcohol interaction
merits further consideration alongside previously reported modes of reactivity and catalysis for
NHCs.
We propose a carbon-centered BrOnsted base20b nucleophile activation for an initial
transesterification followed by a rapid O--N acyl-transfer reaction (Scheme 3) to be operational
in our chemistry. Monitoring the IMes-catalyzed coupling of y-lactone im (Table 1, entry 15,
C=O, 1779 cm-') with ethanolamine (2a) by React-IR proceeded to give amide 4ma (Table 1,
entry 15, C=O, 1648 cm-1), while a weak absorbance for a fleeting O-(acyl)ethanolamine 12ma
(Scheme 1, 12 R = (CH 2)30H, C=O, 1736 cm') was observed during the reaction. 14
Additionally, monitoring the IMes-catalyzed amidation of methyl benzoate (lb) with
ethanolamine (2a), in THF-d8 by 1H NMR spectroscopy clearly demonstrated the intermediacy of
O-(benzoyl)-ethanolamine 12ba (Scheme 3, 12 R = Ph). 14 ,22 Furthermore, the addition of an
authentic sample of ester 12ba (0.12 equiv) to an amidation reaction of methyl benzoate (ib)
with ethanolamine (2a), in progress (at 2h, 41% conversion) under optimal reaction conditions
Mes
H RCO 2R' Mes 8- R Mes RHN O H Hi
8c H N 6+ H HIjs O NH2  Ho H OMes Mes
+ 2a 9 NH2  10 NH2
-R'OH
Mes
H N :-- H-OH CIN , R -
Mes 8 S8Mes a- R
O-*N-acyl- O
O transfer O -H--
R[ N-OH L R ýo,_NH2 I H Nb+ RR NHH Mes
H 4 12 11 NH2
Scheme 3. Proposed reaction mechanism.
led to rapid O--N acyl-transfer within minutes, providing amide 4ba (Table 1, entry 2) in 90%
yield upon completion of the experiment (8 h). 14 The poor reactivity of 6-aminohexan-l-ol, 2-
hydroxymethylaniline, and (2S,3S)-pseudoephedrine in coupling with methyl phenylacetate (la)
under our standard conditions may be due to a slow O--N acyl-transfer 3 and/or an unfavorable
initial transesterification reaction'"x in the latter case.24
Further Investigations of Carbene-Alcohol Hydrogen-Bonded Complexes
Having identified a carbene-alcohol hydrogen bonded complex, we sought to investigate
the steric and electronic effects of the alcohol on the nature of the complex (Scheme 4). For
comparison to the IMes-HOMe complex 8b we examined a bulky alcohol, triphenylmethanol
(7e) and a more acidic alcohol, 2,2,2-trifluoromethanol (TFE, 7f).
Mes MesMes C6D 6 (0.05 M) Mes
N: + ROH 200 N :-H-OR
N N
Mes 7b,e,f Mes
3 R= bMe- R= Me- 8b
e Ph3C- Ph3C- 8e
f CF3CH2- CF3CH 2- 8f
Scheme 4. Hydrogen-bond interaction between IMes and alcohols. Mes = 2,4,6-trimethylphenyl.
It is interesting to compare the X-ray structure of IMes-HOMe with the more labile X-ray
structure of IMes-HOCPh3 (Figure 2).25 The solid-state structure of complex 8e revealed a
distorted hydrogen-bond between the hydroxyl proton and the carbene. Hydrogen bond
formation is expected to relax the N1-C2-N3 bond angle of the carbene toward an
C(4)
Figure 2. Thermal ellipsoid representation of complex 8e.
imidazolium ion. It could then be reasoned that the degree of proton transfer (i.e., strength of the
hydrogen bond) would be reflected in the N 1-C2-N3 bond angle of the carbene. The N 1-C2-N3
bond angle of the carbene moiety in 8e is 101.9(2)0, which is closer to the observed angle in the
free carbene (101.4o)5b than the imidazolium chloride (108.6o).2oa This angle is however smaller
than that of the methanol complex 8b at 102.53(16)0. Interestingly, in the triphenylmethanol
complex 8e the hydrogen atom is 0.84(3) Angstrom below the imidazolinyl azaheterocycle
plane, a non-optimal orientation for hydrogen-bond interaction with the carbene lone pair (Figure
2, ~260 from planarity). 21 The length of the hydrogen-bond interaction in
IMes-triphenylmethanol complex (8e) was found to be 2.856(3) A that is slightly longer than the
corresponding hydrogen-bond interaction (2.832(2) A) in the methanol complex 8b by 0.02 A.
We also studied the formation of a complex between IMes (3) and TFE (7f) to examine
electronic effects on such carbene alcohol complexes. This alcohol was expected to be a better
proton donor due to the increased acidity of TFE (pKa (DMSO) TFE = 23.5, pKa (DMSO)
MeOH = 29.0) 26 compared to other alcohols we had examined. We obtained high quality
crystals from toluene solutions containing equal molar ratio of IMes (3) and TFE (7f). Indeed,
the X-ray structure of these crystals clearly illustrated a complete proton transfer to afford an
imidazolium ion derivative (Figure 3). Interestingly, rather than a 2,2,2-trifluoroethoxide
counter ion another molecule of 3 was bound to the C2-proton of the imidazolium ion. The
2,2,2-trifluoroethoxide was stabilized by a hydrogen-bond interaction with a TFE molecule
(Figure 3). Analysis of the structure suggests a hydrogen-bond interaction between the 2,2,2-
trifluoroethoxide with the C4-proton of the imidazolinyl fragment while TFE is engaged in a
hydrogen-bond interaction with the C4-proton of the imidazolium ion in the crystal structure.
Figure 3. Thermal ellipsoid representation of the crystal obtained from IMes (3) and TFE (7f). Atoms labeled with
an A after the atom name are generated from the parent atom by the symmetry operator x+1, y, z.
A carbene-imidazolium interaction was also observed in the solid state by Arduengo 2oa
when a 1:1 mixture of 3 and 3*HPF 6 (or 3 and 3*HOTf) were allowed to crystallize.
Interestingly, in these structures the C2-carbon of the two heterocycles exhibited an averaged 13C
NMR resonance at 175 ppm, midway between the resonances expected for a carbene and an
imidazolium ion.2" Interestingly, in our studies of the IMes-TFE (1:1) solution in benzene (0.5 M
in C6D6 at 20 'C) we observe a downfield 13C NMR resonance for the C2-carbon at 194.7 ppm
which is closer to the free carbene (219.4 ppm 0.5 M in C6D6 at 20 oC). Additionally, all other
carbon resonances save those related to the methyl groups appear as two unequal resonances.
These appear as a broad minor resonance blending into a sharp major resonance in the '3C NMR
spectra. Using variable temperature NMR we observed that at 70 oC in C6D6 (0.5 M), all signals
appear to sharpen, however not all pair of carbon resonances coalesce. 27 Importantly, upon
cooling the sample from 70 'C (after extended heating, >12 h) to 20 oC there was no
decomposition, providing spectra identical to those obtained prior to heating. Interestingly, we
also examined the 1H NMR of the IMes-TFE (1:1) solution in benzene and observed a
significant dependence as a function of TFE equivalents (from 1.0 to 5.0 equiv). 28 Cumulatively,
our observations suggest a dynamic equilibrium in the solution involving multiple species only
one of which is seen in the crystal structure shown in Figure 3 (Scheme 5).
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Scheme 5. Dynamic interaction of IMes 3 with TFE (7f).
The observation with TFE described above and the effect of solvation paralleled those of
IMes (3) in protic solvents. Dissolution of IMes (3) in MeOD-d4 led to deuterium incorporation
at C4/5 of the azaheterocycle (96.5% at 0.5 M in MeOD-d 4 at 20 oC). 2 9 A residual protium
resonance at 8.13 ppm is similar to the C2-imidazolium chloride signal for the C2-H (8.10 ppm).
The 13C NMR resonances corresponding to the C4/5 in methanolic solution of IMes were found
at 126 ppm as a triplet (JCD = 32 Hz), similar to the imidazolium chloride salt (126 ppm). The
resonance corresponding to the C2 in this methanolic solution of IMes was at 139.9 ppm as a
broad singlet 30 and not in the region observed for IMes-HOMe (1:1) in aprotic solvent (i.e., ~200
ppm). These results indicate that dissolution of IMes in methanol provides a solvated
imidazolium methoxide in contrast to the hydrogen-bonded complex seen in aprotic solvents.
Given the stability of imidazolium salts we sought to investigate the chemistry of IMes
dissolved in MeOD-d 4. A solution of IMes in methanol (0.05 M) persisted unchanged for six
weeks at -10 oC under an argon atmosphere by NMR. A methanolic solution of IMes (as the
solvated imidazolium methoxide) is also more resistant to hydrolytic decomposition. Addition
of deionized and degassed water (1.0 equiv) to a solution of IMes in MeOD-d 4 (0.05 M, 20 °C)
did not lead to decomposition over 24 h. Notably, rapid decomposition (<5 min) was observed
when deionized and degassed water (1.0 equiv) was added to a solution of IMes in C6D, (0.05 M,
20 'C). The solvated imidazolium methoxide mentioned above is resistant to hydrolytic
decomposition even upon addition of large excess of water (30.0 equiv) over 1 week.3 1
The protium/deuterium exchange at C4/5-carbons of the solvated imidazolium methoxide
samples described above hinted at a reversible access to the free carbene. This is due to the
observation that while such protium/deuterium exchange is very rapid in the case of the carbene
structure, it is significantly slower in methanolic solution of imidazolium chloride. Indeed, the
IMesNHC*MeOH complex 8b was accessible after removal of the excess methanol and was used
in complex formation with Mo(CO) 6 to give IMesNHC*Mo(CO) 5 13 in 86% yield (Scheme 6).32
These observations suggest an alternative means for the storage of carbenes alongside the
formation of BEt3 adducts32 and Ag-complexes. 33
Fe M h
N (solvent) N + OCH3 volatiles;
N 24 h N Mo(CO) 6
Mes Mes PhMe, 110 0C
29 h Aro%/
3
Scheme 6. Synthesis of complex 13 from methanolic IMes (3).
The strength and nature of the hydrogen-bond interaction between IMes (as a
representative NHC) and alcohols is greatly sensitive to the solvent and the particular alcohol.
The more sterically congested the alcohol, the weaker the interaction with the carbene. A more
acidic alcohol leads to greater involvement of imidazolium alkoxides in equilibrium with other
hydrogen-bond complexes. Dissolution of IMes in methanol leads to formation of a solvated
imidazolium methoxide. Evaporation of the volatiles and desolvation of robust imidazolium
alkoxide solutions returns the carbene-alcohol (1:1) complex that may be used in organometallic
complex formation or used directly in transformations employing them as catalysts.
Synthesis of Optically Active Imidazopyridium Salts
With a broader appreciation of the dynamic interplay between alcohols and NHCs, we
considered the possibility of rendering certain reactions enantioselective by utilizing chiral
carbene complexes. Chiral carbene complexes are indeed known, and a variety of them have
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Figure 4. A representative collection of chiral azolium salts.
Subtle electronic and steric effects can often play a dramatic role in the yield and/or
enantioselectivity of a NHC reaction. Therefore it is of great interest to have ready access to a
wide variety of different NHC's. Recently NHC's based on the imidazo-[1,5-a]-pyridinium ring
system 23 were reported by Lassaletta3 5 and Glorius 36, and the use of salt 24 as a highly reactive
umpolung catalyst was nicely demonstrated by Miyashita (Figure 5).37 We were drawn to this
particular ring system because of the flexibility the pyridinium ring allows for fine-tuning of the





Figure 5. Imidazo-[1,5-a]-pyridinium salts.
A variety of transformations catalyzed by NHC's have been developed.8 Many of these
methodologies employ an in-situ deprotonation strategy for the generation of the reactive NHC's
from chemically robust azolium salt dervatives. Enders34 and Rovis 34g have employed chiral
triazolium salt precatalysts 20 and 16 very elegantly in a variety of catalytic asymmetric
reactions. Similarly, optically active imidazolium salts 22 and 21 have found applications as
precatalysts by Hoveyda34` and Grubbs34i as precursors to ligands used in organometallic
chemistry.
We envisioned a highly convergent and rapid synthesis of chiral salts by the condensation
of a chiral primary amine 26 with a suitable pyridine derivative 25 to yield the C2-iminopyridine
27 followed by derivatization to the target triflate salts 28 (Scheme 7).36,38
H H2N H CICH 2OPiv
26 R* AgOTf
R O NRR* A R- N-R*N (-H20) R N CH2Cl2  NN.. (40 0C
25 27 28OTf
Scheme 7. Synthetic plan for the formation of optically active triflate salts 28.
Condensation of commercially available 2-formylpyridine (29) with S-a-
methylbenzylamine (98% ee) (30) yielded imine 31 in 97% yield. We found that the crude imine
was sufficiently pure to be used without purification in the next step. Exposure of the imine 31
to CICH2OPiv and anhydrous silver triflate in dichloromethane at 40 'C for 15 h in the dark
yielded the triflate 32 in 73% yield. It should be noted that the imidazo-[1,5-a]-pyridinium salts
are readily purified by flash column chromatography (Scheme 8).
Me
H H2N Ph H Me CICH 2OPiv
30 AgOT
0N oN PN h  NMe
0 EOH CH2Cl2 N--ýN Na 2S04  40 'C,15 h Ph
23 C, 2h OTf73% OTf
29 97% 31 32
Scheme 8. Synthesis of azolium salt 32.
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The synthesis of chiral salts with substitution around the imidazo-[1,5-a]-pyridinium
skeleton were accomplished under identical reaction conditions. We chose to derivatize the C5
position since it was shown to greatly enhance the stability of the resulting carbenes towards
decomposition. 35 2-Formyl-6-methylpyridine (33), obtained from commercially available 2,6-
dibromopyridine in two steps, was readily condensed with amine 30 to afford imine 34. Crude 34
was cyclized to give triflate (-)-35 in 72% yield (Scheme 9). Deprotonation of (-)-35 (1.0 equiv
NaH, 4 mol % KO'Bu, 0.2 M THF, 23 'C, 3 h) afforded the carbene as a thick syrup, with
characteristic 'H NMR resonances39 consistent with those reported by Lassaletta for a related

























Scheme 9. Synthesis of azolium salt 35.
In an effort to minimize rotation of the N-C bond bearing the stereogenic center, thus
"locking" the chiral arm into a secure configuration, we introduced a phenyl substituent at the C1
position. The bisaryl ketone 36 was prepared from 2,6-dibromopyridine in two steps and
condensed with amine 30 in 96% yield. Due to the lowered reactivity of 36, much more
vigorous conditions as compared to 33 were needed to complete the imine formation. Imine 37
was a mixture (47:53) of isomers and was cyclized to give the imidazolium triflate (+)-38 in 40%
yield under the conditions described above (Scheme 10).
Me
Ph H2N Ph Ph Me CICH 20Piv Ph
30 AgOTf
1 op-TsOH 40 0C, 15 hh
Me Toluene Me Me DOTf
36 Na2SO4  40%110 oC, 24 h 37 (+)-38
96%
Scheme 10. Synthesis of azolium salt 38.
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Direct e.e. determinations of the imidazolium triflates could not be performed by HPLC
(normal or reverse phase) analysis. Deprotonation of the triflate salts 35 and 38 with KO'Bu (1.0
equiv) in the presence of elemental sulfur (2.0 equiv) in THF afforded the corresponding
thioureas 39 and 40 in 82% and 78% yields respectively. Thiourea derivatives'4 39 and 40 were
both found to be >98% e.e. by HPLC analysis, thus illustrating that 1) the synthetic route
maintains optical activity throughout, and 2) the free carbenes generated by the deprotonation of
these salts are not epimerized (Scheme 11).
Me 1.0 equiv KOBu NMe
:.N. Ph 2.0equivS 8  Ph
OMe OTf THF, 23 OC, 15 min Me S
35 82% 39
Ph 1.0 equiv KOtBu Ph
N- Me 2.0 equiv S8  Me
SN. Ph THF, 23 OC, 15 min Ph
Me OOTf  Me SOTf 78%
38 40
Scheme 11. Synthesis of thiourea derivatives 39 and 40 for e.e. determination.
In conclusion, we have expanded the library of chiral imidazolium salts to include those
with the imidazo-[1,5-a]-pyridinium skeleton. We have encountered no obstacles with reaction
scale; imidazolium salt 35 was prepared in >4 g without any complications. This route maintains
stereochemical integrity throughout the synthesis of the azolium salts and further to the carbenes.
Conclusion
Our initial attempts at expanding the NHC catalyzed transesterification to amidation led
to the discovery of a facile amidation reaction with 1,2- and 1,3-amino alcohols. We have shown
that with this method, esters are easily converted to co-hydroxy amides with a broad tolerance of
functional groups (Table 1). During the course of our studies, we identified a strong carbene-
alcohol hydrogen bond, which prompted an investigation into the mechanism of this reaction.
Having investigated this reaction by 1H NMR, React-IR, and through X-ray crystallography, we
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propose a nucleophile activation mechanism, allowing for a facile transesterification, followed
by an O--N acyl-transfer reaction forming the product amides (Scheme 1). Further studies on
this unprecedented carbene-alcohol hydrogen bond by both 'IH NMR and X-ray crystallography,
revealed that sterically encumbered alcohols such as triphenylmethanol (7e) form weaker
hydrogen bonds with IMes (3) due to the inability of this alcohol to achieve an optimal hydrogen
bond geometry with 3. Reaction of 3 with acidic alcohols such as TFE (7f) leads to a dynamic
system involving multiply equilibrating species in the solution state, and a carbene-imidazolium
hydrogen bonded complex 8f in the solid state (Scheme 3 and Figure 5). Interestingly,
dissolving 3 in neat methanol affords a solvated imidazolium methoxide with greatly enhanced
stability relative to parent 3, which may be utilized for extended storage of NHCs.
Lastly, a rapid and practical synthesis of chiral imidazo-[1,5-a]-pyridinium salts was
developed. The present approach affords optically active azolium salts which, lead to optically
active carbenes without erosion of optical activity. This protocol is amenable to the large-scale
synthesis of these salts without loss of efficiency.
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Experimental Section
General Procedures. All reactions were performed in oven-dried or flame-dried round
bottomed flasks, modified Schlenk (Kjeldahl shape) flasks, or where indicated in modified
Schlenk vessels designed for the probe of the React-IR1 instrument. The flasks were fitted with
rubber septa and reactions were conducted under a positive pressure of argon. Stainless steel
syringes or cannulae were used to transfer air- and moisture-sensitive liquids. Flash column
chromatography was performed as described by Still et al. using silica gel (60-A pore size, 32-
63 pm, standard grade, Sorbent Technologies).2  Analytical thin-layer chromatography was
performed using glass plates pre-coated with 0.25 mm 230-400 mesh silica gel impregnated with
a fluorescent indicator (254 nm). Thin layer chromatography plates were visualized by exposure
to ultraviolet light and/or by exposure to an ethanolic phosphomolybdic acid (PMA), an acidic
solution of Panisaldehyde (Anis), an aqueous solution of ceric ammonium molybdate (CAM), an
aqueous solution of potassium permanganate (KMnO 4) or an ethanolic solution of ninhydrin
followed by heating (<1 min) on a hot plate (~250 °C). Organic solutions were concentrated on
Btichi R-200 rotary evaporators at ~20 Torr (house vacuum) at 25-35 OC.
Materials. Commercial reagents and solvents were used as received with the following
exceptions: Dichloromethane, diethyl ether, tetrahydrofuran, acetonitrile, and toluene were
purchased from J.T. Baker (CycletainerTM ) and were purified by the method of Grubbs et al.
under positive argon pressure,3 Triethylamine and 2,2,2-trifluoroethanol were distilled from
calcium hydride at 760 Torr under a nitrogen atmosphere. Methanol was distilled from
magnesium methoxide at 760 Torr under a nitrogen atmosphere. Acetic acid was distilled from
5% v/v acetic anhydride and 2% wt/v Cr0 3. Perdeuterobenzene was distilled from CaH2 and
stored over 5A MS pellets. All reagents for NMR experiments were degassed via an argon purge
for at least 10 min. 'Propyl acetate, tbutyl acetate, methyl benzoate, L-leucinol , L-prolinol,
methyl 2-furate and benzyl alcohol were distilled from K2C0 3. Ethanolamine and methylphenyl
acetate were distilled from KOH. Methyl 4-methoxybenzoate was purified by bulb-to-bulb
distillation. Phthalide (1j) was recrystallized from toluene. Triphenylmethanol was
recrystallized from dry hexanes. LiCl was dried at 200 oC under vacuum (-1 Torr) for 24 h then
flame dried and stored in a glove box.
Instrumentation. Proton nuclear magnetic resonance ('H NMR) spectra were recorded with
Varian inverse probe 500 INOVA and Varian 500 INOVA spectrometers and are recorded in
parts per million from internal tetramethylsilane on the 8 scale and are referenced from the
residual protium in the NMR solvent (CHCl3: 8 7.27, C6D6: 8 7.16, DMSO-d 6: 8 2.50, THF-d8 : 8
1.73, 6 3.58). Data is reported as follows: chemical shift [multiplicity (s = singlet, d = doublet, q
= quartet, m = multiplet), coupling constant(s) in Hertz, integration, assignment]. Carbon-13
nuclear magnetic resonance spectra were recorded with a Varian 500 INOVA spectrometer and
are recorded in parts per million from internal tetramethylsilane on the 8 scale and are referenced
from the carbon resonances of the solvent (CDC13: 6 77.23, DMSO-d 6: 8 39.51, C6D6: 8 128.39,
THF-d8 : 8 67.57, 8 25.37). Data is reported as follows: chemical shift [multiplicity (s = singlet, d
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= doublet, q = quartet, m = multiplet), coupling constant(s) in Hertz, assignment]. Infrared data
were obtained with a Perkin-Elmer 2000 FTIR and are reported as follows: [frequency of
absorption (cm-'), intensity of absorption (s = strong, m = medium, w = weak, br = broad),
assignment]. React-IR experiments were performed on an ASI ReactIR 1000 fitted with a silicon
probe. Infrared (IR) spectra were obtained using a Perkin Elmer System 2000 FT-IR
spectrophotometer referenced to a polystyrene standard. Data are represented as follows:
frequency of absorption (cm 1-), intensity of absorption (s = strong, m = medium, w = weak) and
assignment where appropriate. Melting points were determined on an Electrothermal Mel-Temp
melting point apparatus. Gas chromatograpy was performed on an Agilent Technologies 6890N
Network GC System with a HP-5 5% Phenyl Methyl Siloxane column. We are grateful to Dr. Li
Li for obtaining the mass spectroscopic data at the Department of Chemistry's Instrumentation
Facility, Massachusetts Institute of Technology. The structure of N,N-bismesitylimidazolylidene-
methanol complex 8b, bismesitylimidazolylidene-triphenylmethanol complex 8e and
bismesitylimidazolylidene-2,2,2-trifluoroethanol complex 8f were obtained with the assistance of
Dr. Peter Miuller at the X-ray crystallography laboratory of the Department of Chemistry,
Massachusetts Institute of Technology.
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Procedure A
Use of Recrystallized IMes as Catalyst:
o o0 IMes (5 mol%) Ph
Ph i.OM e + H2N POH h N, N.OH
THF, 23 C, 8 h H
la 2a 100% 4aa
N-(2-Hydroxvethyl)-2-phenyl acetamide (4aa, Table 1, entry 1):
To a solution of IMes (3, 30 mg, 98 [tmol, 0.05 equiv.) in THF (1.95 mL) was added
ester la (285 [tL, 1.97 mmol, 1 equiv) and ethanolamine 2a (120 ýtL, 1.97 mmol, 1.00 equiv)
sequentially via a gas-tight syringe. Monitoring the reaction mixture by TLC and GC analysis
indicated complete conversion after 8 h. The volatiles were removed under reduced pressure on a
rotary evaporator, and the resulting residue was purified by flash column chromatography on
silica gel (10% MeOH in CH2Cl 2) to afford the amide 4aa as a white powder (355 mg, 100%).
For characterization data, please see below.
Procedure B
In Situ Generation of IMes as Catalyst:
IMes *HCI
O (6.5 mol %) Ph
Ph+JOMe + H2 N _OH I Ph N OH
tBuOK (5.0 mol %) H
la 2a THF, 23 C, 2 h 4aa
96%
N-(2-Hydroxyethyl)-2-phenyl acetamide (4aa):
A flame-dried flask was charged with IMes*HCI (44 mg, 128 [tmol, 0.065 equiv) and
'BuOK (11 mg, 98 [tmol, 0.050 equiv) and sealed under an argon atmosphere. THF (1.95 mL)
was added via a gas-tight syringe and the resulting suspension was vigorously stirred for 30 min.
Ester la (285 [tL, 1.97 mmol, 1 equiv) and ethanolamine 2a (120 ýtL, 1.97 mmol, 1.00 equiv)
were sequentially added via a gas-tight syringe. After 2 h, the yellow homogenous mixture was
concentrated under reduced pressure on a rotary-evaporator. The resulting residue was purified
by flash column chromatography on silica gel (5% MeOH in CH2C12) to afford the amide 4aa as
a white solid (340 mg, 96%).
Use of 1,3-dimethylimidazolium iodide (IMe*HI) and 1,3-dicyclohexyl-imidazolium
chloride (IcHx*HCI) in place of IMes*HCI provided the desired product in 95 and 88% yield,
respectively.
11H NMR (500 MHz, CDC13, 20 'C): 8 7.35-7.38 (m, 2H, PhHm), 7.26-7.32 (m,
3H, PhH,,), 5.97 (br-s, 1H, NH), 3.66 (app-q,
J = 5.0 Hz, 2H, CH2OH), 3.59 (s, 2H, PhCH 2),
3.37 (app-q, J = 5.0 Hz, 2H, NCH 2), 2.87 (br-
s, 1H, OH).
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13C NMR (125.8 MHz, CDC13, 20 'C): 6 172.7 (Camide), 134.8 (PhCipso), 129.7
(PhCorrho), 129.3 (PhCm,,,ea), 127.7 (PhCara),
62.7 (CH2OH), 43.9 (PhCH2), 42.9 (NCH2).
FTIR (thin film) cm7': 3293 (s, O-H), 3087 (w), 2925 (m), 1645 (s,
C=O), 1550 (m).
HRMS (ESI) (m/z): calc'd for C10H13NO2 [M+H]÷: 180.1019
found: 180.1018
M.p.: 65-66 oC
TLC (5% MeOH in CH2Cl2) Rf. 0.40 (UV, KMnO 4).
Control Experiments:
All experiments were conducted under standard conditions used above for direct comparison. In
the absence of IMes (3), incubation of equimolar amounts of esters la and lb with 2a at 23 OC
for 12 h provides less than 2 and 1% respectively, of the corresponding amides 4aa and 4ba.
The use of sodium methoxide and potassium 'butoxide in place of IMes (3) in the coupling of la
and 2a resulted in complete consumption of la within 5 h and gave 60% and 74% isolated yield
of 4aa, respectively. Use of 1,3-bis(2,4,6-trimethylphenyl)imidazoin-2-ylidene (SIMes),
prepared by in situ deprotonation (SIMes*HCI 6.5 mol% and potassium 'butoxide 5 mol%) did
not provide a detectable amount (<2%) in 5h and returned the starting ester la.
Competition Experiment (Figure 2):
0 H2N ,-OH IMes (5 mol %) 0
Ph l OMe + 2a Ph _ _N_ _, OHTHF, 23 C, 4 h H
la H2 N Ph 4aa6 99%
N-(2-Hydroxyethyl)-2-phenyl acetamide (4aa):
To a solution of IMes (3, 30 mg, 98 tmol, 0.05 equiv) in THF (1.95 mL) was added the
ester la (255 [pL, 1.97 mmol, 1 equiv), ethanolamine (2a, 120 JpL, 1.97 mmol, 1.00 equiv), and
benzylamine (6, 215 RL, 1.97 mmol, 1.00 equiv) sequentially via a gas-tight syringe under an
argon atmosphere. After 4 h, TLC analysis indicated complete conversion of ester la to the
desired amide 4a. The volatiles were removed under reduced pressure on a rotary-evaporator. 'H
NMR analysis of the residue indicated an equal mixture of amide 4a and benzylamine (6). To
facilitate chromatographic separation, acetic acid (100 pL, 1.75 mmol, 0.89 equiv) was added
and the residue was purified by flash column chromatography on silica gel (5% MeOH in
CH2Cl2) to afford the amide 4aa as a white solid (350 mg, 98.5%). For characterization data,
please see above.
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React-IR Monitoring of the Amidation Reaction
H2N OH
2a
IMes (5 mol %) HO,. 0  NH2  HO N0 OH
THF, 23 OC, 6 h H
88% 12m 4ma
4-Hydroxy-N-(2-hydroxyethyl)-butyramide (4ma, Table 1, entry 15):
An oven-dried React-IR flask was charged with IMes (3, 30 mg, 98 [imol, 0.05 equiv)
under a nitrogen atmosphere and the reaction vessel was sealed, moved out of the glove-box, and
fitted to the React-IR probe under a stream of Argon. Anhydrous and deoxygenated THF (1.95
mL) was added to dissolve the IMes. A background spectrum was collected, ester Im (150 [L,
1.97 mmol, 1 equiv) followed by ethanolamine (2a, 120 RiL, 1.97 mmol, 1.00 equiv) were added
sequentially via a gas-tight syringe, and the reaction progress was monitored. After 6 h, the
reaction was complete, the volatiles were removed under reduced pressure on a rotary-
evaporator, and the resulting residue was purified by flash column chromatography on silica gel
(10% MeOH in CH2CI2) to afford the amide 4ma as a solid (261 mg, 88%).
1H NMR (500 MHz, DMSO-d6, 200 C):
13C NMR (125.8 MHz, DMSO-d6, 20 oC):
FTIR (CHC13) cm-':
HRMS (ESI) (m/z):
8 7.78 (br-t, J = 5.0 Hz, 1H, CONH), 4.61 (t, J
= 5.5 Hz, 1H, OH), 4.45 (t, J = 5.5 Hz, 1H,
OH), 3.34-3.38 (m, 4H, NCH2CH2OH,
CH 2CH2CH 2OH), 3.08 (q, J = 6.0 Hz, 2H,
NCH2), 2.09 (t, J = 7.5 Hz, 2H, CH 2CONH),
1.61 (app-quintet, J = 7.3 Hz, 2H,
CH2CH 2CH2).
8 172.3 (Camide), 60.4 (CH2OH), 60.0
(CH2OH), 41.5 (NCH2), 32.1 (CH2CONH),
28.7 (CH 2CH2CH2).
3447 (m, O-H), 3006 (w), 2946 (w), 1648 (s,
C=O), 1525 (m).
calc'd for C6H13NO3 [M+Na]+: 170.0788
found: 170.0786
55.5-56.5 oC
TLC (5% MeOH in CH2Cl2) Rfi 0.18 (UV, KMnO 4)
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0C 0
React-IR Monitoring of IMesNHC-catalyzed amidation of y-lactone 1m to amide 4ma.
The intermediate ester 12ma was observed within 2 min. Although ester 12ma proved to
be exceedingly difficult to isolate for direct verification of the absorbance at 1736 cm- ', a similar
ester (Ph(CH2)14CO2CH2CH2N(CH3)2) has been reported to have an absorbance at 1730 cm-' (T.
Siatra-Prpastaikoudi, A. Papadaki-Valiraki, A. Tsantili-Kakoulidou, L. Tzouvelekis, A. Mentis,
Chem. Pharm. Bull. 1994, 42, 392-394). Additionally, we have prepared samples of O-
benzoylethanolamine (see below) and O-4-hydroxybutanoyl-N,N-dimethylethanolamine and
detected their carbonyl absorbances at 1721cm -' and 1741 cm-', respectively.
'H NMR Monitoring of the Amidation Reaction
SO IMes (5 mol %) O
Oe HM +H THF-da, 23 C, 24 h H
Ib 2a 85% 4ba
N-(2-Hydroxyethyl)-benzamide (4ba):
An NMR tube was charged with IMes (3, 11 mg, 35 [tmol, 0.05 equiv) and THF-d8 (700
[tL) and sealed under a nitrogen atmosphere in a glove-box. Methyl benzoate lb (87 iLL, 0.71
mmol, 1 equiv) and ethanolamine (2a, 43 [LL, 0.71 mmol, 1.0 equiv) were added sequentially via
a gas-tight syringe and the reaction progress was monitored by 'H NMR spectroscopy over 24 h.
The volatiles were removed under reduced pressure on a rotary-evaporator, and the resulting
yellow residue was purified by flash column chromatography on silica gel (5% MeOH in
CH 2Cl2) to afford the amide 4ba 4 as a white solid (101 mg, 85%).
4 For a previous synthesis of amide 4ba using benzoyl chloride, see: A. Morcuende, M. Ors, S. Valverde, B. Herrand6n, J. Org.
Chem. 1996, 61, 5264-5270.
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11H NMR (500 MHz, CDCI3 , 200C):
13C NMR (125.8 MHz, CDC13, 20 oC):
FTIR (thin film) cmr-:
HRMS (ESI) (m/lz):
TLC (5% MeOH in CH2Cl2) Rf.
8 7.78-7.79 (m, 2H, PhHo), 7.49-7.53 (m, 1H,
PhH,), 7.27-7.45 (m, 1H, PhH,), 6.74 (br-s,
1H, NH), 3.83 (app-q, J = 6.0 Hz, 2H,
CH2OH), 3.64 (app-q, J = 5.5 Hz, 2H, NCH 2),
2.89 (br-s, 1H, OH).
6 168.8 (Camide), 134.3 (PhCips,), 131.9 (PhC,),
128.8 (PhCm), 127.2 (PhCo), 62.7 (CH2OH),
43.1 (NCH2).
3326 (s, O-H), 2936 (w), 2879 (w), 1636 (s,
C=O), 1542 (s).
calc'd for CgHINO2 [M+Na]+: 188.0682
found: 188.0678
54-55 OC
0.43 (UV, KMnO 4)




IMes (10 mol %)
LiCI (10 mol %)
2 THF, 23 0C
2a 2 h (41% conversion);O
e On N H2
12ba, (0.12 equiv)






A flame dried React-IR cell was charged with IMes (3, 60.0 mg, 197 ýtmol, 0.100 equiv)
and anhydrous LiCl (8 mg, 0.2 mmol, 0.1 equiv), and was sealed under a nitrogen atmosphere in
a glove-box. The reaction vessel was placed onto the probe under a stream of Argon and THF
(1.95 mL) was added via a gas-tight syringe to give a clear colorless solution. Methyl benzoate
lb (246 ýLL, 1.97 mmol, 1 equiv) and ethanolamine (2a, 120 [tL, 1.97 mmol, 1.00 equiv) were
added sequentially via a gas-tight syringe. The reaction progress was monitored for 2 h (41%
conversion). A solution of the sensitive ester 12ba (0.12 equiv, the sample was a 43:57 ratio of
12ba:4ba, see below for preparation; 27% expected increase in final product) in THF (535 [tL)
was added to the reaction in progress. Monitoring of the reaction mixture (IR and TLC) was
continued for an additional 8 h. The conversion to amide 4ba proceeded as expected after an
initial burst upon addition of ester 12ba. The ester 12ba was rapidly consumed and within 20
min the ester was no longer detectable by TLC (the carbonyl frequencies of esters 12ba and lb
were not sufficiently resolved for clear monitoring by IR). The volatiles were removed under
reduced pressure on a rotary-evaporator, and the resulting crude orange residue was purified by
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flash column chromatography on silica gel (100% THF) to afford the amide 4ba as a white solid
(370 mg, 90%). For characterization data, please see above.
Preparation of the ester 12ba: A suspension of O-benzoyl-N-Cbz-ethanolamine (197 mg,
657 tmol, 1.00 equiv) and palladium on carbon (5% wt/wt, 197 mg, 92.6 Rtmol, 0.14 equiv) in
THF (650 [tL) was vigorously stirred under a hydrogen atmosphere. Monitoring the reaction
mixture by TLC indicated complete removal of the nitrogen protective group and formation of
ester 12ba in 2 h. To avoid IMes deactivation in the amidation reaction, the ester 12ba was
purified under a nitrogen-atmosphere (glove-box) by flash column chromatography (0.5 x 2.5
cm, 100% THF) on dry silica gel (dehydrated by heating 200 *C for 48 h) to give a sample of the
sensitive ester 12ba along with the corresponding amide 4ba as a clear oil (88.5 mg, 82%, 536
[tmol, 43:57 ratio of 12ba:4ba) which was diluted with THF (535 [LL) and used above.
1H NMR (500 MHz, CDC13, 200C, 43:57 mixture of 12ba:4ba, ester 12ba noted by *): 6 8.06-
8.08 (m, 2H, PhHo*), 7.78-7.80 (m, 2H,
PhHo), 7.58 (tt, J = 7.5 Hz, 1.5 Hz, 1H,
PhH,*), 7.53 (tt, J = 7.0 Hz, 1.5 Hz, 1H,
PhHp), 7.44-7.48 (m, 4H, PhHm, PhHm*), 6.61
(br s, 1H, NH) 4.37 (app-t, J = 5.5 Hz, 2H,
OCH 2*), 3.86 (app-t, J = 5.0 Hz, 2H,
CH 2OH), 3.66 (app-q, J = 5.2 Hz, 2H, NCH 2),
3.10 (app-t, J = 5.5 Hz, 2H, NCH 2*), 1.72 (br-
s, 3H, NH2*, OH).
Experimental Procedures for Remainder of Compounds in Table 1
O O
'N OMe + -H2N _ýOH 2 IMes (5 mol %) N-N ,
LiCI (5 mol %) H
lb 2a THF, 23 C, 6 h 4ba
94%
N-(2-Hydroxyethyl)-benzamide (4ba, Table 1, entry 2):
To a solution of IMes (3, 30 mg, 66 p[mol, 0.05 equiv) and anhydrous lithium chloride (3
mg, 7 [imol, 0.05 equiv) in THF (1.30 mL) was added methyl benzoate lb (190 [tL, 1.31 mmol,
1 equiv) and ethanolamine (2a, 80 C[L, 1.9 mmol, 1.0 equiv) sequentially via a gas-tight syringes
at 23 °C under an Argon atmosphere. After 9.5 h, the volatiles were removed under reduced
pressure on a rotary-evaporator, and the resulting orange residue was purified by flash column
chromatography on silica gel (100 % THF) to afford the amide 4ba as a white solid (205 mg,






IMes (5 mol %)
H2N - OH THF, 23 "C, 24 h
87%
0
4 3 2 1
Me 6 • H
O 4ca
4-Acetyl-N-(2-hydroxvethyl)-benzamide (4ca, Table 1, entry 3):
A solution of IMes (3, 30 mg, 98 ýtmol, 0.05 equiv) in THF (1.95 mL) followed by
ethanolamine (2a, 120 tL, 1.97 mmol, 1.00 equiv) was added sequentially via a gas-tight syringe
to a flame-dried round bottom flask containing the ester Ic (351 mg, 1.97 mmol, 1 equiv) under
an argon atmosphere. Amide 4ca began to precipitate after 40 min. After 24 h, the volatiles
were removed under reduced pressure on a rotary-evaporator and the resulting red residue was
purified by flash column chromatography on silica gel (5% MeOH in CH2C12) to afford the
amide 4ca as a white powder (354 mg, 87%).
1H NMR (500 MHz, CDC13, 20 oC):
'
3C NMR (125.8 MHz, CD30D, 20 oC):
FTIR (CHC13) cmf1:
HRMS (ESI) (m/z):
8 8.02 (dt, J = 8.0 Hz, 1.5 Hz, 2H, C4H), 7.88
(dt, J = 8.0 Hz, 1.5 Hz, 2H, C3H) 6.71 (br-s,
1H, NH), 3.88 (app-q, J = 5.0 Hz, 2H,
CH 2OH), 3.67 (app-q, J = 5.2 Hz, 2H, NCH 2),
2.64 (s, 3H, CH 3), 2.43 (t, J = 4.8 Hz, 1H,
OH).
8 199.8 (Cketone), 169.6 (Camide), 140.6
139.9 (C2), 129.7 (C4), 128.8 (C 3),
(CH2OH), 43.8 (NCH2), 27.0 (COCH 3).
(C5),
61.6
3452 (m, O-H), 3020 (w), 2995 (w), 1687 (s,
C=O), 1660 (s, C=O).
calc'd for C11H13NO3 [M+H]+: 208.0968
found: 208.0968
136-137 oC




+ H2 - OHH2N
IMes (5 mol %)






4-Cyano-N-(2-hydroxyethyl)-benzamide (4da, Table 1, entry 4):
A solution of IMes (3, 30 mg, 98 ýtmol, 0.05 equiv) in THF (1.95 mL) followed by
ethanolamine (2a, 120 [tL, 1.97 mmol, 1.00 equiv) was added sequentially via a gas-tight syringe
to a flame-dried round bottom flask containing the ester Id (317 mg, 1.97 mmol, 1 equiv) under
an argon atmosphere to give a maroon mixture. After 24 h, the volatiles were removed under
reduced pressure on a rotary-evaporator and the resulting residue was purified by flash column
chromatography on silica gel (5% MeOH in CH2CI2) to afford the amide 4da as a white powder
(361 mg, 96%).
'H NMR (500 MHz, CDC13, 20 °C):
'
3C NMR (125.8 MHz, DMSO-d 6, 20 oC):
FTIR (CHC13) cm-':
HRMS (ESI) (mlz):
8 7.90 (d, J = 7.5 Hz, 2H, C4H), 7.75 (d, J =
8.0 Hz, 2H, C3H), 6.69 (br-s, 1H, NH), 3.87
(app-q, J = 4.8 Hz, 2H, CH2OH), 3.66 (app-q,
J = 5.2 Hz, 2H, NCH 2), 2.26 (br-t, J = 4.3 Hz,
1H, OH).
8 165.0 (Camid), 138.6 (C2), 132.4 (C4), 128.1
(C3), 118.4 (CN), 113.5 (C5), 59.6 (CH2OH),
42.4 (NCH2).
3451 (m, O-H), 2995 (w), 2940 (w), 2234 (m,
nitrile), 1664 (s, C=O).
calc'd for C1oH1oN20 2 [M+H]+: 191.0815
found: 191.0816
108-109 oC





IMes (5 mol %)






N-(2-Hydroxyethyl)-4-trifluoromethyl benzamide (4ea, Table 1, entry 5):
A flame dried React-IR cell was charged with IMes (3, 30 mg, 98 itmol, 0.05 equiv) and
sealed under a nitrogen atmosphere in a glove-box. The reaction vessel was placed onto the
probe under a stream of Argon and THF (1.95 mL) was added via a gas-tight syringe to give a
clear colorless solution. Ester le (317 tL, 1.97 mmol, 1 equiv) and ethanolamine (2a, 120 [L,
1.97 mmol, 1.00 equiv) were added sequentially via a gas-tight syringe. The reaction progress
was monitored for 24 h. The volatiles were removed under reduced pressure on a rotary-
evaporator, and the resulting orange residue was purified by flash column chromatography on
silica gel (10% MeOH in CH2C12) to afford the amide 4ea as a white powder (436 mg, 95%).
1H NMR (500 MHz, CDC13, 20 oC):
13C NMR (125.8 MHz, DMSO-d 6, 20 oC):
FTIR (CHC13) cm-':
HRMS (ESI) (m/lz):
8 7.89 (dd, J = 8.5 Hz, 1.0 Hz, 2H, C4H), 7.70
(dd, J = 8.3 Hz, 1.0 Hz, C3H), 6.76 (br-s, 1H,
NH), 3.86 (app q, J = 5.0 Hz, 2H, CH20OH),
3.66 (app-q, J = 5.3 Hz, 2H, NCH 2), 2.56 (t, J
= 5.0 Hz, 1H, OH).
8 165.2 (Camide), 138.3 (C2), 131.0 (q, J2 CF =
31.9 Hz, C5), 128.1 (C 3), 125.3 (app-t, J3CF =
3.8 Hz, C 4), 124.0 (q, JCF = 272.6 Hz, CF3),
59.6 (CH20OH), 42.3 (NCH2).
3452 (m O-H), 2997 (w), 2943 (w), 1662 (s,
C=O), 1327 (s, C-F).
calc'd for C1oHIOF 3NO2 [M+H]+: 234.0736
found: 234.0735
118-119.5 oC




OMe + H O HH2N
IMes (5 mol %)





4-Fluoro-N-(2-hydroxyethyl)-benzamide (4fa, Table 1, entry 6):
To a solution of IMes (3, 30 mg, 98 Rmol, 0.05 equiv) in THF (1.95 mL) at 23 'C, was
added ester If (255 [L, 1.97 mmol, 1.00 equiv) followed by ethanolamine (2a, 120 [L, 1.97
mmol, 1 equiv) sequentially via a gas-tight syringe. After 18.5 h, the volatiles were removed
under reduced pressure on a rotary-evaporator, and the resulting residue was purified by flash
column chromatography on silica gel (10% MeOH in CH2C12) to afford the amide 4fa5 as a white
solid (318 mg, 88%).
'
1H NMR (500 MHz, CDCl3, 20 oC): 8 7.80 (m, 2H, C4H), 7.10 (m, 2H, CqH), 6.70
(br-s, 1H, NH), 3.83 (app-t, J = 5.0 Hz, 2H,
CH 2OH), 3.62 (app-q, J = 5.2 Hz, 2H, NCH2),
2.82 (br-s, 1H, OH).
'
3C NMR (125.8 MHz, CDCI3, 20 'C):
FTIR (thin film) cm-':
HRMS (ESI) (mlz):
8 167.7 (Camide), 165.0 (d, JcF
130.5 (d, J4cF = 3.5 Hz, C2),
8.6 Hz, C3), 115. 8 (d, J 2cF
62.4 (CH2OH), 43.0 (NCH2).
3292 (s, O-H), 2980 (w), 163'
(m), 854 (m).
= 252.2 Hz, C5),
129.5 (d, J3CF =
= 21.9 Hz, C4),
6 (s, C=O), 1560
calc'd for C9,H1 FNO2 [M+H]+: 184.0768
found: 184.0769
91.5-92.5 oC
TLC (10% MeOH in CH2Cl2) Rf. 0.56 (UV, KMnO4)
s For an alternative synthesis of amide 4fa using an electrochemical method starting with ester If, see: K. Arai, S. Tamura, T.






IMes (5 mol %)
LiCI (5 mol %)
THF, 23 "C, 24 h
69%
0




N-(2-Hydroxyethyl)-4-methoxy benzamide (4ga, Table 1, entry 7):
A solution of IMes (3, 30 mg, 98 [tmol, 0.05 equiv) and anhydrous lithium chloride (4
mg, 0.1 mmol, 0.05 equiv) in THF (1.95 mL) followed by ethanolamine (2a, 120 p[L, 1.97 mmol,
1.00 equiv) was added sequentially via a gas-tight syringe to a flame-dried round bottom flask
containing the ester Ig (327 mg, 1.97 mmol, 1 equiv) under an argon atmosphere to give a
maroon mixture. After 24 h, the volatiles were removed under reduced pressure on a rotary-
evaporator and the resulting residue was purified by flash column chromatography on silica gel
(5% MeOH in CH2Cl2) to afford the amide 4ga as a white powder (264 mg, 69%).
1H NMR (500 MHz, CDCl 3 , 20 oC):
13C NMR (125.8 MHz, CDC13, 20 oC):
FTIR (thin film) cm-':
HRMS (ESI) (m/z):
TLC (5% MeOH in CH2Cl2) Rf.
8 7.76 (d, J = 8.5 Hz, 2H, C3H), 6.93 (d, J =
8.5 Hz, 2H, C4H), 6.57 (br-s, 1H, NH), 3.86
(s, 3H, OCH 3), 3.84 (m, 2H, CH 2OH), 3.63
(app-q, J = 5.2 Hz, 2H, NCH2), 2.79 (br-s, 1H,
OH).
8 168.5 (Camide), 162.5 (Cs), 129.0 (C3), 126.5
(C2), 113.9 (C4), 62.6 (CH2OH), 55.6 (OCH3),
43.1 (NCH 2).
3332 (s, O-H), 2940 (w), 1633 (s, C=O), 1559
(m), 1252 (m).
calc'd for CloH 13NO 3 [M+H]÷: 196.0968
found: 196.0964
97-98 oC
0.38 (UV, KMnO 4)
118
+ H2 N OH
2a
IMes (5 mol %)






N-(2-Hydroxyethyl)-acetamide (4ha, Table 1, entry 8):
A flame dried React-IR cell was charged with IMes (3, 30 mg, 98 [tmol, 0.05 equiv) and
sealed under a nitrogen atmosphere in a glove-box. The reaction vessel was placed onto the
probe under a stream of Argon and THF (1.95 mL) was added via a gas-tight syringe to give a
clear colorless solution. Ester lbh (265 [tL, 1.97 mmol, 1 equiv) and ethanolamine (2a, 120 C[L,
1.97 mmol, 1.00 equiv) were added sequentially via a gas-tight syringe. The reaction progress
was monitored for 24 h. The volatiles were removed under reduced pressure on a rotary-
evaporator, and the resulting orange residue was purified by flash column chromatography on
silica gel (10% MeOH in CH2C12) to afford the amide 4ha6 (200 mg, 99%).
'H NMR (500 MHz, CDC13, 200 C):
13 C NMR (125.8 MHz, CDC13, 20 oC):
FTIR (thin film) cm-':
HRMS (ESI) (m/z):
TLC (10% MeOH in CH2Cl2) Rf.
8 6.29 (br-s, 1H, NH), 3.72 (t, J = 4.5 Hz, 2H,
CH2OH), 3.41 (app-q, J = 5.2 Hz, 2H, NCH2),
3.25 (br-s, 1H, OH), 2.02 (s, 3H, CH3).
8 171.7 (Camid), 62.3 (CH2OH), 42.7 (NCH 2),
23.4 (CH3).
3298 (s, O-H), 2963 (m), 1652 (s, C=O), 1559
(m), 1261 (s).
calc'd for C4H9NO2 [M+Na]+: 126.0525
found: 126.0531
0.29 (KMnO 4)
N-(2-Hvdroxvethvl)-acetamide (4ha, Table 1, entries 9-11):
The same procedure as above was used for entries 9-11 (Table 1). For consistency all
experiments were allowed to proceed only for 24 h prior to isolation of the product. The
experiments with benzyl acetate, 'propyl acetate, and 'butyl acetate gave 95, 34, and 0% yield of
the desired amide 4ha. For characterization data, please see above.
6 For a previous synthesis of amide 4ha using acetic acid, Ph3SbO, and P4S,0 at 50 *C, see: R. Nomura, T. Nakano, Y. Yamada,





+ H2 N - OH
IMes (5 mol %)
THF, 23 'C, 4.5 h
99%
N-(3-Hydroxypropyl)-2-phenyl acetamide (4ab, Table 1, entry 12):
To a solution of IMes (3, 30 mg, 98 [tmol, 0.05 equiv) in THF (1.95 mL) at 23 °C, was
added ester la (285 [tL, 1.97 mmol, 1 equiv) and 1-amino-3-propanol 2b (151 tL, 1.97 mmol,
1.00 equiv) sequentially via a gas-tight syringes. After 4.5 h, the volatiles were removed under
reduced pressure on a rotary-evaporator and the resulting residue was purified by flash column
chromatography on silica gel (5% MeOH in CH2 Cl2 ) to afford the amide 4ab7 as a white solid
(379 mg, 99%).
1H NMR (500 MHz, CDC13, 200C):
13C NMR (125.8 MHz, CDCl3, 20 oC):
FTIR (thin film) cm-':
6 7.36-7.39 (m, 2H, PhHm), 7.30-7.33 (m,
2H, PhHo), 7.27-7.27 (m, 1H, PhHP), 5.76 (br-
s, 1H, NH), 3.61 (s, 2H, PhCH 2), 3.58 (app-q,
J = 5.5 Hz, 2H, CHzOH), 3.38 (app-q, J = 6.5
Hz, 2H, NCH 2), 3.09 (td, J = 6.5 Hz, 3.0 Hz,
1H, OH), 1.61 (app-pentet, J = 6.0 Hz, 2H,
CH2CH 2CH 2).
8 172.6 (Camide), 134.9 (PhCipso), 129.6 (PhCo),
129.2 (PhCn), 127.6 (PhCp), 59.3 (CH2OH),
43.8 (PhCH2), 36.6 (NCH2), 32.3
(CH 2CH2CH2).
3247 (s, O-H), 3084 (m), 2946 (m) , 1630 (s,
C=O), 1567 (s).




TLC (5% MeOH in CH2Cl2) Rf. 0.31 (UV, KMnO 4)









Oe-OMe + H2N 'OH
IMes (5 mol %)
LiCI (5 mol %)





N-(3-Hydroxypropyl)-benzamide (4bb, Table 1, entry 13):
To a solution of IMes (3, 20 mg, 66 jtmol, 0.05 equiv) and anhydrous LiCl (3 mg, 0.07
mmol, 0.05 equiv) in THF (1.30 mL) was added ester lb (164 [tL, 1.31 mmol, 1 equiv) and 1-
amino-3-propanol 2b (100 [iL, 1.31 mmol, 1.00 equiv) sequentially via a gas-tight syringe. After
9 h, the volatiles were removed under reduced pressure on a rotary-evaporator and the resulting
residue was purified by flash column chromatography on silica gel (5% MeOH in CH2C12) to
afford the amide 4bb8 as a clear oil (229 mg, 97%).
'1H NMR (500 MHz, CDC13, 200C):
'
3C NMR (125.8 MHz, CDC13, 20 oC):
FTIR (thin film) cm-':
6 7.78-7.79 (m, 2H, PhH,), 7.52 (tt, J = 7.0,
1.5 Hz, 1H, PhHP), 7.44-7.47 (m, 2H, PhHm),
6.64 (br-s, 1H, NH), 3.73 (app-q, J = 6.0 Hz,
2H, CH2OH), 3.66 (app-q, J = 6.0 Hz, 2H,
NCH2), 3.15 (br-t, J = 6.0 Hz, 1H, OH), 1.81
(app-quintet, J = 6.0 Hz, 2H, CH 2CH 2CH2).
6 168.8 (Camide), 134.2 (PhCipso), 131.6 (PhCP),
128.5 (PhCm), 127.0 (PhCo), 59.9 (CH2OH),
37.4 (NCH 2), 31.8 (CH2CH2CH).
3323 (s, O-H), 3066 (m), 2944 (s), 1639 (s,
C=O), 1545 (s).
HRMS (ESI) (mlz):
TLC (5% MeOH in CH2Cl2) Rf.








IMes (5 mol %)
+ H2N OH 3 24 hTHF, 23 "C, 24 h
66%
O




N-(2-Hydroxyethyl)-2-hydroxymethyl benzamide (41a, Table 1, entry 14):
A flame dried React-IR cell was charged with IMes (3, 30 mg, 98 [mol, 0.05 equiv) and
sealed under a nitrogen atmosphere in a glove-box. The reaction vessel was placed onto the
probe under a stream of Argon and THF (1.00 mL) was added via a gas-tight syringe to give a
clear colorless solution. A solution of ester 11 (264 mg, 1.97 mmol, 1 equiv) in THF (0.95 mL)
was added to the cell followed by ethanolamine (2a, 120 [L, 1.97 mmol, 1.00 equiv) via a gas-
tight syringe. The reaction progress was monitored for 24 h. The volatiles were removed under
reduced pressure on a rotary-evaporator, and the resulting yellow residue was purified by flash
column chromatography on silica gel (10% MeOH in CH2Cl2) to afford the amide 41a as a solid
(105 mg, 66%).
1H NMR (500 MHz, DMSO-d6, 20°C):
13 C NMR (125.8 MHz, DMSO-d6 , 20 oC):
FTIR (CHCl3) cm-':
HRMS (ESI) (m/z):
TLC (10% MeOH in CH2Cl2) Rf.
8 8.34 (br-t, J = 5.3 Hz, 1H, NH), 7.52 (d, J =
7.5 Hz, 1H, C3H), 7.42-7.44 (m, 2H, C5H and
C6H), 7.29 (t, J = 7.5 Hz, 1H, C4H), 5.28 (t, J
= 6.5 Hz, 1H, ArCH2OH), 4.73 (t, J = 6.5 Hz,
1H, CH 2OH), 4.58 (d, J = 6.0 Hz, 2H,
ArCH2OH), 3.49 (app-q, J = 6.5 Hz, 2H,
CH 2OH), 3.29 (app-q, J = 6.0 Hz, 2H, NCH2).
6 168.8 (Camid), 140.2 (C7), 135.2 (C2), 129.7
(C5), 127.6 (C3), 127.4 (C4), 126.6 (C6), 61.1(CH2OH), 59.8 (ArCH2OH), 42.0 (NCH 2).
3442 (m, O-H), 3003 (w), 2940 (w), 1644 (s,
C=O), 1526 (w).
calc'd for CjoH 13NO3 [M+Na]÷: 218.0788
found: 218.0783
63-64 oC








IMes (5 mol %)






N-(1-(S)-Benzyl-2-hydroxvethyl)-pyridin-4-yl acetamide (4kc, Table 1, entry 16):
Ester In (265 [L, 1.97 mmol, 1.00 equiv) was added via a gas-tight syringe to a solution
of IMes (3, 30 mg, 98 jpmol, 0.05 equiv.) in THF (1.95 mL) at 23 *C under an argon atmosphere.
The resulting bright-yellow solution was transferred via cannula to a flask containing solid L-
phenylalaninol (2c, 298 mg, 1.97 mmol, 1 equiv) under an argon atmosphere and the resulting
mixture was set to stir vigorously. After 15 min, a yellow-homogenous solution resulted and
after an additional 30 min, the amide product 4nc began to precipitate. After 4 h, monitoring of
the reaction mixture by TLC indicated complete conversion to the desired amide 4nc. The
volatiles were removed under reduced pressure on a rotary-evaporator and the resulting beige-
residue was purified by flash column chromatography on silica gel (5% MeOH in CH2Cl2) to
afford the amide 4nc as an off-white solid (461 mg, 86%).
'H NMR (500 MHz, DMSO-d6, 200C):
13C NMR (125.8 MHz, DMSO-d 6, 20 oC):
FTIR (thin film), cm-':
HRMS (ESI) (m/z):
TLC (10% MeOH in CH2Cl2) Rf.
8 8.40 (d, J = 5.8 Hz, 2H, CH2,6-pyr), 8.07 (d, J
= 8.5 Hz, 1H, NH), 7.21-7.24 (m, 2H,
PhCHm), 7.16-7.19 (m, 3H, PhCHo,), 7.08 (d,
J = 6.1 Hz, 2H, CH3,5_pyr), 4.86 (t, J = 5.5 Hz,
1H, OH), 3.91 (m, 1H, NCH), 3.30-3.43 (m,
4H, CH2CONH, CH2OH), 2.85 (dd, J = 13.7,
5.2 Hz, 1H, PhCH 2), 2.60 (dd, J = 13.6, 9.1
Hz, 1H, PhCH 2).
6 168.4 (Camidj, 149.2 (C2,6pyr), 145.3 (C4-pyr),
139.1 (PhCIpso), 129.1 (PhCo), 128.1 (PhCm),
125.9 (PhCp), 124.3 (C3,5-pyr), 62.7 (CH2OH),
52.5 (NCH), 41.6 (CH2CONH), 36.6
(CH2Ph).
3316 (s, O-H), 3059 (w), 2919 (w), 1637 (s,
C=O), 1538 (m).





IMes (5 mol %)





N-(2-Furoyl) L-Phenylalaninol (41c, Table 1, entry 17):
Ester lo (211 tiL, 1.97 mmol, 1 equiv) was added via a gas-tight syringe to a solution of
IMes (3, 30 mg, 98 ýtmol, 0.05 equiv.) in THF (1.95 mL) at 23 'C under an argon atmosphere.
The resulting bright-yellow solution was transferred via cannula to a flask containing solid L-
phenylalaninol (2c, 298 mg, 1.97 mmol, 1.00 equiv) under an argon atmosphere. After 24 h, the
volatiles were removed under reduced pressure on a rotary-evaporator and the resulting beige-
residue was purified by flash column chromatography on silica gel (2% MeOH in CH2Cl2) to
afford the amide 4oc as an off-white solid (428 mg, 89%).
1H NMR (500 MHz, CDC13 , 200 C):
13C NMR (125.8 MHz, CDC13, 20 oC):
FTIR (CHCl3) cm-':
HRMS (ESI) (m/z):
6 7.42 (m, 1H, C3H), 7.31-7.34
PhHm), 7.23-7.28 (m, 3H, PhHo,),
1H, CsH), 6.65 (br-d, J = 6.0 Hz,
6.49 (dd, J = 3.2, 2.5 Hz, 1H, C4H)
1H, NCH), 3.77 (m, 1H, CH 2OH),
1H, CH 2OH), 2.99 (d, J = 7.5













6 158.8 (Camide), 147.7 (C2), 144.2 (C 5), 137.7
(PhCipso), 129.4 (PhCo), 128.7 (PhCm), 126.8
(PhCp), 114.6 (C3), 112.3 (C4), 63.5 (CH2OH),
52.6 (NCH 2), 37.2 (CH2Ph).
3425 (m, O-H), 3000 (w), 2948 (w), 1653 (s
(C=O), 1595 (s).
calc'd for C14H15NO 3 [M+H]+: 246.1125
found: 246.1126
94.5-95.5 oC














IMes (5 mol %)
THF, 23 0C, 15 h
84%
Me




Ester In (265 [tL, 1.97 mmol, 1.00 equiv) was added via a gas-tight syringe to a solution
of IMes (3, 30 mg, 98 [tmol, 0.05 equiv.) in THF (1.95 mL) at 23 'C under an argon atmosphere.
To the resulting bright-yellow solution was added L-leucinol (2d, 255 [L, 1.97 mmol, 1 equiv)
under an argon atmosphere and the resulting mixture was set to stir vigorously. After 1.5 h, the
amide product 4nd began to precipitate. After 15 h, monitoring of the reaction mixture by TLC
indicated complete conversion to the desired amide 4nd. The volatiles were removed under
reduced pressure on a rotary-evaporator, and the resulting beige residue was purified by flash
column chromatography on silica gel (5-310% MeOH in CH2CI2) to afford the amide 4nd as an
off-white solid (391 mg, 84%).
IH NMR (500 MHz, DMSO-d 6, 200C)




8 8.46 (d, J = 5.0 Hz, 2H, CH 2,6.pyr), 7.90 (d, J
= 8.5 Hz, 1H, NH), 7.26 (d, J = 5.5 Hz, 2H,
CH3,.pyr), 4.70 (t, J = 5.3 Hz, 1H, OH), 3.77(m, 1H, NCH), 3.47 (d, J = 14.5 Hz, 1H,
CH2CONH), 3.43 (d, J = 14.0 Hz, 1H,
CH2CONH), 3.32 (m, 1H, CH2OH), 3.24 (m,
1H, CH2OH), 1.55 (septet, J = 6.5 Hz, 1H,
CH3CHCH3), 1.29 (m, 2H, CH 2i-Pr), 0.84 (d,
J= 6.5 Hz, 3H, CH3), 0.79 (d, J = 6.5 Hz, 3H,
CH3).
6 168.5 (Camide), 149.4 (C2,-pyr), 145.6 (C4pry),
124.4 (C35-pyr), 63.8 (CH2OH), 48.8
(CH2CONH), 41.7 (NCH), 24.3 (CH(CH3)2),
23.3 (CH2i-Pr), 21.8 (CH3)
3430 (m, O-H), 2993 (m), 2959 (m), 1666 (s,
C=O), 1603 (m).
calc'd for C13H 2oN20 2 [M+H]÷: 237.1598
found: 237.1608
106.5-107.5 oC





IMes (5 mol %)






N-(2-thiophenecarbonyl) L-Leucinol (4pd, Table 1, entry 19):
Ester 1p (228 tL, 1.97 mmol, 1.00 equiv) was added via a gas-tight syringe to a solution
of IMes (3, 30 mg, 98 [tmol, 0.05 equiv) in THF (1.95 mL) at 23 °C under an argon atmosphere.
To the resulting bright-yellow solution was added L-leucinol (2d, 255 RL, 1.97 mmol, 1 equiv)
under an argon atmosphere. After 24 h, the volatiles were removed under reduced pressure on a
rotary-evaporator and the resulting yellow-residue was purified by flash column chromatography
on silica gel (5% MeOH in CH2Cl2) to afford the amide 4pd as a white solid (343 mg, 77%).
'
1H NMR (500 MHz, CDCl3 , 20°C):
'
3C NMR (125.8 MHz, CDCI3, 20 oC):
FTIR (CHCl3) cm-':
HRMS (ESI) (mlz):
TLC (10% MeOH in CH2Cl2) Rf.
8 7.51 (m, 1H, C3H),7.48 (dd, J = 5.0, 1.0 Hz,
1H, C5H), 7.07, (m, 1H, C4H), 6.19 (br-s, 1H,
NH), 4.32 (m, 1H, NCH), 3.78 (d, J = 11.0
Hz, 1H, CH 2OH), 3.65 (dd, J = 10.5 Hz, 5.0
Hz, 1H, CH 2OH) 2.82, (br-s, 1H, OH), 1.70
(m, 1H, CH3CHCH3), 1.54 (ddd, J = 9.5, 6.0,
5.5 Hz, 1H, CH2i-Pr), 1.44 (ddd, J = 5.5, 5.5,
8.5 Hz, CH 2i-Pr), 0.97 (d, J = 1.5 Hz, 3H,
CH 3), 0.96 (dd, J = 1.5 Hz, 3H, CH3).
6 162.8 (Camide), 139.1 (C2), 130.4 (C5), 128.4
(C3), 127.8 (C4), 65.8 (CH 2OH), 50.5 (NCH),
40.4 (CH3CHCH3), 25.2 (Ci-Pr), 23.2 (CH3),
22.5 (CH3).
3438 (m, O-H), 3003 (w), 2959 (w), 1641 (s,
C=O), 1537 (m).
calc'd for C,1 H17NO2 S [M+H]÷: 228.1053
found: 228.1045
67-70 oC







IMes (5 mol %)





N-Phenylacetyl-L-Prolinol (4ae, Table 1, entry 20):
Ester la (283 [lL, 1.97 mmol, 1.00 equiv) and L-prolinol (2e, 192 [lL, 1.97 mmol, 1
equiv) were added sequentially via a gas-tight syringe to a solution of IMes (3, 30 mg, 98 I[mol,
0.05 equiv) in THF (1.95 mL) at 23 °C under an argon atmosphere. After 4 h, the volatiles were
removed under reduced pressure on a rotary-evaporator, and the resulting yellow-residue was
purified by flash column chromatography on silica gel (5% MeOH in CH2Cl2) to afford the
amide 4ae9 as a pale yellow oil (428 mg, 99%).
1H NMR (500 MHz, CDCI3, 200 C):
13C NMR (125.8 MHz, CDCl3, 20 oC):
FTIR (thin film) cm-':
8 7.33-7.36 (m, 2H, PhH.), 7.26-7.29 (m,
3H, PhH,i), 5.08 (dd, J = 8.0, 2.5 Hz, 1H,
OH), 4.25 (ddd, J = 14.1, 8.5, 2.5 Hz, 1H,
NCHCH2OH), 3.66-3.71 (m, 3H, PhCH2,
CH2OH), 3.56-3.62 (m, 2H, CH 2OH, NCH 2),
3.45 (dt, J = 10.5, 7.0 Hz, 1H, NCH 2), 2.05
(dt, J = 19.9, 7.5 Hz, 1H, NCHCH2CH2), 1.91
(app-septet, J = 7.0 Hz, 1H, NCHCH2CH2),
1.85 (m, 1H, NCHCH2CH 2), 1.57 (sextet, J =
7.0 Hz, 1H, NCHCH2CH 2).
6 172.7 (Camide), 134.5 (PhCipo), 129.1 (PhCo),
129.0 (PhCm), 127.2 (PhCp), 67.8
(NCHCH 2OH), 61.8 (NCHCH2OH), 48.2
(NCH2), 42.7 (PhCH2), 28.6 (NCHCH2CH2),
24.7 (NCHCH2CH2).
3383 (s, O-H), 3062 (w), 2954 (m), 1620 (s,
C=O), 1429 (m).
HRMS (ESI) (mlz):





9For a previous synthesis of amide 4ae by acylation of the phenylacetyl chloride, see: F. A. Davis, L. C. Vishwakarma,








IMes (5 mol %)






N-(N-Boc-Glycyl)-L-Phenylalaninol (4c., Table 1, entry 21):
A solution of IMes (3, 30 mg, 98 [lmol, 0.05 equiv) in THF (1.95 mL) was added to a
suspension of N-Boc-glycine methyl ester (1q, 373 mg, 1.97 mmol, 1.00 equiv) and L-
phenylalaninol (2c, 298 mg, 1.97 mmol, 1 equiv) via a gas-tight syringe under an argon
atmosphere. Within 5 min, amide 4qc began to precipitate. After 17 h, the volatiles were
removed under reduced pressure on a rotary-evaporator, and the resulting yellow-residue was
purified by flash column chromatography on silica gel (5 -- 10% MeOH in CH2Cl2) to afford the
amide 4qc as a white crystalline solid (506 mg, 83%).
'1H NMR (500 MHz, CDCl3, 200 C):
13C NMR (125.8 MHz, CDC13, 20 oC):
FTIR (CHCl3) cm-':
HRMS (ESI) (m/z):
6 7.30-7.33 (m, 2H, PhH.), 7.21-7.26 (m,
3H, PhH,,), 6.34 (br-d, 1H, NamideH), 5.10 (br-
s, 1H, NcabmateH), 4.19 (m, 1H, NCH), 3.75
(d, J = 5.5 Hz, 2H, CH 2CONH), 3.70 (m, 1H,
CH 2OH), 3.59 (m, 1H, CH 2OH), 2.92 (d, J =
7.5 Hz, 1H, CH 2Ph), 2.89 (dd, J = 7.5, 4.5 Hz,
2H, CH 2Ph), 2.58-2.75 (br-d, 1H, OH), 1.46
(s, 9H, (CH3 )3).
8 170.1 (Camide), 156.5 (Ccarbamate), 137.7
(PhCipso), 129.4 (PhCo), 128.8 (PhCm), 126.9
(PhCp), 80.6 (C(CH 3)3), 63.7 (CH2OH), 53.0
(NCH), 44.6 (BocNHCH2), 37.2 (PhCH2),
28.5 (CH3)3).
3424 (m, O-H), 2984 (m), 2935 (m), 1699 (s,
C=O), 1674 (s, C=O).
calc'd for C16H 24N20 4 [M+H]+: 309.1809
found: 309.1811
134-135 OC




IMes (5 mol %)










N-(N-Boc-Glycyl)-L-1-Methyl-Tryptophanol (4qf, Table 1, entry 22):
A solution of IMes (3, 30 mg, 98 [mol, 0.05 equiv) in THF (1.95 mL) was added via a
gas-tight syringe to a suspension of N-Boc-glycine methyl ester (1q, 373 mg, 1.97 mmol, 1.00
equiv) and L-1-methyl-tryptophanol (2f, 402 mg, 1.97 mmol, 1 equiv) under an argon
atmosphere at 23 *C. After 1.5 h, the volatiles were removed under reduced pressure on a rotary-
evaporator and the resulting yellow residue was purified by flash column chromatography on
silica gel (5% MeOH in CH2Cl2) to afford the amide 4qf as a white foam (628 mg, 88%).
1H NMR (500 MHz, DMSO-d6, 200C)
'
3C NMR (125.8 MHz, CDC13, 20 OC):
FTIR (CHC13) cm-':
HRMS (ESI) (mlz):
TLC (10% MeOH in CH2Cl2) Rf.
6 7.61 (m, 2H, C4H, NmideH), 7.36 (d, J = 8.0
Hz, 1H, CqH), 7.12 (t, J = 7.8 Hz, 1H, C6H),
7.08 (s, 1H, C1H), 7.01 (t, 1H, C5H), 6.91 (br-
t, J = 5.8 Hz, 1H, NabamaH), 4.76 (br-t, J =
5.0 Hz, 1H, OH), 3.94 (m, 1H, NCH), 3.72 (s,
3H, NCH3), 3.54 (dd, J = 16.5, 6.5 Hz, 1H,
BocNHCH2) 3.49 (dd, J = 16.5, 6.0 Hz, 1H,
BocNHCH 2), 3.30-3.40 (m, 2H, CH2OH),
2.29 (dd, J = 14.5, 6.5 Hz, 1H, CH 2Ar), 2.74
(dd, J = 14.0, 6.3 Hz, 1H, CH2Ar), 1.38 (s,
9H, (CH 3)3).
6 170.2 (Cmide), 156.4 (Ccrb~ama), 137.1 (Cs),
128.2 (C3), 127.7 (CI), 121.9 (C4), 119.3 (C5),
119.0 (C6), 110.1 (C,), 109.5 (C2), 80.5
(C(CH3)3), 64.0 (CH 2-OH), 52.5 (NHCH),
44.6 (BocNHCH 2), 32.9 (NCH 3), 28.5
(C(CH3)3), 26.6 (CH2Ar).
3424 (m, O-H), 3004 (m), 2935 (m), 1706 (s,
C=O), 1673 (s, C=O).










IMes (5 mol %)







Ir 2c 007-o 4rc
N-(N-Boc- 1-Methyl-L-Tryptophanoyl)-L-Phenylalaninol (4rc-(SS), Table 1, entry 23):
A solution of IMes (3, 30 mg, 98 ýtmol, 0.05 equiv) in THF (1.95 mL) was added via a
cannula to a suspension of N-Boc-l-methyl-tryptophan methyl ester (ir, 655 mg, 1.97 mmol,
1.00 equiv) and L-phenylalaninol (2c, 298 mg, 1.97 mmol, 1 equiv) under an argon atmosphere.
After 18.5 h, the volatiles were removed under reduced pressure on a rotary-evaporator, and the
resulting yellow-residue was purified by flash column chromatography on silica gel (2% MeOH
in CH2 Cl2) to afford the amide 4rc as a white crystalline solid (781 mg, 88%). Chromatographic
enrichment of amide 4rc was not attempted (crude product, >94%de). The product was found to
be >94%de and >98%ee by chiral HPLC analysis [Chirapak AD-H; 3.0 mL/min; 10% i-PrOH in
hexanes; tR(major-4rc-S,S) = 8.12 min, tR(minor-4rc-R,S) = 11.8 min. tR(not present-4rc-SR) =
9.9 min tR(not present-4rc-R,R) = 14.8 min]. The L-phenylalaninol (2c) and the precursor to ester
Ir, 1-methyl L-tryptophan, were used as received from Aldrich (>98%ee).
1H NMR (500 MHz, CDC13, 200C)
13C NMR (125.8 MHz, CDC13, 20 OC):
FTIR (CHC13) cm-':
HRMS (ESI) (mlz):
6 7.66 (d, J = 8.0 Hz, 1H, C4H), 7.14-7.33 (m,
6H, ArH), 7.01 (m, 2H, ArH), 6.90 (s, 1H,
C1H), 5.78 (br-s, 1H, NamideH), 5.16 (br-s, 1H,
NcarbamateH), 4.36 (br-s, 1H, BocNHCH), 4.01
(br-s, 1H, NCH) 3.74 (s, 3H, NCH 3), 3.32 (m,
3H, CH 2Ar and CH 2OH), 3.10 (dd, J = 14.0,
7.5 Hz, 1H, CH 2OH), 2.67 (dd, J = 14.0, 8.0
Hz, 1H, CH 2Ph), 2.60 (m, 1H, CH 2Ph), 2.08
(br-s, 1H, OH).
6 172.0 (Camide), 155.7 (Ccarbamate), 137.6 (C8),
137.1 (PhCpso), 129.3 (C3), 128.6 (PhCm),
128.0 (CI, PhCo), 126.7 (PhCp), 122.1 (C4),
119.5 (C5), 119.1 (C6), 109.5 (C7), 109.2 (C2),
80.3 (C(CH3)3), 63.3 (CH2OH), 55.8
(BocNHCH), 52.9 (NHCH), 36.8 (CH2 Ph),
32.8 (NCH 3), 28.6 (CH2Ar), 28.4 (C(CH3)3).
3422 (m, O-H), 3005 (m), 2935 (m), 1705 (s,
C=O), 1669 (s, C=O).
calc'd for C2 6H3 3N30 4 [M+H]': 452.2544
found: 452.2541
149-150 oC
TLC (10% MeOH in CH2C12) Rf. 0.50 (UV, KMnO4)
130
Mes
: + H-Q -







Representative Experimental Procedure for Complex 8b (Table 2, entry 2):
Anhydrous methanol (14.0 [iL, 32 ýtmol, 1.0 equiv) was added to a solution of IMes (3,
100 mg, 32.0 imol, 1 equiv) and C6D6 (700 [tL) in an NMR-tube under a nitrogen atmosphere in
a glove-box. Alternatively, this complex is quantitatively formed upon removal of excess
methanol from a solution of IMes in methanol under reduced pressure. Slow crystallization of
complex 8b from toluene affords high quality crystals that have the same 'H NMR (C6D6)
spectrum as complexes formed in solution.
8 6.78 (s, 4H, ArH), 6.38 (s, 2H, C4H), 4.37
(s, 1H, OH), 3.10 (s, 3H, CH3OH), 2.13 (s,
18H, ArCH3).
8 209.7 (C2), 138.5 (ArCip,o), 138.1 (ArCo),
135.6 (ArCp), 129.5 (ArC.), 121.2 (C4), 48.1
(CH3OH), 21.4 (p-CH3), 18.2 (o-CH3).
The IMes-tert-butanol, -ethanolamine and -benzyl alcohol complexes (Table 2, entries 1 and 3-
4) were prepared as described above and the data is shown below. For completeness and direct
comparison, the relevant 1H and 13C NMR data for IMes (3) is listed below:
IMes-HO'Bu (8a):
'H NMR (500 MHz, C6D6, 20 oC, 0.05M):
IMes-HOCHzCH 2NH 2 (8c):
'H NMR (500 MHz, C6D6, 20 oC, 0.05M):
IMes-HOCH 2Ph (8d):
'H NMR (500 MHz, C6D6, 20 'C, 0.05M):
8 6.80 (s, 4H, ArH), 6.43 (s, 2H, C4H), 2.81
(s, 1H, OH), 2.16 (s, 12H, CH 3), 2.15 (s, 6H,
CH 3), 1.07 (s, 3H, C(CH3)3).
8 6.78 (s, 4H, ArH), 6.37 (s, 2H, C4H), 5.24
(s, 1H, OH), 3.27 (t, J = 5.3 Hz, CH2OH),
2.45 (t, J = 5.0 Hz, CH 2NH2), 2.14 (s, 6H,
Ar(CH 3)p), 2.12 (s, 12H, Ar(CH3),).
8 7.05-7.21 (m, 5H, C6H5), 6.76 (s, 4H, ArH),
6.33 (s, 2H, C4H), 5.8-6.2 (br-s, 1H, OH),
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IMes-Alcohol Complexes (Table 2)
IMes-HOMe (8b):
1H NMR (500 MHz, C6D6, 20 0C, 0.05M):




1H NMR (500 MHz, C6D6 , 20 oC, 0.05M):
CH 2), 2.14 (s, 6H, Ar(CH 3)p),
Ar(CH3)0).
6 7.30 (m, 6H, Ph3Ho), 7.01 (m,
Ph3H,,Ph3Hm), 6.79 (s, 4H, ArH), 6.34 (s,
C4H), 5.93 (br s, 1H, OH), 2.16 (s,





'H NMR (500 MHz, C6D6 , 20 'C, 0.5M) major resonances: 6 10.75 (br s, 1H, OH), 6.73 (s, 4H,
ArH), 6.49 (s, 2H, C4H), 3.66 (q, JHF = 9.7 Hz,
2H, CF 3CH 2), 2.12 (s, 6H, Ar(CH3)p), 1.95 (s,
12H, Ar(CH3)0).
13C NMR (125.8 MHz, C6D6 , 20 oC, 0.5M) major
IMes (3):
1H NMR (500 MHz, C6D6 , 20 oC, 0.5 M):




CD 3OD, 24 h
23 oC;
C6 D6 , 23 oC
resonances: 8 194.7 (C2), 138.8 (ArCipso), 137.0
(ArCo), 135.3 (ArC,), 129.6 (ArCm), 127.3 (q,
JCF, = 280.9 Hz, CF3) 121.9 (C4), 60.4 (app q,
J2 CF = 32.4 Hz, CH2CF3), 21.3 (p-CH3), 17.9
(o-CH3).
8 6.81 (s, 4H, ArH), 6.50, (s, 2H, C4H), 2.15
(s, 6H, Ar(CH3)p), 2.07 (s, 12H, Ar(CH 3)o).
8 219.4 (C2), 139.6 (
135.7 (ArC,), 129.5 (P
(p-CH3), 18.4 (o-CH3).
ArCipso), 137.6 (ArCo),






IMes (3, 100 mg, 32.0 ýtmol, 1.0 equiv) was dissolved in methanol-d4 (700 tL) and kept
under argon atmosphere for 24 h. Removal of the methanol-d4 under reduced pressure
quantitatively afforded the hexadeuterated complex 8b-dM.'0 Dissolution of the residue in C6D6(700 ýtL) followed by NMR analysis indicated that the complex was >95% deuterated at the C45.
IMes-d2-DOMe-d 4 (8b-dM):
'H NMR (500 MHz, C6D6, 20 oC, 0.5M): 6 6.77 (s, 4H, ArH), 6.39, (s, <0.1H, C4,5H-
residual), 5.88 (br-s, OH-residual), 3.11
(pentet, J = 1.5 Hz, CD 2HOD-residual), 2.11
(s, 6H, p-CH3), 2.06 (s, 12H, o-CH3).
'0 For prior reports regarding preparation of doubly deuterated NHCs, see: M. K. Denk, J. M. Rodezno, J. Organometal. Chem.
2000,608, 122-125 and M. L. Cole, C. Jones, P. C. Junk, New J. Chem. 2002, 262, 1296-1303.
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13C NMR (125.8 MHz, C6D6, 20 oC, 0.5M):
IMes-d2- DOMe-d4 (8b-d2):
1H NMR (500 MHz, THF-d,, 20 TC, 0.5 M):
13C NMR (125.8 MHz, THF-ds, 20 oC, 0.5 M):
8 203.9 (C2), 138.4 (ArCo), 137.9 (ArCpso),
135.5 (ArC,), 129.5 (ArCm), 121.1 (t, JcD =
27.0 Hz, C4), 48.0 (heptet, JcD = 20.9 Hz,
CD3OD), 21.3 (p-CH3), 18.2 (o-CH3).
8 6.96 (s, 4H, ArH), 7.11, (s, <0.15H, C4,5H-
residual), 5.33 (br-s, OH-residual), 2.31 (s,
6H, p-CH3), 2.09 (s, 12H, o-CH 3).
8 212.4 (C2), 139.3 (ArCipso), 138.2 (ArCp),
136.0 (ArCo), 129.6 (ArC,,), 121.6 (t, JCD =
29.4 Hz, C4), 47.3 (heptet, JcD = 20.8 Hz,
























5-Methyl-2-(1-S-phenylethyl)-imidazo[1 ,5-alpyridin-2-ium triflate ((-)-35):
To a solution of the aldehyde 33 (1.99 g, 16.43 mmol, 1 equiv) in absolute EtOH (32 mL)
was added S-a-methylbenzylamine 30 (2.09 mL, 16.43 mmol, 1.00 equiv) followed by Na 2SO4(3.2 g). The suspension was stirred for 2 h, and the Na2SO4 was removed by gravity filtration.
The resulting solution was concentrated in vacuo to yield 3.47 g of a light orange oil that was
used without further purification (94 % crude yield). To a solution of the imine 34 (3.47 g, 15.47
mmol, 1 equiv) in CH2Cl2 (150 mL) was added chloromethylpivalate (3.14 mL, 21.66 mmol,
1.40 equiv) and AgOTf (4.77 g, 18.56 mmol, 1.2 equiv). The suspension was heated to 40 oC in
the dark for 14 h. The dark suspension was cooled to 23 'C and was filtered through a plug of
Celite (3" diameter x 1" height). The filter cake was rinsed with MeOH (2 x 20 mL) and the
filtrate was concentrated in vacuo to yield 8.8 g of a dark purple oil. Purification of the crude by
flash column chromatography (1" x 10.5", 100 % CH2Cl2 -- 2 % MeOH in CH2C12) afforded
triflate 35 as a light beige powder (4.14 g, 72 %). The e.e. of the salt was determined to be 98.6
% by conversion to the thiourea 39 and analysis by HPLC (Chirapak AD-H, 30 % isopropanol in
hexanes, 1.0 mL/min, tmajor 6.99 min, tminor = 4.83 min).
'H NMR (500 MHz, CDC13, 20 °C):
13C NMR (125.8 MHz, CDC13, 20 'C):
FTIR (neat) cm-':
HRMS (ESI) (m/z):
8 10.80 (s, 1H, C3H), 7.61 (s, 1H, CH), 7.52-
7.54 (m, 2H, PhH), 7.41-7.48 (m, 4H, PhH
and CsH), 7.16 (dd, J = 9.5 Hz, 7.0 Hz, 1H,
C7H), 6.86 (dt, J = 7.0 Hz, 1.0 Hz, 1H, C6H),
6.30 (q, J = 7.0 Hz, 1H, CH 3CH), 2.83 (s, 3H,
Pyr-CH 3), 2.13 (d, J = 7.0 Hz, 3H, CH 3CH).
6 137.9, 133.5, 131.1, 129.7, 129.6, 127.4,
125.6, 123.5, 120.9 (q, JCF = 320.2 Hz, CF3),
116.9, 116.1, 111.8, 61.4 (CH3CHPh), 21.0
(CH3-Pyr), 18.2 (CH3CHPh).
3106 (m), 1662 (w), 1562 (w), 1457 (w), 1259
(s).
calc'd for C,6H, 7N2 [M+]: 237.1386
found: 237.1393
[a] 20D:
TLC (10 % MeOH in CH2C12), Rf.
-43 (c = 0.49, CHCl3)




/ 0N O 30 ,.
N 10 mol %
p-TsOH
Me Toluene
















To a solution of the ketone 36 (150 mg, 0.760 mmol, 1 equiv) in toluene (4.00 mL) was
added S-a-methylbenzylamine 30 (107 [tL, 0.837 mmol, 1.10 equiv) followed by p-TsOH.H 20(14.5 mg) and Na2SO4 (1.00 g). The suspension was heated to 110 oC for 24 h then allowed to
cool to 23 'C whereupon the ammonium tosylate precipitated as long white needles. The solvent
was concentrated in vacuo and the light orange gel was diluted with hexanes (2.0 mL) and
gravity filtered. The filter cake was washed with hexanes (3 x 2 mL) and the filtrate was
concentrated in vacuo to yield 220 mg (96 %) of an orange oil which was used without further
purification. The imine was found to be a 47:53 ratio of isomers by 1H NMR. To a solution of
the imine 37 (220 mg, 0.732 mmol, 1 equiv) in CH 2Cl2 (7.00 mL) was added
chloromethylpivalate (150 [tL, 1.02 mmol, 1.40 equiv) and AgOTf (226 mg, 0.878 mmol, 1.2
equiv). The suspension was heated to 40 oC in the dark for 15 h. The black suspension was
cooled to 23 oC and was filtered through a plug of Celite (1" diameter x 0.5" height). The filter
cake was rinsed with MeOH (3 x 3 mL) and the filtrate was concentrated in vacuo to yield a
thick red oil. Purification of the crude by flash column chromatography (1" x 10", 1 % MeOH in
CH2C12 -" 10 % MeOH in CH2CI2) afforded a red oil which was diluted with CH2Cl2 (1 mL) and
the product was precipitated by addition of Et2O (10 mL). Evaporation of the solvents yielded
the triflate 38 as an off-white solid (136 mg, 40 %). The e.e. of the salt was determined to be
98.3 % by conversion to the thiourea 40 and analysis by HPLC (Chirapak AD-H, 100% hexanes
to 30 % isopropanol in hexanes over 10 min, 2.0 mL/min, tmjo, = 5.14 min, tmino, = 4.75 min).
1H NMR (500 MHz, CDCI3, 20 oC):
13C NMR (125.8 MHz, CDCI3, 20 'C):
8 10.07 (s, 1H, C3H), 7.63, (app tt, J = 7.8 Hz,
1.3 Hz, 1H, Pyr-PhHpa,,), 7.56 (t, J = 7.8 Hz,
2H, CHPhH), 7.24-7.28 (m, 5H, CHPhH and
Pyr-PhH), 7.25 (d, J = 10.0 Hz, 1H, C8H),
7.16 (m, 2H, Pyr-PhH), 7.12 (dd, J = 9.5 Hz,
7.0 Hz, 1H, C7H), 6.90 (dt, J = 6.5 Hz, 0.5 Hz,
1H, C6H), 5.80 (q, J = 7.0 Hz, 1H, CHPh),
2.95 (s, 3H, Pyr-CH 3), 2.24 (d, J = 7.5 Hz, 3H,
CHCH3).
6 138.4, 134.5, 131.2, 129.8, 129.5, 129.3,
129.1, 126.9, 125.9, 125.6, 124.9, 123.3, 120.9
(q, J = 320.5 Hz, CF3), 117.1, 115.2, 60.3








TLC (10 % MeOH in CH 2C12), Rf.
[M+]: 313.1699
+5 (c = 0.505, CHCI3)
0.48 (UV, KMnO 4)
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Table 1. Crystal data and structure refinement for 04152final.
Identification code 04152final






Unit cell dimensions a = 14.9026(16) A
b = 16.6125(17) A










Completeness to theta = 25.000
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2sigma(I)]
R indices (all data)















Full-matrix least-squares on F 2
3411 / 1/234
1.175
R1 = 0.0509, wR2 = 0.1134
R1 = 0.0676, wR2 = 0.1214
0.588 and -0.167 e.A-3
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Table 2. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (A2x 103)
for 04152final. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor.
x y z U(eq)
N(1) 6662(1) 746(1) 7418(2) 22(1)
N(3) 7698(1) 67(1) 6389(2) 25(1)
C(2) 7305(1) 195(1) 7881(2) 25(1)
C(4) 7307(1) 522(1) 5047(2) 26(1)
C(5) 6654(1) 952(1) 5695(2) 25(1)
C(11) 8447(1) -475(1) 6261(2) 25(1)
C(12) 8299(1) -1212(1) 5450(2) 27(1)
C(13) 9030(1) -1725(1) 5386(3) 33(1)
C(14) 9878(1) -1525(1) 6096(3) 33(1)
C(15) 9996(1) -783(1) 6878(3) 33(1)
C(16) 9291(1) -243(1) 6988(2) 28(1)
C(17) 7386(1) -1448(1) 4676(3) 37(1)
C(18) 10660(2) -2099(2) 6002(3) 47(1)
C(19) 9440(1) 553(1) 7864(3) 40(1)
C(21) 6076(1) 1074(1) 8633(2) 22(1)
C(22) 5174(1) 852(1) 8531(2) 21(1)
C(23) 4633(1) 1157(1) 9750(2) 24(1)
C(24) 4969(1) 1669(1) 11035(2) 25(1)
C(25) 5872(1) 1874(1) 11096(2) 27(1)
C(26) 6443(1) 1585(1) 9914(2) 25(1)
C(27) 4777(1) 295(1) 7165(2) 28(1)
C(28) 4367(2) 1991(1) 12337(3) 38(1)
C(29) 7421(1) 1816(1) 10038(3) 35(1)
0(1) 7891(1) -406(1) 11145(2) 42(1)
C(30) 8177(2) -1189(1) 10717(3) 40(1)

















































































































Symmetry transformations used to generate equivalent atoms:
Table 4. Anisotropic displacement parameters (A2X 103) for 04152final. The anisotropic
displacement factor exponent takes the form: -2n 2[ h 2 a*2U11 + ... + 2 h k a* b* U 12 ]
U"1  U22  U33  U23  U'3  U'2
N(1) 22(1) 25(1) 20(1) 1(1) 1(1) 2(1)
N(3) 22(1) 30(1) 22(1) 3(1) 3(1) 3(1)
C(2) 22(1) 30(1) 24(1) 1(1) 2(1) 1(1)
C(4) 26(1) 31(1) 21(1) 3(1) 1(1) -1(1)
C(5) 27(1) 27(1) 22(1) 4(1) -1(1) 1(1)
C(11) 23(1) 31(1) 21(1) 5(1) 8(1) 4(1)
C(12) 27(1) 32(1) 24(1) 6(1) 6(1) 0(1)
C(13) 38(1) 31(1) 30(1) 4(1) 9(1) 6(1)
C(14) 29(1) 46(1) 24(1) 8(1) 7(1) 12(1)
C(15) 21(1) 54(1) 25(1) 5(1) 2(1) 3(1)
C(16) 25(1) 38(1) 23(1) 4(1) 4(1) 1(1)
C(17) 32(1) 38(1) 43(1) -2(1) 3(1) -3(1)
C(18) 42(1) 60(2) 40(1) 8(1) 5(1) 24(1)
C(19) 32(1) 48(1) 39(1) -6(1) 0(1) -5(1)
C(21) 24(1) 20(1) 20(1) 3(1) 2(1) 3(1)
C(22) 24(1) 19(1) 20(1) 2(1) -2(1) 1(1)
C(23) 22(1) 25(1) 25(1) 2(1) 1(1) 2(1)
C(24) 31(1) 21(1) 22(1) 2(1) 3(1) 4(1)
C(25) 37(1) 22(1) 21(1) -3(1) -1(1) -2(1)
C(26) 27(1) 22(1) 26(1) 4(1) -1(1) -1(1)
C(27) 26(1) 31(1) 26(1) -5(1) -2(1) -1(1)
C(28) 44(1) 39(1) 34(1) -7(1) 9(1) 3(1)
C(29) 31(1) 37(1) 37(1) -5(1) 0(1) -10(1)
0(1) 60(1) 37(1) 29(1) 0(1) -2(1) 7(1)
C(30) 41(1) 43(1) 36(1) 9(1) -1(1) 7(1)
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Table 5. Hydrogen coordinates ( x
for 04152final.
104) and isotropic displacement parameters (A2x 10 3)











































































































































































Table 6. Torsion angles [o] for 04152final.
C(5)-N(1)-C(21)-C(26)












Symmetry transformations used to generate equivalent atoms:




Table 7. Crystal data and structure refinement for 04150.
Identification code 04150


















Completeness to theta = 26.7300
Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2sigma(I)]
R indices (all data)
Largest diff. peak and hole
a= 76.44(3)0.
3= 83.54(3)0.








6758 [R(int) = 0.0000]
99.7 %
0.9965 and 0.9944
Full-matrix least-squares on F2
6758/ 1 /396
1.148
R1 = 0.0793, wR2 = 0.1571
R1 = 0.1060, wR2 = 0.1672
0.400 and -0.317 e.A-3
143
Table 8. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (A 2x 103)
for 04150. U(eq) is defined as one third of the trace of the orthogonalized Ui tensor.



















































































































































































































































































































































































































































































































































H(1 8A)-C(1 8)-H(1 8B)
C(14)-C(18)-H(18C)
H(1 8A)-C(1 8)-H(1 8C)

































































H(1 8A)-C(1 8)-H(1 8E)
H(1 8B)-C(18)-H(1 8E)
H(1 8C)-C(1 8)-H(1 8E)
H(1 8D)-C(1 8)-H(1 8E)
C(14)-C(18)-H(18F)
H(1 8A)-C(1 8)-H(1 8F)
H(1 8B)-C(1 8)-H(1 8F)
H(1 8C)-C(1 8)-H(1 8F)

















































































































Symmetry transformations used to generate equivalent atoms:
Table 10. Anisotropic displacement parameters (A 2x 103) for 04150. The anisotropic
displacement factor exponent takes the form: -27 2[ h2 a*2U11 + ... + 2 h k a* b* U 12 ]
U11  U22  U33  U23  U13  U12
0(1) 23(1) 16(1) 22(1) -4(1) -2(1) -13(1)
C(30) 16(1) 16(1) 18(1) -3(1) 0(1) -9(1)
C(31) 17(1) 12(1) 16(1) 2(1) -2(1) -5(1)
C(32) 21(2) 22(2) 25(2) -2(1) -3(1) -8(1)
C(33) 20(2) 34(2) 27(2) -3(1) 4(1) -9(1)
C(34) 30(2) 23(2) 23(2) -7(1) 9(1) 0(1)
C(35) 41(2) 20(2) 24(2) -9(1) 4(1) -11(1)
C(36) 25(2) 22(1) 22(2) -5(1) 3(1) -12(1)
C(41) 19(1) 11(1) 14(1) -6(1) 3(1) -5(1)
C(42) 20(1) 16(1) 16(1) -2(1) -3(1) -7(1)
C(43) 26(2) 23(1) 21(1) -10(1) 6(1) -15(1)
C(44) 37(2) 17(1) 16(1) -5(1) 6(1) -14(1)
C(45) 30(2) 13(1) 19(1) -3(1) -7(1) -3(1)
C(46) 18(1) 16(1) 25(2) -9(1) 0(1) -8(1)
C(51) 17(1) 14(1) 21(1) -3(1) 1(1) -11(1)
C(52) 23(1) 18(1) 19(1) -3(1) -1(1) -11(1)
C(53) 19(1) 19(1) 32(2) -9(1) 8(1) -9(1)
C(54) 14(1) 17(1) 34(2) 5(1) -5(1) -5(1)
C(55) 25(2) 27(2) 19(1) 3(1) -3(1) -14(1)
C(56) 18(1) 20(1) 20(1) -5(1) 4(1) -10(1)
C(2) 13(1) 18(1) 15(1) -2(1) 0(1) -5(1)
N(1) 14(1) 15(1) 19(1) -4(1) 3(1) -6(1)
C(11) 15(1) 12(1) 21(1) -7(1) 3(1) -6(1)
C(12) 21(1) 17(1) 25(2) -9(1) 0(1) -8(1)
C(13) 16(1) 19(1) 35(2) -10(1) -6(1) -2(1)
C(14) 16(1) 28(2) 36(2) -21(1) 7(1) -10(1)
C(15) 28(2) 27(2) 22(2) -11(1) 9(1) -18(1)
C(16) 18(1) 17(1) 22(1) -5(1) 1(1) -8(1)
C(17) 31(2) 30(2) 24(2) 0(1) -6() -7(1)
C(18) 21(2) 51(2) 57(2) -31(2) 14(2) -15(2)
C(19) 27(2) 28(2) 24(2) 0(1) -1(1) -9(1)
C(5) 26(2) 20(1) 28(2) -11(1) 7(1) -13(1)
C(4) 22(2) 26(2) 28(2) -11(1) 8(1) -16(1)
N(3) 15(1) 18(1) 18(1) -6(1) 3(1) -8(1)
C(21) 15(1) 17(1) 22(1) -8(1) 5(1) -10(1)
C(22) 17(1) 20(1) 17(1) -5(1) 3(1) -12(1)
C(23) 16(1) 17(1) 19(1) -2(1) -3(1) -6(1)
C(24) 18(1) 20(1) 22(1) -8(1) 4(1) -11(1)
C(25) 24(2) 22(1) 13(1) -3(1) 2(1) -13(1)
C(26) 17(1) 17(1) 21(1) -4(1) 0(1) -9(1)
C(27) 23(2) 26(2) 17(1) -3(1) 2(1) -8(1)
C(28) 24(2) 24(2) 21(2) -5(1) 3(1) -2(1)




Hydrogen coordinates ( x 104) and isotropic displacement parameters (A 2x 10 3)
x y z U(eq)
H(10) 4010(30) 8340(20) 2972(17) 22
H(32) 5821 6952 2220 28
H(33) 7372 5763 1223 35
H(34) 6799 4387 557 36
H(35) 4640 4244 873 35
H(36) 3093 5427 1867 27
H(42) 1032 6383 3091 21
H(43) 731 4577 4088 25
H(44) 2494 3066 5081 27
H(45) 4583 3331 5072 27
H(46) 4903 5105 4068 23
H(52) 1032 8796 3565 24
H(53) -1117 10685 3050 28
H(54) -1550 11392 1597 28
H(55) 159 10165 674 28
H(56) 2296 8240 1190 23
H(13) -1164 13664 2818 29
H(15) 525 11120 5043 28
H(17A) 253 13766 1599 47
H(17B) 1651 12304 1571 47
H(17C) 1782 13617 1790 47
H(18A) -2732 13598 3945 62
H(18B) -2096 13366 4847 62
H(18C) -2212 12080 4580 62
H(18D) -1961 12431 4969 62
H(18E) -2597 12663 4068 62
H(18F) -2481 13949 4334 62
H(19A) 3015 9850 5250 43
H(19B) 3996 10418 4605 43
H(19C) 3747 9122 4461 43
H(2) 3974 12916 3096 27
H(3) 6225 11786 2323 28
H(23) 9543 6418 2020 22
H(25) 7771 9165 -141 23
H(27A) 8443 6719 3343 35
H(27B) 6749 7659 3337 35
H(27C) 7783 8354 3415 35
H(28A) 11002 6628 588 40
H(28B) 10016 7242 -229 40
H(28C) 10112 5833 422 40
H(29A) 5645 11955 471 37
H(29B) 4541 11274 698 37
H(29C) 5464 11101 -156 37
148
X-ray crystal structure of NN-bismesitylimidazolylidene-trifluoroethanol complex 8f:
149
Table 12. Crystal data and structure refinement for 05015.
Identification code 05015






Unit cell dimensions a= 14.9225(5) A a= 900.
b = 18.7163(8) A 3= 900.
c = 30.8310(13) A y = 90.
Volume 8610.9(6) A3
Z 16
Density (calculated) 1.248 Mg/m3
Absorption coefficient 0.094 mm-'
F(000) 3424
Crystal size 0.20 x 0.20 x 0.20 mm3
Theta range for data collection 1.87 to 30.030.
Index ranges " 0<=h<=21, 0<=k<=26, 0<=1<=43
Reflections collected 199412
Independent reflections 12591 [R(int) = 0.0531]
Completeness to theta = 30.030 100.0 %
Absorption correction Semi-empirical from equivalents
Max. and min. transmission 0.9814 and 0.9814
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 12591 / 2 / 542
Goodness-of-fit on F2  1.050
Final R indices [I>2sigma(I)] RI = 0.0521, wR2 = 0.1278
R indices (all data) R1 = 0.0686, wR2 = 0.1424
Largest diff. peak and hole 0.634 and -0.273 e.A-3
150
Table 13. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (A2x 103)
for 05015. U(eq) is defined as one third of the trace of the orthogonalized UiJ tensor.































































































































































































































































































































































































































































































































































Symmetry transformations used to generate
equivalent atoms:
153
Table 15. Anisotropic displacement parameters (A2x 103) for 05015. The anisotropic
displacement factor exponent takes the form: -2t 2[ h2 a*2 U 11 + ... + 2 h k a* b* U 12 ]
























































































































































































































































































































































































































Table 16. Hydrogen coordinates ( x 104) and isotropic displacement parameters (A2x 10 3)
for 05015.


























































































































































































































Table 17. Torsion angles [0] for 05015.
N(1)-C(2)-C(2')-N(3') 89.52(14)
Symmetry transformations used to generate equivalent atoms:
Table 18. Hydrogen bonds for 05015 [A and °].
D-H...A d(D-H) d(H.. .A) d(D...A) <(DHA)
O(1)-H(1)...O(1') 0.916(14) 1.520(14) 2.4354(13) 176.9(18)
Symmetry transformations used to generate equivalent atoms:
156
Appendix A
Spectra for Chapter I
157
exp2 S2pul
SAMPLE DEC. & VT






at 3.200 dmf 1
np 64000 dseq
sw 10000.0 dres
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_njection Date : 8/8/2006 9:10:38 AM Seq. Line : 1
Sample Name Location : Vial 1
Acq. Operator : Inj : 1






: 8/8/2006 9:11:05 AM
(modified after loading)
: C:\HPCHEM\2\METHODS\DIAST1.M.







Page 1 of 2
Area Percent Report
;orted By : Signal
ultiplier : 1.0000
)ilution : 1.0000
Tse Multiplier & Dilution Factor with ISTDs
;ignal 1: MWD1 A, Sig=220,16 Ref=360,100
)eak RetTime Type Width Area
# [min] [min] [mAU*s
--- I ----------- I ------ I ----------
1 11.858 PB 0.6182 2585.91675








Results obtained with enhanced integrator!
'igrnal 2: MWDI B, Sig=254,16 Ref=360,100
'eak RetTime Type Width Area
# [min] [min] [mAU*s]
-I-----I----I -----I------- I
1 11.858 BB 0.6104 663.39410









Results obtained with enhanced integrator!
;igrnal 3: MWD1 C, Sig=300,8 Ref=360,100
igrial 4: MWD1 D, Sig=350,16 Ref=360,100
)ignral 5: MWD1 E, Sig=215,16 Ref=360,100
3eak RetTime Type Width Area Height Area
# [min] [mini [mAU*sl [mAU] %
- I ---- I-------- --------
1 11.858 PB 0.6178 3665.81055 90.27012 49.6775
2 22.991 PB 1.1018 3713.41357 48.90760 50.3225
Pot als : 7379.22412 139.177ý2
Results obtained with enhanced integrator!
*** End of Report ***
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Page 2 of 2
Injection Date : 8/8/2006 4:42:15 PM . Seq. Line : 1
Sample Name : Location : Vial 2
Acq. Operator : Inj : 1















Page 1 of 2
Area Percent Report
aorted By : Signal
ul tiplier : 1.0000
)ilution .: 1.0000
Ise Multiplier & Dilution Factor with ISTDs
;ignal 1: MWD1 A, Sig=220,16 Ref=360,100
>eak RetTime Type Width Area Height Area
# .[min) [min] . [mAU*s] [mAU] %.
----- --- j'.... I------------ I ----- --------
1 23.033 VV 0.9641 5360.91748 70.42066 100.0000
'otals : 5360.91748 70.42066
Results obtained with enhanced integrator!
;igcnal 2: MWD1 B, Sig=254,16 Ref=360,100
'eak RetTime Type Width Area Height Area
# [min] [min] [mAU*s] I [mAU] %
- I ------ ---- -------II----------
1 23.041 VB 0.8716 1318.07544 18.05686 100.0000
'otals : 1318.07544 1.8.05686
Results obtained with enhanced integrator!
,ignal 3: MWD1 C, Sig=300,8 Ref=360,100
;ignal 4: MWD1 D, Sig=350,16 Ref-360,100
;ignal 5: MWD1 E, Sig=215,16 Ref=360,100
'eask RetTime Type Width Area Height Area
# [min] [min] [mAU*s] [mAU] %
SI --------- I----- I -------I ------ I--------
1 23.030 VV 1.0140 7638.75244 100.13385 100.0000
'otals : 7638.75244 100..13385
Results obtained with enhanced integrator!
*** End of Report ***
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expl s2pul
SAMPLE
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Injection Date : 8/25/2006 4:36:58 PM Seq. Line.: 1
Sample Name : Location : Vial 1
Acq. Operator : Inj : 1
Inj. Volume : 1 1A,
Acq. Method : C:\HPCHEM\2\METHODS\DIAT1 .M
Last changed : 8/10/2006 9:12:26 AM
Analysis Method : C:\HPCHEM\2\METHODS\DIAST1.M







Page 1 of 2
Area Percent Report
o0rted By : Signal
4ultiplier : 1.0000
)i lution : 1.0000
Jse Multiplier & Dilution Factor with ISTDs
3ignal 1: MWD1 A, Sig=220,16 Ref=360,100
)eak RetTime Type Width Area Height Area
# [min] [min] [mAU*s] [mAU] %
I I I --------------- I-------- -------- I
1 8.168 VV 0.3799 4729.16699 186.43048 51.1452-
2 14.797 VB 0.6735 4517.38184 101.44996 48.8548
'otals : 9246.54883 287.88044
Results obtained with enhanced integrator!
;ignal 2: MWD1 B, Sig=254,16 Ref=360,100 ,
'eak..RetTime Type Width Area Height Area
S# [min] [min] [mAU*s] [mAU] %
-I----- I---- I-----I-------I--------- --------
1 . 8.169 VV 0.3825 1285.78845 50.59615 50.8871
2 14.793 VV' 0.6615 1240.95898: 27.54830 49.1129
'otals : 2526.74744 78.14444
Results obtained with enhanced integrator!
;igrnal 3: MWD1 C, Sig=300,8 Ref=360,100 .
'eak RetTime Type Width Area Height Area
# [min] [min) [mAU*s] [mAUJ. %
-------- I----I1---- I -------- I--------- I------
1 8.170 BB 0.3812 441.07721 .17.42985 52.1192
2 14.793 VB. 0.5962 405.20792 9.37651 47.8808
'otals : 846.28513 26.80636
Results obtained with enhanced integrator!
;igrnal 4: MWD1.D, Sig=350,16 Ref=360,100
ignral 5: MWD1 E, Sig=215,16 Ref=360,100.
?eak RetTime Type Width Area .Height Area
# [min] [min) [mAU*s] [mAU]
-- i--- I ---I ----- I ---------------------
1 8.168 VV .0.3797 5157.93701 203.47020 50.0545
2 14.797 VB 0.6910 5146.70264 111.82165 49.9455
Totals : 1.03046e4 315.29185
Results obtained with enhanced integrator!
*** End of Report ***
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Page 2. of 2
Injection Date : 8/25/2006 5:09:48 PM Seq. Line : 1
Sample Name . Location .: Vial 1
Acq. Operator Inj : 1
Inj Volume : 1 il
Acq. Method : C: \HPCHEM\2\METHODS\DIAST1.M
Last changed : 8/10/2006 9:12:26 AM
Analysis Method : C:\HPCHEM\2\METHODS\DIAST1.M







Page 1 of 2
Area Percent Report
;orted By Signal
u Iltiplier : 1.0000
Ji lution : .0000
ise Multiplier & Dilution Factor with ISTDs
;ignal 1: MWD1 A, Sig=220,16 Ref=360,100
'eak RetTime Type Width Area Height Area
# [min] [min] [mAU*s] [mAU] %
--I-----I ---- I --- -------I -- -----I
1 14.869 VV 0.6733 7974.86328 175.11238 100.0000
'otals : 7974.86328 175.11238
Results obtained with enhanced integrator!
;igrnal 2: MWD1 B, Sig=254,16 Ref=360,100
)eak RetTime Type Width Area Height Area
# [min] [min] [mAU*s] [mAU] %
--I------- I I I ----- I - ---- -------
1 14.870 VV 0.6657 2145.04810 47.42588 100.0000
rotals : 2145.04810 47.42588
Results obtained with enhanced integrator!
3ignxial, 3: MWD1 C, Sig=300,8 Ref=360,100
?eak RetTime Type Width Area Height Area
# [min] [min] [mAU*s ]. [mAU]... %
------ I---- I-------- ----------
1 14.871 PB 0.6027 704.74915 16.16243 100.0000
otals : 704.74915 16.16243
Results obtained with enhanced integrator!
3igrnal 4: MWD1 D, Sig=350,16 Ref=360,100
aig•nal 5: MWD1 E, Sig=215,16 Ref=360,100
Peak RetTime Type Width Area Height Area
# [min] [min] [mAU*s ] [mAU] %
- --------------- I ------- ------I-----
1 14.869 VB 0.6633 8502.20898 190.29601 100.0000
Totals : 8502.20898 190.29601
Results obtained with enhanced integrator!
*** End of Report.***
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Injection Date : 2/4/2007 2:02:53 PM Seq. Line : 1
Sample Name : Location': Vial 1
Acq. Operator Inj : 1






: 2/4/2007 2:18:18 PM
(modified after loading)
: C:\HPCHEM\2\METHODS\DIAST1.M
: 4/20/2008 10:58:06 AM
trnr~r ý f zrl = I n=A -nrr
SO2Ph









MWD1 C, Sig=300,8 Ref=360,100









I II . . I -- I I . I . I I I I I I I . I . I I I I . I . . . . . I 1 I r -I I 1 I-
Area Percent Report










Signal 1: MWD1 A, Sig=220,16 Ref=360,100
Peak RetTime Type Width
# [min] [min]
----I---------I----
1 8.273. PB 1.0746










Totals : 1-.33799e4 163.94855
Results Obtained.with enhanced integrator!
Signal 2: MWDI B, Sig=254,16 Ref=360,.10.0.
Peak RetTime Type Width Area Height Area
# [min] [min]) [mAU*s . [mAU] %
- --- I -- ------ I-----I -:-I '-------.- -------- I
1 8.271 PB 0.9890 1210.04333 :17.32205 50.9955
2 13.517 BB 1.1372 1162.79785 : 113 .31084 49.0045
Totals : 2372.84119 30.63289
Results. obtained with enhanced integrator!
Signal 3: MWD1 C, Sig=300,8 Ref=360,100
Peak RetTime Type
# [min]





Signal 4: MWD1 D,






Width Area .Height "  Area
[min] [mAU*s [mAU* ; %
I----------------- -- '--- --------
0.7330 150.77000 2.41303 49.2840














Totals : 1.864994e4, 227 .24438
•. :.. : ; .:...
Results obtained with enhanced integrator'!..
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Page 1 of 2











Use Multiplier & Dilution Factor with ISTDs.
Signal 1: MWD1 A, Sig=220,16 Ref=360,100
Peak RetTime Type Width Area Height Area.
# [min] [min] [mAU*s] ]. [mAU] %
---- I ----- I-- - I ----- ------- -I I-------
1. 13.292 BB. 1.3205 5109.18359 56.41901 100.0000
Totals : 5109.18359 5-6.41901
Results obtained with enhanced integrator!
Signal 2: MWD1 B, Sig=254,16 Ref=360,100
Peak RetTime Type Width Area . Height . Area
# [min] [min] [mAU*s ] [mAU] %
---- I ----- I---- I ----- I - - I----- I
1 13.292 BB 1.0247 884.91693 10.46322 100.0000
Totals : 884.91693. .1:046322
Results obtained with enhanced integrator!
Signal 3: MWD1 C, Sig=300,8 Ref=360,100
Signal 4: MWD1 D, Sig=350,16 Ref=360,100
Signal 5: MWD1 E, Sig=215,16 Ref=3601 100
Peak RetTime Type Width Area.- : Height Area
# [min] [min] [mAU* s ] [mAUI %
- --- -------- ---- I------------ -- ------- -
1 13.291 BB 1.3380 7069.39355 ,78.10255 100.0000
Totals : 7069.39355 78.10255
Results obtained with enhanced integrator!
*** End of Report- ***
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Injection Date : 10/8/2006 11:14:12 AM Seq. Line : 1
Sample Name : Location : Vial 1
Acq. Operator Inj : 1
Inj Volume : 1 il
Acq. Method : C:\HPCHEM\2\METHODS\DIAST1.M
Last changed : 10/5/2006 8:02:15 PM
Analysis Method : C:\HPCHEM\2\METHODS\DIAST1.M
Last changed : 4/21/2008 7:35:37 AM
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Page 1 of 2
Area Percent Report .
-- - - - - - -
Sorted By : Signal
Multiplier : 1.0000
Dilution : 1.0000
Use Multiplier & Dilution Factor with ISTDs
Signal 1: MWD1 A, Sig=220,16 Ref=360,100
Peak RetTime Type Width Area Height Area
# [min] [min] [mAU*s] [mAU] %
- ----------------------- I-------1--------------
1 7.588 BV 0.4916 245.93385 ' 6.46734 .50.4826
2 11.675 VV 0.5146 241.23187 5.64461 49.5174
Totals : 487.16573 12.11195
Results obtained with enhanced integrator!
Signal 2: MWD1 B, Sig=254,16 Ref=360,100
Peak RetTime Type Width Area Height Area
# [min] [min] [mAU*s ] . : [mAU] %
- ---I- --I ---- I----- I - - ------------------ I
1 7.589 BB 0.4437 118.53646 3.68065 47.6941
2 11.676 BV 0.4996 129.99820 3.13637 52.3059
Totals : 248.53466 6.81702
Results obtained with enhanced integrator!
Signal 3: MWD1 C, Sig=300,8 Ref=360,100
Peak RetTime Type Width Area- Height Area
# [min] [min] [mAU*s ] [mAU] %
---- I-----I ---- I -----I-------------------
1 7.589 BB 0.4477 81.09453 ;2.51831 49.1445
2 11.679 BB 0.4839 83.91788 2.09222 50.8555
Totals : 165.01241. 4.61052
Results obtained with enhanced integrator!
Signal 4: MWD1 D, Sig=350,16 Ref=360,100
Signal 5: MWD1 E, Sig=215,16 Ref=360,100
Peak RetTime Type Width Area . Height Area
# [min] [min] [mAU*s] [mAU] %
I ----- I I I ------ -. --------I
1 7.589 MM 0.5859 405.42715 11.53222 47.8422
2 11.674 MM 0.7279 441.99927 10.12015 52.1578
Totals : 847.42642 21.65237
Results obtained with enhanced integrator!
*** End of Report ***
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Seq. Line : 1
Location : Vial 1
Inj : 1
Inj Volume : 1 pl
: C:\HPCHEM\2\METHODS\DIAST1.M
: 10/5/2006 8:02:15 PM
: C:\HPCHEM\2\METHODS\DIAST1.M
: 4/21/2008 7:37:23 A'M
(modified after loading)
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Area Percent Report
Sorted By : Signal.
Multiplier : 1.0000
Dilution : 1.0000
Use Multiplier & Dilution Factor with ISTDs
Signal 1: MWD1 A, Sig=220,16 Ref=360,100
Peak RetTime Type Width Area Height Area
# [min] [min] [mAU*s] [mAU] %
---- I 1 1----- - I ------- 1 1------------I
1 11.944 VB 0.6221 1205.06702 29.16266 100.0000
Totals : 1205.06702 29.16266
Results obtained with enhanced integrator!
Signal 2: MWD1 B, Sig=254,16 Ref=360,100
Peak RetTime Type Width Area.. .Height Area
# [min] [min] [mAU*s ] [mAU] %
-------------- I•---- I ------ I ---- -------- I
1 11.947 VB 0.5942 712.70563 17.31634 100.0000
Totals : 712.70563 17,31634
Results obtained with enhanced integrator!
Signal 3: MWD1 C, Sig=300,8 Ref=360,100
Peak RetTime Type Width Area. Height Area
# [min] [min] [mAU*s] [mAU]... %
---- I--- -- I------I------ --------- I-----1 11.946 VV 0.6064 502.43103 11.95302 100.0000
Totals : 502.43103 11.95302
Results obtained with enhanced integrator!.
Signal 4: MWD1 D, Sig=350,16 Ref=360.,100
Signal 5: MWD1 E, Sig=215,16 Ref=360,100
Peak RetTime Type Width Area Height Area
# [min] [min] [mAU*s] • [mAU] %
------------- I --------- I----- --------- I-----
1 11.943 VB 0.6284 2234.56982 •53.59673 100.0000
Totals : 2234.56982 53.59673
Results obtained with enhanced integrator!
**" End of Report ***
188
Page 2 of 2
exp2 s2pu1l
SAMPLE




































































































1 ' I i 1 ----
___ __L__i_·~C·
....... 7:.








































































































































/ i 11 J






































































rkil' I77 r 7 li T`7777m777fydW3L1Milll%
II ., 1
Iflfl :~n~W1IIIWWfrUWV~WIU1U'PIIlqfIWNIUNUflMAfNIWREl
200 180 160 140 120 100 80 20 0
"Me
- , I . . .11 . . ..
.1flý ITV'Pr W IDUI~YILIUI'rmIW~YIl~rf Forry~ huUYullr1c k1"NEO·iD-fEI···UNM'MMMN N wI f I wff Inpfrw mIH La.. IL AL~i · _IIH~lmwlwxw ll ffpHrm H:
60
'"'""'"'"""'"""""'*"'"'~"'"'""";'"" '" ""'' '"'"'
"Fim "•,•, . 77,..1"m
7 - -r -r r r * - -. T- - I . ... . . . .
ppm









.JJ~b/'-.al L.(. IL = . ii,.Ltid i.'•'. :AL*I [I I ..A ai. g. III ,lA;..La,=
I















































-1 I- I~--r - 7
2800 2400 2000 1800
cm-1





























































































































I 1 I I 1 I I [ [ 1 1 I I 1 I 1 I I 1 1 I 1 I 
| ( 1 I I | 1 I I I | I I
:C
I/ tJUl · J ~J ~---------J ~-~-J \u
exp2 s2pul
SAMPLE










































































200 1 8 
0 ~~~ 1 6 4 2 0 08 02 p
40
n -~- ------------ ~------- ---------- - ·--------------------- ------- ·------- lrrrrrrrC~lr~rrrr qwI 'Y
-WWPWVIRý100 --- r - --- c -·d··RA- Utalil
-------------- ~------ *·r'wrrri·krrJL-L-------u·-· ,-c---· -- ·- .- ~--1.-,-.--
' I•' ,r :~-- _ , . .. , . . . . . . . . ..
t!.II
: 180 .160 140 120 100 80
• . i • I0







































3600 3200 2800 2400 1400 1200 1000 800 600 400.0






















Acq. time 3.200 soc
Width 100q0.0 Hz
16 repetitions
OBSERVE H1, 500.2336478 MIIr
DATA PROCESSING
FT size 131072
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Relax. delay 0.763 sac
Pulse 69.0 dlegrees
Acq. time 1.736 sec
Width 37735.8 )lz
1580 repetitions
OBSERVE C13, 125,7839031 Milt





Line broadening 1.0 Hz
FT size 131072
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Injection Date : 2/13/2007 8:5-8:29 AM Seq. Line : 1
Sample Name Location : Vial 61
Acq. Operator : Inj : 1






d : 2/10/2007'9:47:40 AM
thod : C:\HPCHEM\2\METHODS\OA.M





Page 1 of 2
..· I
Area Percent Report..
orted By Signal ..
ultiplier : i.0000
ilution : 1 000.
se Multiplier & Dilution Factor with STDs
ignal 1: MWD1 A, Sig=220,16 Ref=360,100
eak RetTime Type Width Area . Height Area
# [min] [min] [mAU*s) [mAUl . %
-------------- 1-----I ...- ------ I
1 12.521 MM 1.2608 4.3.4096e4. 573.83820 49.:5407
2 19.205 MM 1.7759 4.42145e4 414.94598 50.4593
otals : . 8.76241e4" 988.78418
Results obtained with enhanced integrator!,
igrnal.2: MWD1 B, Sig=254,16 Ref=360,100
eak RetTime Type Width Area Height. Area.
# [min] [min] [mAU*s] " [mAU]. %
--- I----------i------- i-------7 I :7-------I--- 1-
1 12.522 MM 1.2447 2.05821e4. .-275.60135 50.0302
2 19.205 MM 1.7217 2.05573e4 1.98.99901 49.9698
otals : 4.11395e4 474.60036.
Results obtained with enhanced integrator!
ignal 3: MWD1 C, Sig=300,8 Ref=360,100
eak RetTime Type Width Area. Height Area
# [min] [min] [mAU*s]. [mAU] %
--- I-----I-- .- I-----I------- I------- I-------
1 12.522 MM 1.2932 4219.13281 54.37683, 52.7221
2 19.204 MM 1.6471 3783.45142 38.28338 47.2779
otals : 8002.58423 .92.66021
Results obtained with-enhanced integrator!.'
ignal 4: MWD1 D, Sig=350,16 Ref=360,100,
:igrnal 5: MWD1 E, Sig=215,16 Ref=360,10:0
'ea.k RetTime Type Width Area Height Area
# [min] [min] :[mAU*s ] [mAU] %
S1 I ------- 1 -------- I
1 12.521 MM 1.2510 4.91013e4 654.13672 49.7080
2 19.205 MM 1.7468 4.96782e4 . 473.99106. 50.2920
?ot-als : 9.87796e4 1128.12778
Results obtained with enhanced integrator!
-----------------------------------------------------------
*** End of Report ***
203
Injection Date : 5/19/2007 6:20:19 PM Seq. Line : 1
Sample Name : Location : Vial 51
Acq. Operator : Inj : 1













Page 1 of 2
Area Percent Report
;orted By : Signal''
lultiplier : 1.0000 '
)ilution : 1. 0000
Tse Multiplier & Dilution Factor with ITSTDs
;ignal 1: MWD1 A, Sig=220,16 Ref=360,100
leak RetTime Type Width Area.
# [min] . [min) [mAU*s]
.__ I-------I---- I-----I ----- 1
1 12.637 MM 0.1826 31.50595









Results obtained with enhanced integrator!
:ignal 2: MWD1 B, Sig=254,16 Ref=360jlO0 .
'eak RetTime Type Width Area ..Height Area
# [min] [min) [mAU*s). [mAU] . %
-I-- --- I------l I ----- -
1 12.971 MM 1.2766 141.24713. :1.84410 0.4781





























Results obtained with enhanced integrat.or!
igaial 4: MWD1 D, Sig=350,16 Ref=360,100..,
3ig~nal 5: MWD1 E, Sig=215,16 Ref=3.60,100
?eak RetTime Type Width
# [min] [min]
-- I ------ I ----I ------
1 12.777 MM 0.2445
2 18.395 MM 1.6219
Area. . Height , Area
[mAU*s.] [mAU : %
I---- , -L I
51.77533 3.52983 0.5868
8772.22266. .90.14417 99.4132
Potals : 8823.99799 93.67401 -
Results obtained with enhanced .integrator!
*** End- of Report ***
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Page 2 of 2
exp2 s2pul
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Injection Date : 1/27/2007 1:39:21 PM Seq. Line : 1
Sample Name Location : Vial 59
Acq. Operator : Inj : 1
Inj Volume : 10 2i
Acq. Method : C:\HPCHEM\2\METHODS\JAMES1.M
Last changed : 1/23/2007 5:10:06 PM I -
Analysis Method : C:\HPCHEM\2\METHODS\OA.M
Last changed : 5/21/2007 1:04:56 PM
(modified after loading)
Area Percent Report
Sorted By : Signal.
Multiplier : 1.0000
Dilution : 1.0000
Use Multiplier & Dilution Factor with ISTDs
Signal 1: MWD1 A, Sig=220,16 Ref=360,100
Peak RetTime Type 'Width Area Height Area
# [min] [min] [mAU*s]. [mAU] %
----I ----- I --- ------- I --------- I ------ I
1 8.341 MM 1.1761 2.02992e4 287.65393 60.1816
2 19.288 MM 2.5754 1.34307e4 86.91595 39.8184
Totals : 3.37299e4 374.56989
Results-obtained with enhanced integrator!
Signal 2: MWD1 B, Sig=254,16 Ref=360,100
Peak RetTime Type Width Area Height Area
# [min]. [min] [mAU* s ] [mAU] %I. . ---- --- I -  I----- -------------- I-----
1 8.348 MM 1.1882 1751.81079 24.-57288 64.4876
2 19.273 MM 2.2994 964.69812>. 6.99241 35.5124
Totals : 2716.50891:'i 31.56529
Results obtained with enhanced integrator!
Signal 3: MWD1 C, Sig=300,8 Ref=360,100
Peak RetTime Type Width Area Height • Area
# [min] [min) [mAU*s] [mAU] %
I ----..--- I I----
1 8.340 MM 1.2739 504.27307 . 6.59755 64.0619
2 19.343 MM 2.5752 282.89249 1.83089 35.9381
Totals : - - 787.16556 8.42844
Results obtained with enhanced integrator!
Signal 4: MWD1 D, Sig=350,16 Ref=360,100
Signal 5: MWD1 E, Sig=215,16 Ref=360,100
Peak RetTime Type ':Width. Area Height Area
# [min] [min] [mAU*sl [mAU] %
----I-------I I -------.- I -------------------
1 8.341 MM 1.1824 2.15690e4 304.03726 59.2907
2 19.281 MM 2.6255 1.48094e4 94.00824 40.7093
Totals : 3.63784e4 398.04550
Results obtained with enhanced integrator!
*** End of Report ***
213
Injection Date : 5/23/2007 9:43:56 AM Seq. Line : 1
Sample Name : Location : Vial 51
Acq. Operator : Inj:
Inj Volume : 1 pl
Acq. Method : C:\HPCHEM\2\METHODS\JAMES1.M
Last changed : 5/22/2007 7:26:42 PM
Analysis Method : C:\HPCHEM\2\METHODS\OA.M
Last changed : 5/23/2007 10:54:19 AM
(modified after loading)
Page 1 of 3
Area Percent Report
Sorted By : Signal
Multiplier : 1.0000
Dilution . 1.0000
Use Multiplier & Dilution Factor with ISTDs
Signal 1: MWD1 A, Sig=220,16 Ref=360,100
Peak RetTime Type
# [min]
- - -- I ------- ----
1 8.320 MM
Totals
Width Area Height Area
[min] [mAU*s] [mAU] %
1------ -I----------I ---------- I--------
0.9147 8089.29248 147.40128 100.0000
8089.29248 147.40128
Results obtained with enhanced integrator!
Signal 2: MWD1 B, Sig=254,16 Ref=360,100
Peak RetTime Type Width
# [min] [min]
1 8.321 MM----- 0.9107




3118.70630 57.07457 100.00003118.70630, 57.07457 100.0000
3118.70630 57.07457
Results obtained with enhanced integrator!
Signal 3: MWD1 C, Sig=300,8 Ref=360,100
Peak RetTime Type
# [min]
---- I ------- I --- I
1 8.320 BB
Totals :
Width Area Height Area
[min] [mAU*s]. [mAU] %
---- I -------------------- I------
0.7424 671.77313 12.55270 100.0000
671.77313 12.55270
Results obtained with enhanced integrator!
Signal 4: MWD1 D, Sig=350,16 Ref=360,100
Signal 5: MWD1 E, Sig=215,16 Ref=360,100
Peak RetTime Type Width
# [min] [min]
S---- ----- I  







Results obtained with enhanced integrator!














Relax. delay 2.000 soc
Pulse 89.0 degrees
Acq. time 3.000 sec
Width 5302.2 liZ
16 repetitions
OBSERVE 111 499.7417206 MHz
DATA PROCESSING
Line broadening 1.0 liz
FT size 262144
Total time 1 min, 20 sec
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-- -T I --F -- I I 1 1 1 1 1 1 1 1 1 1 I I I I I I I I I I II I I I I 
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Relax. delay 0,763 sac
Pulse 65.4 degrees








Line broad ening 1.0 Hz
FT size 131072
Total time 1 hr, 25 mIin,
I
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Relax. delay 2.000 sec
Pulse 89.0 degrees
Acq. time 3.001 sec
Width 10504.2 Hz
13 repetitions
OBSERVE H1, 499.7417200 Hill
DATA PROCESSING
FT size 262144
Total time 1 min, 20 sec
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ppm
L7TJ LrLF-J I-r-L, L. I-F
0.99 1.01 0.98
0.94 1.04 1.00
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Relax. delay 0.763 sac
Pulse 65.4 degrees
Acq. time 1.736 sec
Width 28070.2 fHz
2048 repetitions
OBSERVE C13, 125.7832275 MlIz





Line broadening 1.0 Ilz
FT size 131072
Total time 1 hr, 25 min, 3 uoec
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Relax. delay 2.000 sac
Pulse 89.0 degrees
Acq. time 3.001 sec
Width 10504.2 IIz
16 repetitions
OBSERVE 01, 499.741/206 Mil1
DATA PROCESSING
Line broadlenlng 1.0 lIz
FT size 262144
Total time 1 min, 20 sec
If - .
~J K L UU. ~ L1
I I 1 0 ' I T I -I 1-- I I I I I i I I l I I r II I I
11 1o0 8 7 6 5 4 3 2 1 ppm

















Relax. delay 0.763 eoc
Pulse 69.0 degrees
Acq. time 1.737 sec
Width 23391.8 Hz
1656 repetitions
OBSERVE C13, 125.7832583 Milz





Line broadening 0.3 112
FT size 131072
Total time 2 hr, 51 min, 19 sec
J ! a 6 b I -1- IIt,' . d aaP s, M * , M ,
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ý I ý . I I I
exp3 s2pul
SAMPLE








































































































40 20 0 ppm
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Relax. delay 0.763 sec
Pulse 69.0 degrees
Acq. time 1.736 sec
Width 37735.8 Hz
256 repetitions
OBSERVE C13, 125.7837511 MHz





Line broadening 1.0 Hz
FT size 131072
Total time 10 min, 44 sec
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SAMPLE DEC. & VT
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(-)-Ditryptophenaline (2)
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SAMPLE DEC. & VT
date May 11 2007 dfrq 500.233
solvent CDC13 dn H1
file exp dpwr 37
ACQUISITION dof -500.0
sfrq 125.796 dm y
tn C13 dmm w
at 1.736 dmf . 10000
np 131010 dseq
sw 37735.8 dres 1.0
fb not used homo n
bs .8 PROCESSING
ss 1 lb 0.30
tpwr 53 wtfile
pw 6.9 proc ft
dl 0.763 fn 131072
tof 631.4• math f.
nt le+06
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MPLE DEC. & VT
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expl s2pul
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SAMPLE DEC. & VT
date Jun 10 2004 dfrq 125.677







tn H1 dres 1.0
at 3.277 homo n
np 65536 PROCESSING
sw 9998.8 wtfile
fb not used proc ft
bs 16 fn 65536
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exp2 s2pul
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I · · · 1 7 I I I ~I I t ppm
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IY ' J `
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4000.0 3000 2000 1500 1000 400.0
cm-1
expl s2pul
SAMPLE DEC. & VT
date Nov 29 2004 dfrq 125.677










fb not used proc
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Relax. delay 0.763 sec
Pulse 65.4 degrees
Acq. time 1.736 sec
Width 37735.8 Hz
32 repetitions
OBSERVE C13, 125.7832458 MHz





Line broadening 0.3 Hz
FT size 131072
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Relax. delay 0.763 sec
Pulse 65.4 degrees
Acq. time 1.736 sec N
Width 37735.8 Hz H
1544 repetitions
OBSERVE C13, 125.7839025 MHz CH20
DECOUPLE H1, 500.2356514 MHz
Power 37 dB 41acontinuously on
OH
H


































































































--- - · -· · I~I -) ~ 1 I -I I I -I I I 1 i I I 1 r I I -I I I I I 1
expl s2pul
SAMPLE




















































































11, .. I.1. . A ,i' .,Ii A .I.. . A . --.. .
.-6 - --. -y I f
.r.l..br. l~..~. l  .
rWix r. 1 1-Ve N
180
160 140 120 100 0 60 40T
160 140 tao 100 80 60 40
I 7 11?frPT'f"rlPi ,11, 7 17 r7 I"ýIýjhl41 F 1, 'VUr4 ý' ' Ir Wil 1 IMMR"'r '"" ""'1 ""'"'"•1 i II' =, -1. . . .· .. ..l·.. .. -.1 - . . A . . -ý . L.r. l. l .1 1 . L . .- I.- h I I .' 1. A~l
1 I-IIl~ l7 17lr yiII11I F-77I i)'
20 0 p p I
1,- - - - I , -- I I























































































































7- I I I

















































































































































.2..WYIW~~*~L~U~YYY"·Y~LJ·'Y-~ ~L"'YY'I-'~~~L·""LL' WIU··IIIP~~···-IYI()~bUbY~·kY~YhW~IUJ(Yvrw*mkrWlkJ1W;iwcm~li~e~ wikw TT-··""ww lc~~~~r ~ U-"" CMm~~y~~~~)h(()"""sr aln r n - v. . .m ~ n-~, nr1~11.
. . . . . .,.-~-~C-~ - , . . . . . . . . . . . -
I
III
200 60180 160 140 120 100 O ppm




















11 10 9 8 7 6 5 4 3 2 1 ppm






































































































































L(~a~~b~LIYLY~Y~JIIl~WIII*lb~YUJIYI~IYY~C LIW~dlWIHkll~LJm~OW uYlulu~ua~ ~IYlhY1~L~YLblliLL~*LYIIY·WYYULUYUYIYUC" ~IYYUU IP~(tk(~~(~~l(~~(lYC*Y·~LUjY~.-· luU~i~VLL~LUirr~la~lUI·IIL~LrYlLIYL~HLLHllr~rrm~l~ln*





60 40 I . 0160
' 1















































































































































-- -- ·-~--~--~-~--~-~-~-- . -·-·-1 ·--....-
" a
(p Oq



























































































































































200 1 1 140 120 100 8 60 40 2p






































SAMPLE DEC. & VT






at 3.277 dmf 1
np 65536 dseq
sw 9998.8 dres


























ins 1.000 fn 6
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SAMPLE DEC. & VT
date Nov 20 2004 dfrq 125.796
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SAMPLE DEC. & VT
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Relax. delay 0.763 sec
Pulse 65.4 degrees
Acq. time 1.736 sec
Vidth 37735.8 Hz
1520 repetitions
OBSERVE C13, 125.7832360 MHz





Line broadening 0.3 Hz
FT size 131072
Total time 63 minutes
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Injection Date :3/5/2005 6:18:41 PM Seq. Line : 1
Sample Name Location : Vial 5
Acq. Operator : Inj : 1
Inj Volume : 1 il
:hod : C:\HPCHEM\2\METHODS\DIAST1.M
inged : 3/5/2005 6:17:57 PM
; Method : C:\HPCHEM\2\METHODS\DIAST1.M










Sorted By : Signal ' :
Multiplier : 1.0000
Dilution : 1.0000
Use Multiplier & Dilution Factor with ISTDs
Signal 1: MWD1 A, Sig=220,16 Ref=360,100
Peak RetTime Type Width Area Height Area
# [min] [min] [mAU*s] [mAU] %
-- I ------- ------- --- - I-------I-------I
1 8.247 VV 0.3799 481.76340 15.52990 19.7389
2 9.945 VV 0.4650 614.19940 15.61203 25.1651
3 11.772 VV 0.5422 456.89044 9.97821 18.7198
4 14.883 VV 0.6835 887.82440 15.42557 36.3761
Totals : 2440.67764 56.54571
Results obtained with enhanced integrator!•
Signal 2: MWD1 B, Sig=254,16 Ref=360,100
Signal 3: MWD1 C, Sig=300,8 Ref=360,100
Signal 4: MWD1 D, Sig=350,16 Ref=360,100
Signal 5: MWD1 E, Sig=215,16 Ref=360,100
Peak RetTime Type Width Area. Height Area
# [min] [min] [mnAU*s] [mAU] %
-I ------- I - ----- I ---------- ---- ------ I--------I
1 8.248 VV 0.4055 477.61615 15.08105 20.2034
2 9.963 VV 0.4773 599.29999 15.02562 25.35.07
3 11.776 VV 0.5342 429.56683 9.52479 18.1709
4 14.945 MM 0.9093 .857.55713 15.71803 36.2751
Totals : 2364.04010 55.34949
Results obtained with enhanced integrator!
*** End of Report ***
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Page 2 of 2
Injection Date : 3/4/2005 4:26:54 PM Seq. Line : 1
Sample Name Location : Vial 3
Acq. Operator Inj 1






d : 3/4/2005 4:26:00 PM
thod : C:\HPCHEM\2\METHODS\DIAST1.M








Page 1 of 2
Area Percent Report


























Results obtained with enhanced integrator!
ignal 2: MWD1 B, Sig=254,16 Ref=360,100.
eak RetTime Type Width
# [min] [min]











Results obtained with enhanced integrator!
ignal 3: MWD1 C, Sig=300,8 Ref=360,100
eak RetTime Type
# [min)
___ I ------- I----
1 8.122 BB
Dtals :
Width Area Height - Area
[min] [mAU*s ] [mAU] i %
1---1-I-------I------ I -------- I0.4502 5233.93945 179.49063 100.0000
5233.93945 179.49063
ýesults obtained with enhanced integrator!
Lgnal 4: MWD1 D, Sig=350,16 Ref=360,100
Lgnal 5: MWD1 E, Sig=215,16 Ref=360,100


















Zesults obtained with enhanced integrator!
-- -~ == =  -Z -=TI -1 ----~- -------- ---
*** End of Report ***
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SAMPLE DEC. & VT
date Aug 14 2004 dfrq 125.677
solvent Benzene dn C13
file exp dpwr 34
ACQUISITION dof 1498.1
sfrq 499.758 dm nnn
tn H1 dmm w
at 3.277 dmf 10000
np 65536 dseq
sw 9998.8 dres 1.0
fb not used homo n
bs 4 DEC2
tpwr 56 dfrq2 0
pw 8.2 dn2
dl 26.000 dpwr2 1
tof 1498.1 dof2 0
nt 16 dm2 n
ct 16 dmm2 c
alock n dmf2 200
gain not used dseq2
FLAGS dres2 1.0
il n homo2 n
in n DEC3
dp y dfrq3 0
hs nn dn3
DISPLAY dpwr3 1
sp -250.1 dof3 0
wp 6246.7 dm3 n
vs 151 dmm3 c
sc 0 dmf3 200
wc 250 dseq3
hzmm 40.00 dres3 1.0
t. is 247.07 homo3 n
O rfl 4564.4 PROCESSING
00 rfp 3578.2 wtfile
th 4 proc ft
ins 18.000 fn 65536
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SAMPLE DEC. & VT
date Oct 9 2005 dfrq 125.67
solvent Benzene dn C1
file exp dpwr 3
ACQUISITION dof 1498.
sfrq 499.749 dm nn
tn H1 dmm
at 3.277 dmf 1000
n 6~Ri drsen
sw 9998.8 dres
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SAMPLE DEC. & VT
date Dec 17 2004 dfrq 125.795
solvent Benzene dn C13
file exp dpwr 37
ACQUISITION dof 0
sfrq 500.235 dm nnn
tn H1 dmm a.c
at 3.200 dmf 10000
np 64000 dseq
sw 10000.0 dres 1.0
fb not used homo n
bs 1 PROCESSING
ss 1 wtfile
tpwr 59 proc ft
pw 9.8 fn 131072
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20 0 -20 ppm
expl s2pul
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Injection Date : 5/20/2005 7:25:32 PM Seq. Line : 2
Sample Name : Location : Vial 21.
Acq. Operator : Inj : 1






: 5/19/2005 9:09:28 AM
: C:\HPCHEM\2\METHODS\AOII0691.M
: 5/20/2005 7:46:20 PM 1
(modified after loading)






Page i of 2
Area Percent Report
ported By : Signal
.ultiplier : 1.0000
Dilution : 1.0000
Jse Multiplier & Dilution Factor with ISTDs




















Cotals : 9885.35547 421.06615
Results obtained with enhanced integrator!
signal 2: MWD1 B, Sig=254,16 Ref=360,100
RetTime Type
[min]






1 4.852 VB 0.2905 784.26221








Results obtained with enhanced integrator!














Potals : 3044.39795 132.76136
Reasults obtained with enhanced integrator!
:ignral 4: MWD1 D, Sig=350,16 Ref=360,100













Results obtained with enhanced integrator!
*** End of Report ***
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Injection Date : 5/20/2005 7:04:24 PM ' Seq. Line : 1
Sample Name Location : Vial 21
Acq. Operator Inj : 1
Inj Volume : 1 pl
Acq. Method : C:\HPCHEM\2\METHODS\DIAST1.M
Last changed : 5/19/2005 9:09:28 AM
Analysis Method : C: \HPCHEM\2\METHODS\AOII0691.M
Last changed : 5/20/2005 6:48:14 PM
(modified after loading)






Page 1 of 2
Area Percent Report
o0rted By : Signal
4ultiplier : 1.0000
)ilution : 1.0000
Jse Multiplier & Dilution Factor with ISTDs
Dignal 1: MWD1 A, Sig=220,16 Ref=360,100
?eak RetTime Type Width Area Height Area
# [min] [min] [mAU*s] I[mAU] %
---- I------- ------- I I I------I
1 4.834 MM 0.4688 151.41840 5.38308. 0.6573
2 6.988 MM 0.4355 2.28856e4 875.91901 99.3427
.otals : 2.30370e4 881.30209
Results obtained with enhanced integrator!
'ignal 2: MWD1 B, Sig=254,16 Ref=360,10:0.
;ignal 3: MWD1 C, Sig=300,8 Ref=360,100
>eak RetTime Type Width Area Height Area
# [min) [min) [mAU*s] .[mAU] %I-----I----  I - ---------- I------ I------I
1 4.825 VB 0.2675 38.52739 1.95838 0.4925
2 6.988 MM 0.4501 7784.01904 288.25955 99.5075
rotals : 7822.54644 29.0.21793
Results obtained with enhanced integrator!
Yignal 4: MWD1 D, Sig=350,16 Ref=360,100
Ligrnal 5: MWD1 E, Sig=215,16 Ref=360,100
?eak RetTime Type Width Area Height. Area
# [min] [min] m [mAU*s] [mAU] %
-- I I----I------I---------I ------ I----- I
1 4.822 VV 0.3380 303.83167 12.05777 0.9527
2 .6.987 MM 0.4526 3.15865e4 1163.02954 99.0473
]otals : 3.18904e4 1175.08731
Results obtained with enhanced integrator!
*** End of Report ***
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Injection Date : 5/24/2005 2:58:35 PM Seq. Line : 1
Sample Name Location : Vial 45
Acq. Operator Inj : 1






d : 5/24/2005 2:57:31 PM
thod : C:\HPCHEM\2\METHODS\DIAST1.M















ion Factor with ISTDs
signal 1: MWD1 A, Sig=220,16 Ref=360,100
Peak RetTime Type
# [min]




Width Area Height Area
[min] [mAU*s] [mAU] %
III-------I-------I
0.1272 1.14547e4 1294.98450 42.8758
0.1774 1.52613e4 1175.71423 57.1242
2.67160e4 2470.69873
Results obtained with enhanced integrator!


















Potals : 5214.30249 521.47635
Results obtained with enhanced integrator!










Potals : 2343.94324 248.29089. .
Results obtained with enhanced integrator!
3ignral 4: MWD1 D, Sig=350,16 Ref=360,10-0
Sigraal 5: MWD1 E, Sig=215,16 Ref=360,100
Peak RetTime Type Width
# [min] [min]
-- - - I ---- I-- I-----
1 4.716 VV 0.1382
2 5.100 VV 0.1987
Totals :
Area Height . Area





Results obtained with enhanced integrator!
---------------------- i------------------------------
*** End of Report ***
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Injection Date : 5/24/2005 3:08:12 PM Seq. Line : 1
Sample Name Location : Vial 41
icq. Operator Inj : 1






5/24/2005 2:57:31 PM '
C:\HPCHEM\2\METHODS\DIA.T1.M
5/24/2005 3:41:07 PM '
334









Dilution Factor with ISTDs





















Results obtained with enhanced integrator!
Sig=254,16 Ref=360,100
3eak RetTime Type Width
# [min) [min]
- I-----I---- I-----
1 4.750 MM 0.1173
2 5.139 MM 0.1725
?otals :.





Results obtained with enhanced integrator!

















-2235.81320 218.33042 . .
Results. obtained with enhanced integrator!
igrmal 4: MWD1 D, Sig=350,16 Ref=360,100






Width Area .Height Area
[min] [mAU*s ] mAU] %
I----------I------- I---I-----
0.1253 294.81195 39.21825 1.0.968
0.2218 2.65855e4 1997.77417 98.9032
2.68803e4 2036.99242
Results obtained with enhanced integrator!
End of Report----------------------------------------
--------------------------------------------------------
*** End of Report ***
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Page 2 of 2
Potals :
3ignal 2: MWD1 B,.
Michael Anthony Schmidt
Massachusetts Institute of Technology
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Teaching assistant for undergraduate introductory organic chemistry at the Massachusetts
Institute of Technology (Dr. Kimberly Berkowski and Professor Barbra Imperiali).
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